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Diabetes Mellitus, a life threatening disease, results in more than 300 million 
deaths every year. Restoration of beta cell mass by transplantation is encouraging as this 
not only repair Type I Diabetes Mellitus but also compensate deficiency in Type II 
Diabetes Mellitus. Clinical studies showed that 10% pro-transplantation patients could be 
insulin free for 5 years and achieve a better living standard. However, shortage of islets 
donation has hampered transplantation. 
Over the last decades, advances in stem cell and regeneration therapy, producing 
insulin-producing cells that can be transplantable, benefit Replacement Therapy. Yet, 
available islet engineering methods are still immature and considerable efforts are 
required for perfection of the Therapy. Most successful protocols used for islet 
engineering mimic in vivo pancreatic organogenesis by stepwise resembling different 
stages of development. As a result, additional developmental clues would help in 
maturation of protocols. 
Vitamin A modulates most tissues development and vitamin D affects beta-cell 
insulin secretion, while both vitamin ligands act through heterodimerization with the 
retinoid X receptor (RXR). However, their mono- and combinatory-effects in modulating 
pancreatic development in human have not been well characterized. Besides, considering 
the storage and regulation of vitamin A and vitamin D by liver, it also raises interests in 
whether fetal liver stroma can induce pancreatic differentiation. 
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Considering inherent difference between human and animals, our group has 
developed isolation, characterization and culture of a population of pancreatic progenitor 
cells (PPCs) from human fetal pancreas for investigations of islet differentiation 
regulated by different morphogens and later, different microenvironments. Aims of my 
project are (1) to identify the proliferative and differentiative effects of vitamin A and 
vitamin D on PPCs; (2) to evaluate the Islet-like Cell Clusters (ICCs) induction potential 
by human fetal liver stroma microenvironment; (3) to further elucidate factors produced 
by liver stromal cells responsible for ICC differentiation. 
Isolation of pancreatic progenitor cells (PPCs) and liver stromal cells (LSCs) from 
discarded fetal tissues were regulated under Clinical Research Ethnics Committee 
(CREC-2005.461). Reverse Transcription Polymerase Chain Reactions (RT-PCR), 
Western blotting and immunocytochemistry were used to examine the expression and 
localization of vitamin D receptor (VDR), retinoic acid receptor (RAR), and Retinoid X 
Receptor (RXR) in PPC. Effects of exogenous addition of all-trans retinoic acid (atRA, a 
form of vitamin A) or/and calcitriol (activated form of vitamin D) on PPC were 
determined by quantitative estimation of cell viability, proliferation, cell death and 
neurogenin-3 (NGN3) genes transcription. On the other hands, PPC and LSC were co-
cultured under modified medium. Resulted PPC growth and PPC derived Islet-like Cell 
Cluster (ICC) differentiation and functions were determined using quantitative estimation 
of cell viability, multiple genes transcription and insulin production. Furthermore, by 
making use of the differential characteristics between 1st and 2nd trimester fetal liver 
derived LSC, candidates responsible were under investigations. 
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Results showed that RAR and RXR were localized in nuclei while VDR were 
expressed in nuclei, cytoplasm and plasma membrane of PPCs. atRA and calcitriol each 
increased PPC viability and proliferation; atRA additionally decreased PPC apoptosis. 
Co-addition of atRA and calcitriol had no additive effects on cell viability but increased 
NGN3 mRNA expression. In addition, trimester liver derived LSC co-culture 
enhanced PPC growth, ICC differentiation and functions without exogenous addition of 
growth factors. Plenty of growth factors' genes were expressed in LSC and insulin-like 
Growth Factor 1 (IGFl), a controversial morphogen involved in regeneration but not 
development, were found contributing for the improvement. 
In conclusion, RAR, RXR and VDR were expressed in PPCs and PPC 
proliferation was promoted by calcitriol or atRA and co-treatment enhances NGN3 
expression in PPC. On the other hands, LSC microenvironment induced PPC growth and 
ICC differentiation and possible factors contributing to improvement was Insulin-like 
growth factor-1 (IGFl). Data were valuable for elucidating mechanisms underlying islet 
development and further modifications of stroma microenvironment would be an 
alternative more effective, economic and efficient way for islets differentiation, where 
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Chapter 1 General Introduction 
1.1 The Pancreas 
Pancreas is an elongated compound gland and composed of exocrine and 
endocrine portions, which are responsible for digestion and absorption of nutrients as 
well as maintaining glucose homeostasis in our body. 
1.1.1 Anatomy of Pancreas 
Pancreas lies retroperitoneally and transversely across posterior abdominal wall 
while being posterior to the stomach between the duodenum on the right and the 
spleen on the left. Structurally, it consists of four parts, i.e. head, neck, body and tail. 
The head of pancreas, which is an expanded part of pancreas, lies within the 
concavity of the duodenum. The ucinate process emerges from the inferior part of the 
head, and lies deep to superior mesenteric vessels. Exchange of oxygen, nutrients and 
wastes were conducted by the superior pancreaticoduodenal artery from 
gastroduodenal artery and the inferior pancreaticoduodenal artery from superior 
mesenteric artery. 
The neck is short and constricted part which connects between the head and the 
body, overlying superior mesenteric vessels. Blood supply is from pancreatic 
branches of splenic artery. The body lies behind the stomach and left of the superior 
mesenteric artery, where blood is supplied from pancreatic branches of splenic artery. 
2 
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On the other hand, the tail is closely related to spleen and passes between layers of the 
aplenorienal ligament with the splenic vessels. The pancreatic branches of splenic 
artery also supply blood to the tail of the pancreas (Keith LM and Anne MRA, 2007). 
Figure 1.1 schematically summarizes the anatomy and structure of the pancreas. 
Copyright © The McGraw-Hill Companies. Inc. Permission required for reproduction or display. 
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Figure 1.1 The anatomy and structure of the pancreas. 
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1.1.2 The Exocrine Pancreas 
The exocrine pancreas has ducts that are arranged in clusters called acinus (Figure 
1.2). Pancreatic juice, including alkaline-rich sodium bicarbonate and digestive 
enzymes, is secreted into the lumen of the acinus, and released into the intralobular 
ducts; its secretions are drained to the main pancreatic duct, starting from the tail of 
the pancreas and running into the head and finally merged with the bile duct to form 
hepatopancreatic ampulla, opens at summit of the major duodenal papilla into the 




/ to the 
basement pancreatic duct 
membrane 
Copyright ©1999 The McGraw-Hill Companies. All rights reserved. 
Fi gure 1.2 Structure of exocrine portions of pancreas. 
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1.1.3 The Endocrine Pancreas 
The endocrine pancreas is made up by 1 million of individual pancreatic islets 
which are called Islet of Langerhans, distributed throughout the whole pancreas. They 
are generally oval or clover leaf shape. They consist of 1-2% mass of the pancreas 
with each size being around � 5 0 to 500 mm in diameter. The major function of 
pancreatic islets is responsible for the regulation of glucose homoeostasis by means of 
releasing a number of peptide hormones in response to absorption of nutrients, via 
neural and hormones as well as autocrine and paracrine mechanisms (Kulkarni et al., 
2004). 
1.1.3.1 Structure of Islets 
In rodents, adult islets are composed of a central core of /5 -cells 
(insulin-secreting), surrounded by a mantle of a-cells (glucagons-secreting), 5-cells 
(somatostatin-secreting), and PP-cells (pancreatic polypeptide-secreting), while 
8-cells disappear after birth (Figure 1.3). The islets are innervated by nerves and in 
intimate contact with blood vessels, thus controlling insulin secretion by nerve signals 
and close monitoring of serum glucose levels, respectively. It is estimated that there 
are 2000 - 4000 /3 -cells, making up of 70 — 80% islets; while there are about 5% 
6-cells and 15 — 20% a-cells or PP-cells. In human, there is, however, no such 
s 
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architecture when compared with rodents; instead, more complex and with several 
mantle core subunits are observed and precise data on patterning are still under 
determination. The architecture between humans and rodents as described above 
might provide evidence for the inherent difference during their development of the 
pancreas (Kulkami et al” 2004). 
Replication rate and turnover rate of fi -cells in adult are formed either by slow 
replication of existing /3 -cells or by differentiation of stem cells located in ductal 
regions. Half-life of islets is approximately 47 days in rodents while it remains to be 
unknown in human (Magami et al., 2002). 
Delta cell Alpha cell 
_ 
Capillaries： 
Copyright © http://www.elp.manchester.ac.uk/叫b proiects/2000/mnbv7lc2/pancreas-htm All rights reserved. 
Figure 1.3 Structure of islets of Langerhans of mouse, showing a � B - a n d Y-cells. 
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1.1.3.2 Functions of a-, P-, y-, 5-, s- and PP-cells in Islets 
In adult human, a-, p-, 8-, s-and PP-cells are identified in Islet of Langerhans. 
They produce glucagons, insulin, somatostatin, ghrelin and pancreatic polypeptide, 
respectively, via mediation of hormonal, autocrine and/or paracrine regulation. Within 
these 4 cell types, /3 -cells are the major type of cells which is responsible for insulin 
secretion so as to maintain glucose homeostasis. 
(3 -cell synthesizes and secretes insulin primarily in response to glucose stimulus 
but also other stimuli, such as nutrients, hormones and nervous signals. Glucose 
stimulates biphasic insulin secretion which is involved in several pathways, say KATP 
channel dependent and K A T P channel independent pathway. The response begins 
after glucose-sensing 1 — 2 mins and peaks at 3 — 4 mins followed by a decline rapidly 
at 8 mins. Initial spikes of insulin release refer to the wave and second wave 
increases gradually and plateau at 25 - 30 mins. 
(a) K A T P channel dependent pathway (first wave) 
Glucose can induce the closure of KATP channel and depolarize the /5 -cell to 
result in an increase in Ca^^ entry to the cell via voltage-dependent Ca^^ channel. This, 
in turn, increases cellular concentration of Ca^^ and triggered a small pool of insulin 
granules release (Figure 1.4). 
(b) K A T P channel independent pathway (second wave) 
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i) The first hypothesis is that glucose induces an increased production of 
glutamine in mitochondria and is exported to cytosol. Glutamine permeabilizes 
13 -cells and increases secretion, thus leading to a larger pool release of insulin 
granules. 
ii) The second hypothesis is that glucose induces an increased ratio of ATP/ADP 
and GDP/GTP ratio, thus leading to activation of K A T P channel and triggering a larger 
pool release of insulin granules. 
iii) The third hypothesis is that glucose stimulates an increase in mitochondria 
citrate level which later release to cytosol. This in turn increases malony-CoA which 
inhibits carnitine palmitoyl trnasferase 1 (CPTl). This results in decrease of fatty acid 
production and permeabilizes /3 -cells and increases 
secretion which leads to a 
larger pool release of insulin granules. (Straub et aL, 2002; Bratanova-Tochkova et al., 
2002) 
8 
Chapter 1 General Introduction 
Voitage dependent 
Ca'' channel 。^二‘ 
ATP-sensitive ^ \ / 
K* channel \ \ \ c , , r Qepciari/attan / 丨 
彰 ！ ： / 
Ca • CAMP 凑 
A I P / A O P ^ ^ ^ 
‘ i 丄 
‘ lelot 
Pyruvate • •， a 
, f transcripllQB 
Glucose-6-phosphate f^Mpro , 
，Glucokinase . 
Glucose / 




SO�JK‘.： F .•4U«:I AS, [X., ftt.t Jii..-.i;d r. S：.. .ort^ O D L. j .ifni^ -^ or. >L. LO-:C-»L"0 '： 
”'•/"_,•?<?々 ？ f.'urfc'p'cs '>f .-fc^ Vor e. 1 7th edition: nttp // j ccc； ir -.odicno. corr 
Copyfiqht % The McGrjvHill Co-npcmicr, Inc.，VI r.qhtJ： foicfvcd 
Figure 1.4 Glucose stimulates insulin secretion ( K ^ channel dependent pathway). 
1.1.4 Overview of Pancreas Development 
Our understandings in human pancreatic development are derived from animal 
studies (Tiso et al.，2009; Pearl et al., 2009), human embryonic cells differentiation 
(D丨Amour et al., 2006; Segev et al., 2004), clinical cases on heterogeneous 
loss-of-function, and histological analysis of discarded tissues from aborted fetus (Du 
et al., 2011; Ozcan et al.，2009). It is believed that most of the transcriptional factors 9 
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in human pancreatic development are similar to those in mouse (Smith et al., 2010; 
Du et al., 2011). 
Pancreas growth and development occur in a stepwise process based on 
observation of organ morphology (Jorgensen et al, 2007), cyto-differentiation (Jensen 
et al., 2004) and change in expression of transcription factors (Sander et al., 1997). 
The development is shown below in Table 1.1 and 1.2. 
1.1.4.1 Organ Morphology 
Endocrine islets, exocrine acini and pancreatic ducts are all derived from the 
endodermal epithelium through a series of inductive interactions with surrounding 
tissues. 
The mouse pancreas is formed by the fusion of a dorsal and ventral epithelial buds 
generated by evagination of foregut endoderm (Spagnoli et al., 2007). Dorsal part 
forms splenic portion (tail and body) and ventral part forms the duodenal portion 
(head) of pancreas. Control of evagination is by the factors released in 6-10 somites 
(Edlund et al., 2002). An evagination of the foregut endoderm starts at approximately 
embryonic day (E)8.5 which marks the start of pancreas development. At this stage, it 
is initially under the influence of notochord (Herrera et al., 1991). The ventral and 
dorsal buds appears in (E)9.5 and after fusion of dorsal aorta, factors release from 
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epithelium of dorsal aorta affects its specification and differentiation. At (E)12.5, 
ventral pancreas and dorsal pancreas fuse and form a intact pancreas. Similar to 
mouse pancreas development (Kaestner et al., 2003) (Figure 1.6), figure 1.5 
summarizes human pancreas development. 
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Figure 1.5 Organ morphology in Pancreas Development in Human. 
(A) At 30 days, the ventral and dorsal pancreatic buds appear. (B) By 35 days, ventral 
pancreas begins migrating posteriorly and (C) fuses with the dorsal pancreatic bud 
during the sixth week of development. (D) In most individuals, the dorsal pancreatic 
bud loses its duct into the duodenum; however, in about 10% of the population, the 
dual duct system persists. 
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1.1.4.2 Cyto-differentiation 
Table 1.1 Important observations in mouse pancreas development. 
(E)8.5 Pancreatic specification 
(E)9.5 Ventral and dorsal pancreas bud appeared 
(E)8.5-(E)12.5 ist transition 
(E)9.5 Glucagon and insulin co-positive cells 
(E)12.5 Dorsal and ventral bud fusion 
( E ) 1 2 . 5 - ( E ) 1 6 . 5 2ND TRANSITION 
(E) 12 • 5 Neural crest cells 
(E) 13 Single hormone expression cells 
(E)16.5 - birth transition 
(E)18 Emergence of all 4 major endocrine cells in vascularized and 
innervated islets 
(Murtaugh LC，2003) 
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Figure 1.6 Schematic diagram of pancreatic development in the mouse. 
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Table 1.2 Important observations in human pancreas development. 
(Desdicioglu et al., 2010) 
4-5 weeks Evagination of human foregut to form ventral and dorsal pancreas 
6-7 weeks Fusions of ventral and dorsal pancreas 
9-11 weeks Mesenchymal tissues infiltrated by ductal epithelial structures 
Small clusters of insulin or glucagons positive cells scattered along or 
residing inside the ductal epithelium 
9-19 weeks PDXl positive cells 
8 weeks Glucagon positive cells 
9 weeks Insulin positive cells 
(1 - 2% cells co-expressed both insulin and glucagons but negative 
for Ki67) 
9 weeks CK19 positive cells 
11 weeks Ghrelin and pancreatic polypeptide positive cells (e and pp markers) 
11 weeks CEL positive cells (Pro-acinar markers) 
>19 weeks PDXl positive only in insulin cells 
9-23 weeks Ki67 positive cells 
23 weeks Vascularized and Glu-2 positive islets 
-Irresponsive to glucose in vitro 
23 weeks Amylase positive cells 
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1,1.4.3 Control by Transcriptional Factors 
Table 1.3 Temporal expression of transcription markers for mice. 





(E)9 ISL-1, PAX6 
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Figure 1.7 A simplified hierarchy of transcription factor expression in the developing 
pancreas. 
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(a) LIM homeobox transcription factor (ISL-1) 
ISL-1 plays a promoting role in pancreatic development (Elshatory et al., 2007). It 
is both an extrinsic factor and intrinsic factor. It can either produced by dorsal 
mesenchyme or expressed in pancreatic progenitor cells. It is expressed at (E)9.0 in 
the dorsal pancreatic epithelial cells to regulate PDXl expression. The expression in 
dorsal mesenchyme is required for maintenance and indirect differentiation for 
exocrine pancreas while intrinsic expression is necessary for endocrine pancreas 
differentiation. 
(b) Pancreatic and duodenal growth factor 1 (PDXl) 
PDXl is a master transcription factor that appears in the earliest stage and marks 
specifically for pancreatic lineage. The expression of PDXl starts in progenitor cells 
(ventral pancreas at (E)8.5 and (E)9 at dorsal pancreas) at the definite endoderm, 
which was triggered by Hnf6, Hb9 and Isll in the dorsal bud and Hexl in the ventral 
bud. Maintenance of the expression is done by the constitutive signals, FGFs, Notch 
and Wnt/b-catenin. It continues its expression until maturation in /5 -cells but not 
exocrine lineages and other endocrine cells. Null PDXl embryo shows an absence of 
pancreas. In human, heterozygous mutations in PDXl is highly susceptible to the 
onset of type 2 diabetes mellitus and complete loss-of-function leads to pancreatic 
aplasia. 
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Initial expression helps to determine the final pancreas size as it controls the 
proper proliferation and commitment of pancreatic progenitor cells. It also involves in 
the early commitment of exocrine lineage as it triggers expression of Ptfla. 
PDXl expression elevates in the late gestation during islets formation and a 
threshold increase is necessary for the activation of differentiation. PDXl control 
expression of NGN3, Arx and other transcription factors to determine the 
specification and ratio of a-, p-, 5-, e-and PP-cells. 
The PDXl, accompanied with NEUROD and MafA, is one of the activators of 
insulin expression by binding to the insulin promoter. It is also a necessary 
transcriptional regulation for glucokinase and glut-2 (Fujimoto et aL, 2009). 
(c) Pancreas specific transcription factor la (Ptfla, p48) 
Accompanied with PDXl, it can convert pancreatic endoderm to pancreatic 
precursors in Xenopus and Zebrafish embryo. It is later, only specifically expressed in 
pancreatic exocrine portions (Jiang et aL, 2008). 
(d) Neurogenin3 (NGN3) 
Neurogenin3 is the master regulator of endocrine specification in pancreatic islet 
differentiation and regeneration. NGN3 belongs to a family of basic helix-loop-helix 
transcription factors. NGN3 expression is first found expressing at (E)9.5 and peak at 
(E) 15.5 and disappeared in adult pancreas, except during regeneration. The NGN3 
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expression is correlated with the and wave where endocrine cells started being 
detected. 
In NGN3 knockout mice, no endocrine cells are found and over-expression of 
NGN3 results in early maturation of endocrine cells. Although the mechanisms by 
which NGN3 is involved in endocrine specification remain unknown, its downstream 
signal molecules have been identified; they include, but name a few, PAX4, ARX, 
NEUROD, NKX2.2, NKX6.1 and NGN3 itself (Rukstalis et al., 2009). 
(e) NKX transcription factors 2.2 
NKX2.2 starts expression in pancreatic bud and contributes to NGN3 expression. 
Yet, it is responsible for the regulation of jS -cell development which is in parallel 
with the expression of Pax4 because Null NKX2.2 embryo shows absent of /3 -cells 
only but not others. NKX2.2 binds to MafA promoter to promote expression of MafA, 
a regulator for insulin expression. NKX2.2 also exerts functions via its downstream 
transcription factor NKX6.1 in regulation of insulin expression (Sander et al., 2000). 
(f) BETA2/neuronal determination factor 
NEUROD, accompanied with PDXl and MafA, is a potent transcription activator 
of insulin by binding to insulin promoter. It is believed to be downstream target of 
NGN3 (Naya et al., 1997). 
(g) Others (Pax4, Arx, Pax6, MafA, MafB) 
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Pax4 is responsible for the suppression of glucagons, ghrelin and Arx and is 
expressed in pluripotent endocrine progenitors. Arx expression promotes a-cells 
development and Null Arx embryo show no expression of a-cells. Pax6 is a paired 
homeodomain transcription factor, which is expressed at (E)9.5 to (E)10.5 and in 
endocrine progenitor cells. It is essential for the expansion of endocrine lineage and 
development of a-cells. MafA is a marker of mature /5 -cells and accompanied with 
NEUROD and PDXl to promote insulin expression. MafB is essential for the 
differentiation of a-and /5 -cells in the second waves. Mutant embryo shows a 
decrease of 50% a and jS -cells. MafB exerts its effect by binding to insulin, 
glucagons and MafA promoters. (Bonal et al., 2008) 
1.1.5 Postnatal Pancreas Development and Regeneration 
In order to maintain glucose homeostasis, it is critical to maintain sufficient 
insulin production. A constant turnover of jS -cells is required to compensate for the 
loss of /3 -cells and increased insulin demand during growth. Postnatal capacity for 
13 -cells renewal appears to diminish rapidly in the mouse (Bonner-Weir S, 2000). At 
neonatal period, /3 -cells are compensatory at a rate of roughly 18% of the total 
number of /3 -cells per day and followed by a severe reduction in growth rate by 2-3% 
per day (Kemp et al., 2003). This is observed in the neonatal regeneration model 
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Starting with different Streptozotocin (STZ) injection day. Butler and co-workers 
concluded that there are residual /5 -cells after 1 year of the onset of autoimmunity in 
TIDM patients (Butler et al., 2007). This suggested that even in human, there may be 
regeneration exists. 
Tissues regeneration can be attained by proliferation of pre-existing cells (Dor et 
al., 2004) and neogenesis (Bouwens, 1998; Wang et al , 1995) (Figure 1.8). Although 
pancreatic /5 -cells were thought to be unable to significantly increase in mass in the 
past, clinical evidence on the pancreatic hyperplasia in obesity and pregnancy has 
recently overthrown this idea (Bernard-Kargar and Ktorza, 2001). /S -cells can be 
compensated with an increase in the demand of insulin. 
1.1.5.1 Proliferation of Pre-existing ^ -cells 
Proliferation of (3 -cells has been demonstrated in the rodent pancreas using BrdU 
labeling (Teta et al., 2005). Several studies have shown that proliferative ability is 
decreased with increasing age (Teta et al., 2005; Chen et al., 2009; Perl et al., 2010). 
Under special conditions, say hyperglycemia, pregnancy and obesity, replication rate 
of /5 -cells increases significantly (Bernard-Kargar and Ktorza A, 2001). 
However, studies of adult human pancreas can only be done by using 
immunocytochemistry in cadaveric or diseased tissues. In human fetal pancreas, Ki67 
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staining can be detected significantly within 9-23 weeks (Sarkar et al, 2008). In 
human adult pancreas, most of the islets showed negative for Ki67 staining; in tissues 
from patients with T2DM, Ki67 staining has not shown a significant increase in 
amount (Hao et al, 2006), suggesting that replication does not seem to be the major 
source of regeneration in adult human. 
1.1.5.2 Neogenesis from Precursor Cells 
Bonner-Weir and colleagues have shown that, in mouse pancreas, new ^ -cells 
can be regenerated by ductal precursors using lineage tracing approach (Laybutt et al., 
2002) despite that some studies exhibit a negative role in neogenesis (Dor et al., 2004). 
This discrepancy may be due to the difference in the use of model. In human pancreas, 
nesidioblastosis/islet neogenesis was observed in clinical diagnosis of chronic 
pancreatitis (Phillips et al., 2007) or asymptomatic pancreatic fibrosis (Woo et al., 
1976). In patients with recurrence of autoimmunity, insulin-positive cells were 
detected in the ductal region of the pancreas (Martin-Pagola et al., 2008). In chronic 
pancreatitis, a-cells increase significantly by the neogenesis of ductal precursors 
(Butler et al , 2003). 
1.1.5.3 Transdifferentiation of other cells 
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Trandifferentiation was found important in producing insulin positive cells in 
adult mouse. In human, presence of insulin-glucagon positive cells during 
development and in pancreatitis is reported (Desdicioglu et aL, 2011; Gao et aL, 2005). 
This suggested a possibility of trandifferentiation of a-cells into yS -cells. And in 
chronic pancreatitis, ductal origin differentiation of a-cells provides large pool of cells 
capable in differentiating to ff -cells (Gao et al., 2005). 
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Figure 1.8 Possible mechanisms of B -cell regeneration. 
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1.2 Diabetes Mellitus 
Endocrine portion of pancreas is involved only a small part of the pancreas; 
however, its function is indispensable for our human body. It is responsible for 
glycemic control in our bodies by producing several regulatory hormones, such as 
insulin. Hypofunction or hyperfunction of the endocrine pancreas has an adverse 
impact on our glucose homeostasis, which, in turn, affects such glucose sensitive 
organs as the brain and subsequently on all parts of the body (Henderson et al., 1981; 
Schulingkamp et al., 2000). There are several types of pancreatic disorders, including 
insulinoma (Athanasopoulos et al., 2011), somatostatinoma (Deschamps et al., 2010) 
and pancreatitis (Braganza et al., 2011). Among them, Diabetes Mellitus is the most 
common in term of mortality and morbidity (Sesti, 2002). 
According to WHO, "Diabetes is a chronic disease that occurs when the pancreas 
is not able to produce sufficient insulin, or when the body does not effectively utilize 
the insulin that is produced by the pancreas. Hyperglycemia, or high concentration of 
blood glucose, is a common complication in patients with uncontrolled diabetes and 
over time it leads to serious damage to many of the body's organ systems, especially 
the nerves and blood vessels." Every year, it causes about 5% of deaths globally and 
are likely to increase by more than 50% in the next 10 years if there is no urgent 
actions in preventing the widespread. Besides, Diabetes and its complications cause a 
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significant economic burden on individuals, families, health systems and countries 
worldwide. WHO estimates that China will lose $558 billion in foregone national 
income in the period 2006-2015 (Data from WHO, 2009). 
Under normal circumstances, human plasma glucose level would be around 
3.8-6.7mM, however, in the diabetes condition, it rises to l l . lmM. (Data from WHO, 
2011) Prolong high glucose concentration, named hyperglycemia, would cause 
various complications, say retinopathy (Oluleye et al., 2010), cardiovascular disease 
(Lefrandt et al., 2010) and diabetic feet (Powlson et al., 2010). Diabetes Mellitus can 
be divided into Type I Diabetes Mellitus (TIDM), Type II Diabetes mellitus (T2DM), 
gestational diabetes and secondary diabetes. (Hober et al., 2010; Athyros et al., 2010; 
Syed et al.,2011) 
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Figure 1.9 Classification of Diabetes Mellitus. 
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1.2.1 Pathophysiology of Diabetes Mellitus and Current Treatments 
1.2.1.1 Type I Diabetes Mellitus 
TIDM, characterized by total or near total deficient in ^ -cell and insulin 
production, is not the most common type of diabetes in adults but it's a frequent 
affecting youth due to its early onset of diabetes. Clinical studies found that it may be 
an inherent disease from the male family member and susceptible genes may locate at 
the HLA class II locus on chromosome 6 (Cheung et al., 2011; Friday et aL, 1999). 
Yet, causes for the onset of autoimmune are still under investigations. The destruction 
of /5 -cells may due to humoral or cellular autoimmunity (Ludvigsson J, 2009). In the 
pass, lack of major immunological markers in /5 -cell has provided evidence on T-cell 
mediated autoimmune attack. Yet, this may not be true now as auto-antibodies against 
13 -cell specific antigens are found in more than 90% patients and this supported the 
hypothesis on humoral autoimmune (William et al., 2002; Schranz et al., 1998). 
Theoretically, TIDM cannot be prevented. However, more therapies and dietary 
habits have proposed to slow down or delay the onset of TIDM. Cyclosporine, 
azathioprine and nicotinamide could be used alone or in combination to protect 
against the immune attack (Palmer, 1996). Insulin therapy is most traditional and 
effective ways in treating TIDM. Yet, due to its non-physiological nature, precise 
control is needed to prevent occurrence of complications (Kansagara et al., 2011). 
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Replacement therapy, such as pancreas transplantation, islets transplantation (de Kort 
et al., 2011) and kidney-pancreas transplantation (Becker et al., 2002) accompany 
with long term introduction of immunosuppressive drugs are useful therapies for 
improving glucose control without insulin supplement. There are patients with 
transplantation, lives a normal live for more than 5 years (de Kort et al., 2011). Yet, 
lack of organs donations has hampered treatment. 
Recent advance in stem cell therapy provide islets engineering (D'Amour, 2006) 
and bone marrow derived mesenchymal stem cell immunomodulatory (Delis et al., 
2006), which can provide more physiological and permanent cure to diabetes. Yet, 
before clinical applications, considerable efforts are still required. 
1.2.1.2 Type II Diabetes Mellitus 
Type II Diabetes Mellitus, previously termed non-insulin-dependent diabetes 
mellitus (NIDDM) or adult-onset diabetes, is the most common form of diabetes, 
accounting for more than 90% cases. It is characterized by progressive loss of insulin 
secretion, reduced jS -cell mass and insulin resistance in peripheral tissues, say livers, 
muscles and adipocytes. Classic symptoms, such as polyuria, glucoseuria, polydipsia, 
polyphagia, fatigue, and weight loss are resulted. Similar to TIDM, complications, 
say retinopathy, neuropathy and diabetes feet, etc. could be resulted. (Data from 
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WHO) Onset of T2DM mostly occurs in middle age or later stage of life and usually 
initiates by combination of genetic and environmental factors. Obesity, lack of 
exercise and over-consumption of alcohol could be the environmental factors. Clinical 
research on genes relating includes TCF7L2, PPARy, FTO, KCNJll, N0TCH2, 
WFSl, CDKALl, IGF2BP2, SLC30A8, JAZFl, and HHEX, etc. (Eriksson et al., 
2001;Krupanidhi et al., 2009; Ahlqvist et al., 2011) 
The initial response of ^ -cell to T2DM is to increase its mass in order to 
compensate insufficient of insulin (Okamoto et al., 2006). However, higher insulin 
secretion results in further insensitize peripheral responsive tissues which result in 
higher demand of insulin. Elevated glucose level resulted from irresponsive of 
peripheral tissues impaired /5 -cells functions by glucotoxicity, lipotoxicity and 
/5 -cell exhaustion, etc. (Takeshi et al., 2010) The temporal increase in /3 -cell mass 
starts to decrease and insulin resistance also increases (Okamoto et al., 2006; Takeshi 
et al., 2010). Apart from jS -cell, dysfunction of a-cell is also involved in T2DM. Due 
to inability to regulate blood glucose, elevated level affects glucagons secretion, 
which results in malfunction of a-cells (Ehses et al., 2009). 
Although it is a more complex situation comparing to TIDM, early stages can be 
reversed by dietary regiments and plenty of exercises (Gulve, 2008). In later stage, 
insulin replacement is required for /5 -cell exhaustion and insulin resistance. First line 
26 
Chapter 1 General Introduction 
medical treatment for T2DM is Metformin while in later stage sulfonylureas, 
nonsulfonylurea secretagogues, a-glucosidase inhibitors and thiazolidinediones are 
introduced (Cheng et al , 2005). In serious case, surgical method, gastric bypass are 
currently considered as an elective procedure. However, due to relative high failure 
rate of surgery and side effects, it is not recommended (Schauer et al., 2003). 
1.2.1.3 Gestational Diabetes 
Gestational Diabetes occurs in pregnant women who have never been diagnosed 
for any type of diabetes ahead. Pregnant women experience in high blood glucose due 
to insufficient insulin production and insulin resistance (Reece et al , 1998). In U.S., 
approximately 4% of pregnant women are diagnosed for gestational diabetes. (Data 
from WHO) Only few symptoms are observed, thus, it is diagnosed only during 
pregnancy screening. Women with family history of T2DM, high maternal age and 
obesity need to take good care about it (Reece et al., 1998; Ben-Haroush et al, 2004). 
Usually, gestational diabetes only diagnosed during pregnancy and after 
pregnancy, blood glucose will return to normal level. However, to mother, rate of 
recurrence of diabetes during life time increases and to babies, "big head" babies, 
hypoglycemia and jaundice may result. Various risk factors are found related to 
gestational diabetes, say weight gain, obesity and higher blood pressure, etc 
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(Garcia-Patterson et al., 1998). Administration of exogenous insulin, plenty of 
exercises and dietary regimens focus on lowering blood glucose are mostly applied 
therapies to prevent mother and fetus suffering from complications. 
1.2.1.4 Secondary Diabetes 
Secondary Diabetes, a rare case of diabetes, occupies only 1% of diabetes and 
initiates by other illnesses, such as pancreatitis, Gushing's syndrome and autoimmune 
diseases, or medications, say glucocorticoids, antiretrovirals and opiates (Choudhuri 
et al., 2009; Catargi et al., 2003; Resmini et al., 2009). It is a temporarily increase in 
plasma blood glucose. Besides, secondary diabetes also includes cases, for example, 
maturity-onset diabetes of the young (MODY) (Fajans et al., 1994), latent 
autoimmune diabetes of the young (LADA) (Zachariah et al., 2008) and Wolfram 
syndrome (Barrett et al., 1995), etc., that cannot be classified as TIDM, T2DM or 
gestational diabetes. Treatments would be focused on the causes, say stop medication 
if it is triggered by certain drugs. 
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1.3 Stem Cell therapy 
Recent stem cell therapy for Diabetes focused in several aspects, including islet 
engineering, immune modulation and regeneration in vivo. Islet engineering, using 
embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) or mesenchymal 
stem cells (MSCs), provided unlimited sources of islets ready for transplantation in 
order to compensate insufficient islets demand. Secondly, post-transplantation 
immuno-rej ections of grafts could be solved by transplanting low-immunogenicity 
iPSC/ESC induced islets, immuno-modulating MSCs and cells fusions by bone 
marrow derived MSCs. Finally, localization and repairment after transplantation 
could be attained by development of vascular and nervous system by undifferentiated 
stem cells, in vivo transdifferentiation of adult cells into insulin producing cells and 
investigation in transplantation sites. 
1.3.1 Stem Cell 
Stem cell, or unspecialized cell, is characterized by its renewal power and ability 
to differentiate into all different tissues or organs under certain physiologic or 
experimental conditions while progenitor cell (precursor cell), or specialized cell, is 
characterized by its limited renewable capacity and limited potential to differentiate to 
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certain lineages. It can be classified based on its degree of potency, i.e. totiopotency, 
pluripotency, multipotency, oligopotency, and unipotency (Nancy, 2005). 
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Figure 1.10 Stem cells classified based on the degree of potency. 
Totipotent and pluripotent stem cells are the cells that have not begun/barely 
started differentiating and be capable of developing into any other type of body cell 
while their difference lies in the ability in differentiating cells in placenta say 
cytotrophoblast layer or syncytiotrophoblast. Multipotency defined by its limited 
power in differentiating to multiple but not all cell types. Oligopotency is the ability 
of progenitor cells to differentiate into a few cell types in a given family. Examples of 
oligopotent stem cells are the hematopoietic stem cells. They can become any of the 
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many types of blood cell, say red blood cells, white blood cells and platelets, etc., but 
not islets nor neurons. Unipotent stem cells can only differentiating to single lineage 
but are considered as stem cells because of their unlimited proliferation ability. For 
example, skin cells can renew themselves indefinitely but cannot become any other 
type of cells (Nancy, 2005). 
1.3.1.1 Mesenchymal Stem Cell 
MSCs are multipotent stem cells that can be isolated from adult or fetal tissues 
and organs, such as liver, adipocyte and pancreas. It is characterized by the expression 
of a raft of primitive markers, say CD90, CD 105 and CD 166，etc. They are capable in 
differentiating into osteoblasts, chondrocytes and adipocytes but not into 
hematopoietic stream (Bernardo et al., 2009). 
Mesenchymal Stem Cell 
Z I \ 
Osteoblasts Adipocytes Chondrocytes 
Copyright © 2011 Sigma-Aldrich. All rights reserved. 
Figure 1.11 Mesenchymal Stem Cell Pathway. 
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(a) Umbilical cord blood derived stem cells 
The youngest, most primitive MSG can be obtained from the umbilical cord tissue, 
namely Wharton's jelly and the umbilical cord blood (Bernardo et al, 2009). 
Comparing to embryonic tissues and bone marrow, they are much easier to obtain and 
there is no ethical issues concerning as they are discarded tissues. They can be 
induced into islet-like cell clusters in vivo through stepwise culturing in 
neuron-condition medium (Chao et al., 2008). After xenotransplantation, they are 
capable in reversing glucose-tolerance stages in the absence of immuno-suppressants. 
(b) Bone marrow derived mesenchymal stem cells 
It is readily available and easily collected (Bernardo et al., 2009). Apart from islet 
engineering, it also capable in regenerating damaged tissues by direct injection to 
recipients (Barbash et al , 2003). Research suggested that after injections, they are 
automatically home to the regenerating pancreas and improve insulin secretion and 
reduce blood glucose level in hyperglycemia mice (Li et al., 2008). Besides, cytokines 
produced by bone marrow stem cell microenvironment has enhanced isolated /3 -cells 
survival and improved their functions (Jung et al., 2011). In addition, it also improved 
T2DM in metabolic control and reduced insulin requirement (Estrada et al., 2008). 
(c) Pancreas derived mesenchymal stem/progenitor cells 
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The advantages of using pancreas derived stem cells or progenitor cells rest on 
their commitment towards the pancreas. Less manipulation is required to obtain fully 
functional jS -cells. As they are less pluripotent and more easily directed, potential of 
triggering tumouriogenesis reduced. Progenitor/stem cells are reported to be present 
in both fetal and adult pancreas that originate from islets, ducts or mesenchymal cells. 
i) Duct epithelial cells 
During development and regeneration, many groups have found that progenitor 
cells reside in ductal origin (Wang et al, 1995). Genetic lineage tracing experiment 
shows that cells expressing carbonic anhydrase II in the ductal region will develop to 
new /? -cells after regeneration (Gu et al., 1994). Moreover, other groups showed that 
NGN3 positive cells are found in the ductal region during regeneration (Liu et al., 
2007). This suggested that in the ductal region, there are a population of stem cells 
which can differentiate to new /5 -cells. Besides, isolated rodent duct cells have been 
shown to differentiate into insulin-producing cells in vitro (Bonner-Weir S et al., 
2000). 
ii) Acinar cells 
Acinar cells are the most common cell type making up the pancreas and share a 
common population of precursors with islets (Slack et al., 1995). With the process of 
dedifferentiation by Notch signalling, acinar cells were shown capable in 
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differentiating into insulin-producing cells in vitro (Esni et al., 2004). Besides, with 
genetic manipulation in PDX1 /NGN3/MAFA, acinar cells were shown improve 
fasting glucose levels in hyperglycemic mice in vivo (Zhou et al., 2008). This process 
involved dedifferentiation and activation of cell cycles, which believe to be less risk 
of tumoriogenesis by pluripotent stem cells. However, utilization of virus raises 
concerns in insertional mutagenesis triggered tumoriogenesis. 
iii) Islets 
Using cells reside in islets may provide a lower barrier for reprogramming into 
insulin producing cells. Lineage tracing has demonstrated that newly generated 
3 -cells derived from pre-existing /3 -cells in adult (Dor, 2006). However, extremely 
slow rate of regeneration has hampered further investigation on underlying 
mechanisms. Some groups suggested that there are precursors reside in islet while 
some suggested that it is the proliferation of pre-existing cells (Dor, 2006; Segev et al., 
2004). Under extreme condition of /5 -cells lost, pancreatic a-cells can transform into 
/5 -cells in vivo (Lu et al., 2010; Thorel et al., 2010). NGN3 positive cells found 
suggested that dedifferentiation occurs. Collombat et al., group has shown that 
reprogram by using transcription factor PAX4 expression can convert a-cells into 
insulin producing cells (Collombat et al., 2009). Although transgene cannot be used in 
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therapy, the idea of conversion of a-cells into /5 -cells can be apply in T2DM with 
relative reduction in ^ -cells but increased a-cells. 
(d) Liver derived mesenchymal stem cells/progenitor cells 
Successful cases are reported by transdifferentiation of fetal/adult liver progenitor 
cells into insulin producing cells raises interest in investigating potential of liver cells 
as a source of islet engineering (Zalzman et al., 2003; Yang et al., 2002). 
Problems encountered are difficulty in isolating stem cell from adult tissues as 
they are very scarce and invasive (Garg et al., 2008). Comparing to other stem cells, 
they have limited proliferation and differentiation potential (Watt et al., 2000; 
Pittenger et al., 1999). Yet, they are more easily directed than other stem cell type as 
they may, to certain extent, have committed lineage (Pittenger et al., 1999). Besides, 
this is also less tumorigenic. 
MSCs having immunomodulatory properties and their power to differentiate into 
insulin-secreting cells make it a promising therapeutic target for diabetes (Le Blanc, 
2003; Fiorina et al., 2009; Karnieli et al., 2007). However, ethical debates have 
limited the use of MSG. 
1.3.1.2 Embryonic Stem Cell 
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ESCs are pluripotent stem cells derived from the inner cell mass of the blastocyst, 
an early-stage embryo. They are capable in differentiate into all derivatives of the 
three primary germ layers: ectoderm, endoderm, and mesoderm. Cell lines, without 
any contaminations, derived from human embryos under completely cell- and 
serum-free conditions are available commercially. Problems encountered are their 
high tumoriogenicity, difficult to control its fate and immunogencity. Moreover, 
ethical debate has also limited the use of human ESC (Baharvand et al., 2004; van der 
Bogt et al., 2006; Blum et al., 2008). 
Shi Y et al., have introduced a novel three-step approach in inducing ESCs to 
differentiate into pancreatic beta cells (Shi et al, 2005) and Chen S et al , also showed 
that a small molecule can direct differentiation of human ESCs into the pancreatic 
lineage (Chen et al., 2009). These provide excellent potential for ESC to be the 
unlimited sources of islets. 
1.3.1.3 Induced Pluripotent Stem Cells 
iPSCs are a pluripotent stem cell artificially derived from a non-pluripotent origin 
by genetic modifications (Takahashi and Yamanaka, 2006; Takahashi et al., 2007), 
miRNA (Anokye-Danso et al, 2011) or proteins (Zhou et al , 2009). Yamanaka and 
Takahashi et al., group has first created iPSCs from mouse skin cells, later, from 
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human skin cells (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). Later, 
Thatava T, et al., has shown that Indolactam V/GLP-1 is capable in mediating 
differentiation of human iPSCs into glucose-responsive insulin-secreting progeny 
(Thatava T et al., 2011), which provide promising potential for the use of iPSCs in 
islet engineering. 
As iPSCs obtained from same host, immunogenicity encountered is resolved 
(Fairchild, 2010). Problem encounter while using iPSCs are its low efficiency in 
induction to iPSCs from mature somatic cells, virus utilized during induction and 
genetic mutations leaving after differentiation (Utikal et al., 2009). 
1.3.2 Islets Engineering 
1.3.2.1 Genetic Modification 
MSCs and mature cell types can be induced to differentiate into functional 
insulin producing cells when PDXl is introduced via recombinant adenoviral vector 
(Li et al, 2007; Noguchi et al., 2006). By using adenovirus to mediate 
PDX1 /NGN3/NEUR0D/PAX4 expression in duct cells, Noguchi et al , demonstrate 
that NEUROD was the most effective inducer (Noguchi et al., 2006) while Collombat 
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et al., group also has shown that overexpression of PAX4 only can a-cells direct into 
insulin producing cells (Collombat et al, 2009). 
1.3.2.2 Directed Differentiation 
Directed differentiation is the hottest and well-studied methods in islet 
engineering. Most successful protocol recently available by D'Amour et al. group is 
also utilizing this method (D'Amour et al., 2006). By stepwise addition of different 
morphogens in culture medium to direct stem cells fate has successfully induced islets 
formation. Directed differentiation of ESC or iPSC involves differentiation into 
definite endoderm, establishment of the primitive foregut endoderm, patterning of the 
posterior foregut and specification and maturation pancreatic endoderm and thus 
endocrine precursors. Yet, in vitro differentiation resulted insulin producing cells still 
encountered major problems, such as non-functional, irresponsive to glucose, 
incomparable c-peptide expression to adult islets. 
1.3.2.3 Microenvironment 
Cells in culture can "condition" the medium where they grow, changing its 
capacity to promote further cell growth or transformation of other cell type and its 
created microenvironment can restore isolated cells' functions (Timmers et al., 2011), 
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maturation of stem cells (Vicente-Salar et al., 2011) and regenerating tissues 
architectures (Schonfeld et al., 1981). Mechanical force, extracellular matrix, 
condition medium and co-culture techniques are commonly employed to mimic 
microenvironment (Nathaniel et aL, 2008). Among them, co-culture was predicted as 
the most powerful tools for maintaining the physiological functions of isolated cells 
because of the presence of cell-cell communications, contact and signalling. 
Recently, Ledran et al., group showed that stromal niche derived from organs 
involved in hematopoiesis can efficiently differentiate ESC into hematopoietic lineage 
(Ledran et al.，2008). Besides, Chen et al, group has promoted /5 -cell differentiation 
by using adult islet cells (Chen et al, 2009). These data have provided us insight in 
microenvironment direct stem cell fate can provide a supportive environment for 
maturation. 
1.3.2.4 In vivo Regeneration 
Final succeed only comes with successful transplantation of functional organs in 
patients. As a result, many groups have tried to transplant their semi-functional/ 
immature organs, even undifferentiated stem cells into different sites of the mouse for 
investigations. Many cases have shown that after transplantation, immature organs 
have reached certain extend of maturation and stem cells can partial recover and 
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regenerate the damaged/ malfunctions organs. From above data, people believe that 
direct transplantation of stem cells or differentiated tissues can recover the disease 
state (Chapel et al., 2003; Orlic et al, 2001). 
1.3.2.5 Cell Fusions 
Cell fusion is another possible way to produce viable cells and to induce cells 
from one tissue into another after transplantation (Nygren et al., 2004). After 
transplantation of pluripotent stem cells or other cells with committed lineage, instead 
of transdifferentiation of original tissues or differentiation of new comers, they fused 
with cells in the site of transplantation to perform a new functions and no 
immuno-rejection occurs. This has been shown by bone marrow-derived cells fused 
with hepatocytes in liver, Purkinje neurons in the brain and cardiomyocytes in the 
heart (Alvarez-Dolado et al., 2003). Furthermore, it has been demonstrated that liver 
transplanted with ICC will lead to the discovery of insulin positive and nuclei positive 
liver cells (Sapir et al., 2005). They contain single nuclei, mitochondrion-rich 
cytoplasm, less glycogen storage granules and multiple insulin secretory granules. 
1.3.2.6 Combinatory Treatment 
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Single direction in differentiation may not be succeeded as organs development 
is a complicate process. As a result, some groups are trying to utilize a mixed method 
to achieve more mature and better glucose responsive insulin-producing cells. For 
example, in vitro hematopoietic differentiation of human ESC is promoted by 
co-culture of human bone marrow stromal cells and with exogenous addition of low 
dose of cytokines (Wang et al., 2005). 
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1.4 The Vitamin A and vitamin D system 
1.4.1 The Vitamin A 
Vitamin A has been long been discovered as a signalling molecule essential for 
several metabolic pathways in adult. Pioneer studies regarding the effects of vitamin 
A in rodents by feeding vitamin A deficient diet have shown its paramount 
importance in several organ developments (Burn et al., 1941). Subsequent studies in 
embryogenesis have shown that vitamin A cooperates with fibroblast growth factors 
(FGFs) and sonic hedgehog (SHH) in embryonic patterning (Chiang et al., 2001). 
Recent advances have shown that exceeding 500 genes are thought to be regulated by 
retinoic acid and functions including normal growth and development, normal vision, 
a healthy immune system, normal reproduction, and healthy skin and barrier functions 
(Balmer et al, 2002; Gerster et al., 1997). 
As vitamin A cannot be synthesized in sufficient quantities by human, it must be 
obtained from the diet. In adult, excess intake of vitamin A is converted by small 
intestine in the form of retinol during absorption and stored in liver hepatocytes or 
hepatic stellate cells (HSCs) which are liver-specific mesenchymal/ stromal cells 
(Blomhoff et al., 1990). In embryo, vitamin A is stored as two forms, namely 
retinoaldehyde and beta-carotene in eggs (Niederreither et al., 2008). In early fetus, 
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vitamin A is stored in hepatoblasts or bipotent hepatic parenchymal progenitors 
(Kutoba et al , 2007). 
Vitamin A includes the compounds retinoic acid (RA), retinal, retinol, and four 
known carotenoids, i.e. alpha-carotene, beta-carotene, gamma-carotene; and the 
xanthophyll beta-cryptoxanthin, where only retinoic acid, retinal and 
beta-cryptoxanthin are the active functional forms. Among them, RA is found 
responsible in many developmental processes, including pancreatic axial patterning 
and development. 
Vitamin A is a lipophilic morphogen, which can readily across cell membrane and 
bind to nuclear receptor to exert effects. Retinoic acid receptor (RARs), consists of 
RAR alpha, beta and gamma, belong to the superfamily of nuclear receptor. 
atRA exerts its effect by binding to RAR alpha, beta or gamma depending on its 
functions which triggers receptors conformational change and release co-repressors. 
Then, it starts to recruit co-activators and RAR will form heterodimer with RXR, 
including RXR alpha, beta and gamma. The heterodimers will then bind to the RAR 
response elements (RARE) and induced signaling cascades. In the absence of RA, 
RAR also recruit RXR and co-repressor to bind to RARE and make the DNA become 
inaccessible for transcription. This may be interpreted as a negative transcriptional 
effect (Niederreither et al., 2008). 
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Although hundreds of genes have been reported to activate by RA, only 
approximately 20 genes were unambiguously to be contained in RARE. Recent 
researches have suggested that diverse repertoire of RA-regulated genes can directly 
or indirectly induce cascades of signals that are responsible for the effects (Balmer et 
al., 2002). Recent research also suggested that RA act on other steroid orphan 
receptors, say Peroxisome proliferator-activated receptors (PPARs) to exert effects 
(Desvergne et al., 1999). 
1.4.2 Vitamin A Metabolism 
Dietary Retinoid, in the form of retinol, retinyl ester or carotenoids, absorpted 
through intestine are converted into retinol (Blomhoff et al., 1990). 
Developmental effects of vitamin A rely tightly on the distribution and amount 
of RA within the tissues through synthesis, metabolism and diffusion gradients. 
Retinol is converted into RA through 2 consecutive reactions. Retinol is firstly 
converted into retinoaldehyde by 2 enzyme families, which is the cytosolic alcohol 
dehydrogenase (ADHs) and microsomal retinol dehydrogenase (RDHs). The 
retinoaldehyde are then oxidized via retinoaldehyde dehydrogenase (RALDH 1, 2, 3) 
which is located in different position during embryogenesis. The conversion of 
retinoaldehyde to RA is the rate limiting step. An alternative pathway cleaving 
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beta-carotene by beta-carotene 15,15'- monooxygenase to retinoaldehyde has been 
suggested during embryogenesis. 
Excess RA can lead to developmental abnormalities and should be converted 
into more polar form (4-OH and 4-oxo RA) by cytochrome P450 26 Al, B1 and CI 
(CYP26A1, B1 and CI). Although more polar form was suggested to be inactive, 
recent advance in search found that they may exert certain actions (Niederreither et al , 
2008). 
Tissue-specific anabolism and catabolism of RA have been studies for the 
regulation of RA, a morphogen, for patterning in development. RALDH displays 
significant patterning in different part of the embryo. For example, RALDH is firstly 
expressed in primitive streak and mesodermal cells but absence in posterior 
embryonic regions, which implies that RA is essential only in primitive streak and 
mesodermal cells but not in posterior embryonic regions (Swindell et al., 1999). 
Mutant of RALDH will cause malformations of embryo which is lethal (Mark et al., 
2006). Figure 1.9 summarizes vitamin A metabolisms. 
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Figure 1.12 Vitamin A metabolism. 
1.4.3 Roles of Vitamin A in Pancreatic Development 
Gain-of-flinction and loss-of-fimction has been introduced to study the effect of 
RA in embryos and fetus. In both RALDH or RAR deficient zebra-fish and mice, they 
lack pancreatic cell types (Mark et al” 2006; Alexa et al., 2009). Besides, RA is an 
instructive signal to anterior endoderm and trigger development of pancreatic cells 
(Stafford et al” 2006). Studies across other species, say amphibian and avian also 
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possess similar results show that RA system is conserved during evolution (Stafford et 
al, 2004). 
RA is essential for several steps of development, to begin with, formation of 
definite endoderm, anterior-posterior axis patterning of the pancreas, induction of 
specification to pancreatic fate and later generation of /5 -cells (Stafford et aL, 2006). 
The position and extent of pancreatic buds not only depend on inductive signals 
from surrounding tissues but also competence of the endoderm. After gastrulation, 
endoderm formed in the receipt of adjacent mesectoderm signals, mediated by FGF4. 
Later the anterior-posterior axis patterning by generation of alternative levels of RA 
by diffusion or site of generation, and bone morphogenetic proteins (BMP) proteins. 
In this case, RA acts as a posteriorising agent of endoderm (Kumar et al., 2003). 
Pancreatic specification depends on the anterior-posterior axis patterning of the 
endoderm and RA derived from adjacent anterior paraxial mesoderm directly act on 
definite endoderm to induce a population of pancreatic precursors. RALDH2 was 
positively expressed in anterior paraxial mesoderm which indicate it is the source of 
RA and sufficient for pancreatic induction (Stafford et al., 2006). 
Besides, the generation of NGN3+ endocrine progenitor cells and further 
differentiation into /5 -cells also depends on the presence of RA, proven by the 
generation of Ipfl/RAR403 transgene mice. The RA induced expression of 
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transcription factors NGN3 which specify the endocrine lineage and preferentially 
generating (3 -cells (Ostrom et al., 2008). 
1.4.4 The Vitamin D 
Vitamin D, is a pro-hormone that can not only regulate calcium homeostasis and 
bone mineralization but also module a wide range of fundamental biological functions 
in different part of the body, including keratinocytes differentiation and 
immuno-modulation. In term of human history, it was firstly discovered during 
industrial revolution. It was discovered in children who worked in sunless factories. 
They were found with severe growth retardation, widening of the ends of the long 
bones and bending legs. By the late 1600s, rickets was recognized as major health 
problem in children. Although nowadays working conditions have improved, many 
cases of vitamin D deficient are still found in people lacking sunlight exposure in 
wintertime, a particular mode of dress and malnutrition in developing countries 
(Soram Khalsa, 2009). 
As vitamin D cannot be synthesized in sufficient quantities by human, it must be 
obtained from the diet. However, little is known about its first made. Bills et al, 
suggested that vitamin D was found primary in oily fish and fish liver oils and it was 
obtained by eating green plankton. A single fish consumed about 1.2% of its body 
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weight every 24hrs and through concentrating power of the food of the food chain, 
they obtained a large amount of vitamin D in fat and livers (Holick MF, 2003). 
VDR belongs to the nuclear receptor superfamily. It contains transactivation 
domain, termed AF-1, a central DNA-binding domain with 2 zinc-finger motifs and 
carboxyl-terminal ligand-binding domain. AF-1 is recognized by coactivator proteins 
and other transcriptional factors and carboxyl terminal ligand-binding domain is 
conserved among different species but diverse enough to recognize specific ligands 
(Carlberg et al., 2007) 
Vitamin D is a lipophilic morphogen, which can readily across cell membrane 
and bind to nuclear receptor to exert effects. VDR functions with heterodimerization 
with Retinoid X receptors (RXRa, (3, y) and binds to calcitriol response element 
(VDRE). Some reports showed that VDR sometimes binds to other nuclear receptors, 
say thyroid hormone receptor and RARs but with strongest binding affinity towards 
RXRs. Besides, there is also secondary responsive gene apart from VDRE but the 
inductions showed a delay response, say a few hours or even a day. They are most 
probably mediated by primary VDRE (Carlberg et al., 2007). 
1.4.5 Vitamin D Metabolism 
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Vitamin D is a prohormone, required conversion in kidney and liver, to become 
active form calcitriol and bind to its target receptor vitamin D receptor (VDR) to 
engender biological functions. It is mainly produced in the skin in response to sunlight 
and obtained from diets. Major sources of vitamin D are oily fish, eggs and livers 
(Figure 1.10). 
Exposure of skin to sunlight with wavelength approximately 295mn can causes 
photolytic conversion of 7-dehydrocholeterol to previtamin D3 followed by 
thermal-isomerization to Vitamin D3. Vitamin D3, also called Cholecalciferol, is 
converted by the hydroxylation steps. Firstly, it is hydroxylation at carbon-25 to 
25-hydroxylvitamin D3 by CYP2R1 and sometimes other hepatic cytochrome P450s, 
which occurs primarily in livers. This is the rate-determining steps and level of 
25-hydroxylvitamin D3 is commonly used as an indicator of vitamin D status. 
25-hydroxylvitamin D3 is afterwards subjected to another hydroxylation at 
carbon-1 to produce la, 25-hydroxylvitamin D3 by CYP27B1, which occurs mostly in 
kidney. Yet, recent researches showed that it also presented in other tissues, say 
keratinocytes to act as autocrine or paracrine functions. Feedback mechanisms by la, 
25-hydroxylvitamin D3 can inhibit over production and minimize vitamin D toxicity. 
Elevating la, 25-hydroxylvitamin D3 can cause an increase in serum calcium and 
phosphate level. 25(OH)D3-24-hydroxylase (CYP24) oxidize at Carbon-23 and 
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Carbon-24 which lead to cleavage of side chain and inactivation. Cooperation of 
CYP24 and CYP27B1 is of vital important in regulating calcitriol level in growth and 
differentiation [Holick, 2003; Carlberg et al” 2007; Kochupillai, 2008; Feldman et al., 
2005]. 
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Figure 1.13. Vitamin D metabolism. 
1.4.6 Metabolic Functions of Vitamin D in Islets 
(A) Type 1 Diabetes Mellitus 
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Several clinical studies have correlated the vitamin D deficient with change in serum 
glucose or insulin level (Scragg et al., 1995) and sometimes, insulin sensitivity 
(Borissova et al., 2003). In animal studies, administration of vitamin D or its 
analogues can inhibit the development of STZ induced Diabetes and inflammation 
induced diabetes (Del Pino-Montes et al, 2004). Also, studies in infants with 
consumption of cod liver oil supplement, rich in vitamin D can reduce risk of TIDM 
development. In TIDM, caused by deficient of islets, this implied vitamin D play a 
certain roles in improving insulin secretion of islets. Beneficial effects of vitamin D 
mainly lie on glucose-induced insulin secretion after 3 hrs administration whereas not 
affecting fasting glucose and insulin concentration (Hypponen et al., 2001; Harris, 
2005). 
(B) Type II Diabetes Mellitus 
Non-obese and young mice fed on a vitamin D-depleted diet has higher incident 
in developing T2DM. On the contrary, vitamin D benefits animal models of diabetes, 
say obese Wistar rats with T2DM. Regular consumption of fish, rich in vitamin D by 
adult have been associated with 60% reduction in developing glucose intolerance. 
T2DM, characterized by insufficient insulin secretion and insulin insensitivity, insulin 
secretion can be improved while insulin insensitivity improvement is still 
controversial (Tai et al , 2008). 
52 
Chapter 1 General Introduction 
1.4.7 Cod Liver Oil 
Cod liver oil, a natural nutritional supplement derived from liver of cod fish, was 
once commonly given to pregnant women for its high value of omega-3, EPA and 
DHA for fetal development and children to prevent rickets or other vitamin D 
deficient symptoms. However, with the high dose of vitamin A presented, it made 
things controversial, especially to pregnant women. Because vitamin A is a 
morphogen, with precise dose would enhance fetal development, however, overdose 
will affect normal fetal development and also cause gestational hypertension to 
mother. As a result, cod liver oil is now only recommended to ease the pain and joint 
stiffness associated with arthritis even with its proven positive effect on wound 
healing, heart, bone, hair and nails growth (Masterjohn, 2009). 
1.4.8 Interactions between Vitamin A and Vitamin D 
Studies have shown that vitamin A and vitamin D may have modulating effects 
in different type of cells. (1) For example, they can synergistically inhibit the 
clonogenicity of MCF-7 and T-47D cells [Koga et al., 1991; Wang et al., 2000]. (2) 
21 
However, excess RA levels antagonise calcitriol's roles in Ca homeostasis (0rnsrud 
et al, 2009). Although mechanisms are still unclear, (3) Retinoid X receptors are 
suspected candidates as they are the common target. Retinoid X receptors (RXRa, (3, 
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y), receptors for 9-cis-retinoid acid (9-cis-RA), are able to form heterodimerization 
partners for several nuclear receptor, say RAR, VDR and Peroxisome 
proliferators-activated receptors (PPARs), etc (Feldman et aL, 2005). As specific 
ligands 9-cis-RA are not detected in any adult or embryo tissues and with exogenous 
addition of 9-cis-RA or any synthetic ligands, embryo defects can be rescued 
(Niederreither et al , 2008), this excludes its effect as a stereoisomer but forming a 
inter-relation molecules with different receptors. 
In additional to sharing common target, (9) research showed that RA cross-talk 
with calcitriol by inhibiting the expression of CYP24 in human prostate cancer (Lou 
et aL, 2005). There is also study suggested that (10) RARgamma2 can interact with 
VDREs and affect vitamin D activity (Koszewski et al., 2010). Besides, (11) RA was 
found to stimulate VDR expression in both tumour and non-tumour bone cells of rats 
(Grigoriadis et aL, 1986). 
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1.5 The Relations of Liver and Pancreas Development 
During embryogenesis, development of neighbouring tissues is under similar 
combinations of transcription factors, differing by just one or a few factors 
(Chia-Ning et al., 2003). In developmental studies, emergence of ventral pancreas is 
related to the emergence of liver as they are specified at the same time and in the 
same general domain of cells (Deutsch et al., 2001). FGF signalling from the cardiac 
mesoderm diverts this endoderm to express genes for liver instead of those for 
pancreas, which implies that devoid of FGF signalling from cardiac mesoderm would 
lead to the development of pancreas (Deutsch et al., 2001, Zaret et al , 2008). In 
addition, lower organisms such as Nile Tilapia, pancreas and liver are not separated as 
hepatopancreas, which shows that their development may be associated (Morrison et 
al., 2004). In addition, vitamin A and D, whose serum level was regulated by liver, 
enhanced islets specification (Ng et al, 2011), which showed that liver and pancreas 
are closely related during development. Further studies in adult pancreatic 
regeneration during obesity, neuronal relay from the liver control regulation of 
/5 -cells mass (Imai et aL, 2009). 
1.5.1 Endoderm Induction for Hepatic and Pancreatic Differentiation of 
ESCs 
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Both hepatic and pancreatic developments are originated from the budding from 
embryonic endoderm. Thus, development of endoderm represents an important step 
and has an integral common role in initiating the early stages differentiation of ESCs 
into hepatocytes and insulin producing cells. 
Common signalling events can induce SOX 17 and FOXA genes in definite 
endoderm, i.e. signalling from Activin/Nodal family members and inhibitory 
signalling from PI3K through insulin/IGF 1 family members. Patterning of the definite 
endoderm to foregut, midgut and hindgut is also of vital importance. Both liver and 
pancreas are budding from the midgut instead of foregut and hindgut (Soto-Gutierrez 
et al., 2008). 
1.5.2 Bipotential Precursor Population within Embryonic Endoderm 
Fate mapping has shown that the liver bud is generated in part from the paired 
lateral domains of the endoderm, immediately anterior to and, partially, intermingled 
with the ventral pancreatic progenitor. Vertebrate endoderm gives rise to epithelial 
lining of the gut and to organs, such as the thymus, liver and pancreas. Specifically, 
the liver and ventral pancreas are out bud at the embryonic endoderm that is next to 
each other and derived from homogenous bipotential precursor populations. The 
developmental fate of liver and pancreas is determined by cardiac mesoderm. Cardiac 
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mesoderm and FGF signalling induce local expression of sonic hedgehog and this will 
in turn inhibit pancreatic specification but not liver development (Deutsch et al., 
2001). 
1.5.3 Pancreatic Islets Promote Mature Liver Hepatocyte Proliferation 
Existence of the liver-trophic substances in the portal venous blood was found and 
the origin of these factors was from the pancreas. In light of this background, 
Kaufmann et al , have investigated the ability of pancreatic islets to enhance growth 
of mature hepatocytes. Islets and hepatocytes were harvested from Lewis rats. It was 
found that pancreatic islets could provide a stimulatory effect on the number of 
hepatocytes in vitro. Legrelle et al., have also shown that a higher proliferation rate of 
hepatocyte is detected in the presence of pancreatic islets. Besides, co-culture of 
pancreatic islets also enhances hepatocyte's albumin secretion rate in higher islets to 
hepatocytes ratio. By selective blockage of insulin and glucagons, proliferative effect 
on hepatocytes by islets was inhibited (Kaufmann et al , 1999). 
1.5.4 Transdifferentiation 
Transdifferentiation takes place when the conversion of cells from one 
differentiated cell type to another. Transdifferentiation involves dedifferentiation of a 
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committed cell back to stem cells and differentiation into new target lineage. It was 
believed that this cannot occur in nature. However, Tsonis group has demonstrated 
new lens regenerates from the dorsal iris after removal of the previous lens in newts 
and salamanders. (Del Rio-Tsonis et al., 1995) Some researchers also regard 
regeneration of /5 -cells from ductal that is originated in pancreas as 
transdifferentiation; however, this has yet to be investigated (Bouwens, 1998). 
(A) Retinoic acid signalling 
Retinoic signalling is one of the vital mechanisms required for both pancreas and 
liver development. Retinoic acid (RA) binds to retinoic receptor and heterodimerize 
with retinoic X receptor to activate many genes required for development. Inhibition 
of Retinoic signalling inhibits early development of endoderm for pancreatic and 
hepatic progenitors. RA signalling suppresses endodermal sonic hedgehog expression, 
which suppresses dorsal pancreatic development and excess RA signal can ablate 
liver development. However, absent of RA signal has no effects on ventral pancreas 
and liver development. This shows that excess RA signal has a similar negative effect 
on ventral pancreas and livers and more researches are required to further elucidate 
reasons behind (Deutsch et al., 2001). 
(B) Wnt signalling family 
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Wnt signalling promoted liver development (Lemaigre et al., 2004) while 
inhibiting in pancreas development (Hebrok, 2003). Metheus mutant embryo defects 
in initial budding of liver but later a liver rudiment was found in the ductular region of 
the pancreas. Metheus mutants include a mutation in the Wnt-family and wnt2bb 
(Zaret, 2008). 
(C) BMP & FGF family 
Cardiac mesoderm BMP and FGF signalling induces local expression of sonic 
hedgehog and this, in turn, inhibits pancreatic specification but not liver development. 
Consistence with developmental studies, combined functions of endogenous BMP and 
supplemented FGF can induce differentiation of hepatocytes from human ESCs and 
shift developmental pathways from hepatic to pancreatic cell differentiation (Mfopou 
et al., 2010). 
In light of these backgrounds, many groups have tried to differentiate pancreatic 
stem cells to hepatocyte and vice versa. It has reported that hepatic oval cells can be 
induced in vitro to form islet like cell clusters, expressing pancreatic markers and 
transplantation could further improve glycemic control of diabetic mice (Yang et aL, 
2002). Both in a pancreatic cell line, AR42J-B13, and in organ cultures of pancreatic 
buds from mouse embryos can be converted into hepatocytes by treatment with a 
synthetic glucocorticoid, dexamethasone (Shen et al, 2000). 
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1.5.5 Transplantation in Liver Niche Promotes Maturation of 
Insulin-producing Cells 
Recent advances in stem cell therapy have shown that current in vitro induction 
protocol cannot promote successful islet engineering. However, it is observed that 
immature and unpurified islets after transplantation have attained more mature 
phenotype and functional. Pancreatic progenitor cells transplantation can be divided 
into orthotopic and heterotopic sites. The former includes pancreas, port vein region 
of liver, spleen and greater omentum and the latter includes subcutaneous, renal 
capsule and the brain. 
Transplanting back into pancreas should be the best place where progenitors can 
be easily localized and thus, repaired injury sites. Yet, due to recurrence of 
autoimmune or pancreatitis, in some cases, it is not recommended to transplant in 
pancreas. Transplantation in other sites, say spleen and greater omentum, localization 
of transplanted precursors is difficult and absent of nerve fibers and less dense 
vascular network in islets observed. For subcutaneous, it is easily operated but 
immune attack on cells are severe. Transplantation in brain is not an easy task 
comparing to other sites. 
Kidney capsule, due to its immune privileged, and portal vein of liver are hottest 
site for transplantation. Recent researched found that liver has an important role for 
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pancreatic regeneration. When comparing to kidney capsule, glycemic control after 
transplantation in liver has greater improvement and better response to intraperitoneal 
glucose challenge. Besides, there are marked differences with regard to the pattern of 
reinnervation of islets as nerve control is of vital importance of insulin secretion. The 
islets implanted into the liver contained a denser network of sympathetic nerve fibers 
than kidney capsule. This indicate transplant in livers promote maturation of 
pancreatic precursors [Chen et al., 2009; Merani et al., 2008". 
1.5.6 Neuronal Relay from the Liver to Pancreatic /3 -cells in Regulation of 
/3 -cell Mass 
/5 -cells proliferate significantly in obesity-related insulin resistance. However, 
underling mechanisms are still unknown. A group has identified a neuronal relay 
originate from liver enhanced insulin secretion and increase in /3 -cells mass. 
Blockage of the relay showed an inhibition in compensatory response during obesity. 
Obesity insulin-resistance induced hepatic selective extracellular signal-regulated 
kinase phosphorylation signalling cascade which activate the afferent splanchnic 
nerve. It transmits signals to the central nervous system and after process, the efferent 
vagus sends signals to control the hyperplasia in pancreas (Figure 1.14). This 
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suggested that an inter-organ communication between liver and pancreas existed 
(Imai et aL, 2009; Imai et al., 2008). 
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Figure 1.14 Obesity induced hepatic ERK activation promotes pancreatic /3 -cell 
proliferation via the neuronal system consisting of afferent and efferent nerves and the 
central nervous system. 
1.5.7 Development of Islets in the Nile Tilapia 
In Nile tilapia, Oreochromis niloticus, was bom with a compact organ, consisting 
endocrine and exocrine as mammals. Yet, after birth, structures modification starts. 
The exocrine pancreas later becomes disseminated, extending along blood vessels 
through the mesenteries and into liver. This migration of the exocrine pancreas 
appears continue throughout the lifespan. 
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A single principle islet with scare scattering secondary islets around it, arise from 
a group of endocrine cells that differentiate in parallel with the surrounding exocrine 
cells in the embryo and early larval stage. A close relationship between small 
secondary islets and pancreatic ducts in young tilapia is reported by Agulleiro et al. 
group. Isolated insulin-positive cells in young tilapia are found at pancreatic duct 
epithelium. It is important to highlight islet development occurs in liver after exocrine 
migration, although interaction of developing islets with mature liver during larval 
stages was not described (Morrison et al., 2004). 
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1.6 The Insulin-like Growth Factor-I (IGFl) 
1.6.1 IGFl System 
Insulin-like growth factors I (IGFl) (70 amino acid) consists of 4 domains, 
namely A, B, C and D with a molecular weight of approximately 7.5 kDa. Due to its 
structural homology with insulin, it is termed as insulin-like growth factors. There is 
also another family member, named Insulin-like growth factors II (IGF2)，which has 
70% similarity with IGFl. 
Copyright • 2010 Dr. A Marek Brzozowski. All rights reserved. 
Figure L15 Structural hot-spots targets in human insulin and IGF-1. 
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Both IGFl and IGF2 exert their biological effects via binding to the receptor 
insulin-like growth factor I receptor (IGFIR), a cell surface tyrosine kinase receptor. 
The IGFIR is a heterotetrameric glycoprotein consisting of two extracellular 
a-subunits and two transmembrane P-subunits linked y disulphide bond. It is 70% 
structurally similar to insulin receptor (IR). Binding of IGFl to IGFIR causes 
autophosphorylation of the receptor and activation tyrosine kinase. It then 
subsequently phosphorylates other cellular component to exert its effect. Its 
downstream components are insulin receptor substrate proteins (IRS-1, IRS-2, IRS-3, 
IRS-4, IRS-5 and IRS-6), Src-homology collagen protein and growth receptor 
bound-2 associated binder-I, etc. In each case, they activate different cascades, 
namely, Akt, Ras-Erk and PIPS etc. Sometimes, it also forms dimerization with IR 
and increases its affinity for IGFl while decreasing its insulin affinity. 
In contrast to IGFIR, binding to insulin-like growth factor II receptor/ 
mannose-6-phosphate receptor (IGF2R/M-6-PR) causes a considerable debate. In 
terms of structure, it is significantly different from IGFIR. It is a monomeric receptor, 
with no intrinsic tyrosine kinase activity. It is composed of 15 cysteine-based repeat in 
extracellular domain (Kulkarni, 2005; Dupont et al., 2003). 
1.6.2 IGFl Regulation 
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IGFl is regulated by a system of receptors, binding proteins and related protease. 
Although the liver is so far identified as the major organ for IGFl production 
accounting for 80% in the circular levels, recent researches have shown that many 
peripheral tissues, such as the pancreas, muscle and bone, also produce IGFl in an 
autocrine/ paracrine manner. The secretion of IGFl is modulated by production of 
Growth Hormone (GH) from anterior pituitary gland and can be retarded by 
under-nutrition, growth hormone insensitivity, lack of growth hormone receptors, or 
failures of the downstream signalling pathway post GH receptor including SHP2 and 
STAT5B. Besides, IGFl in the bloodstream exerts negative feedback regulation on 
hypothalamus and pituitary gland, reduce GH secretion in order to reduce IGFl 
production. 
Approximately 98% of IGF-1 is always bound to one of 6 binding proteins 
(IGF-BP). IGF-1 binds to IGF to transport IGFl in the bloodstream, cerebrospinal 
fluid and body fluid. They determine the bioavailability of IGFl, increase its half-life 
and prevent over-stimulation of cells. IGFBP3 is the predominant IGFBP and 
accompany with acid-labile subunit, a liver derived GH-regulated glycoprotein binds 
to IGFl in a 1:1:1 molar ratio forming ternary complex. In tissues, IGFBPs interact 
with cellular matrix constituents or on cell membrane to regulate interaction between 
IGFl and IGFIR. IGFBP proteases are mainly responsible for the catabolism of 
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IGFBP, which reduce affinity of IGFBP to IGFl, and thus reduce the serum level of 
IGFl. 
Serum IGFl level increased gradually after birth, increase slowly at puberty and 
eventually decrease due to aging. In embryo and fetus, the IGFl level is 
approximately around 30- 50 % to adult, increase with gestational weeks. Figure 1.16 
summarizes IGFs regulations insides human body. (Kulkami, 2005; Dupont et al., 
2003) 
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Figure 1.16 Regulation of circulating and tissue levels of insulin-like growth factors. 
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1.6.3 Roles of IGFl in Pancreatic Development and Regeneration 
IGFl signal provides essential conserved signals for the control of embryonic 
and postnatal development in many species. Studies through transgenic and gene 
knock out mice have demonstrated considerable variety of tissue-specific and 
developmental stage-specific effects. 
For IGFl knockout mice, neonates have reduced birth weight by 40% and die 
shortly after birth, suggesting that IGFl is essential for development. In IGF2 
knockout mice, it also shows a reduction in weight but normal growth afterwards. It, 
thus, proposes that IGF2 is responsible for intrauterine growth. In double mutant of 
IGFl and IGF2 mice, it affects growth more severely, indicating that they act 
independently to stimulate growth. In IGFIR knockout mice, severe growth 
retardation has been observed while IGF2R has an increase in placental mass more 
than 25%, which suggested that IGFIR is essential for embryo development but not 
IGF2R. In natural deletion of exons 4 and 5 IGFl gene, human suffers from severe 
pre- and postnatal growth, developmental defects and mental retardation (Dupont et 
al., 2003). 
The roles of IGFl and IGF2 in development have been proposed by their 
expression in human and rat fetal and neonatal islets (Swenne et aL, 1987; 
Rabinovitch et al., 1982). Exogenous addition of IGFl promotes islet cells DNA 
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synthesis and overproduction of IGFl in /? -cells has resulted in islet hyperplasia. 
However, IGFl and IGFIR deficient mice also resulted in pancreas hyperplasia, 
which may be due to direct inhibition of development and indirect effects. IGFIR 
deficiency in /3 -cells showed a decrease in expression of glucokinase and Glut2, 
which result in failure of glucose-induced insulin secretion and impaired glucose 
tolerance (Yu et al., 2003; Lu et al., 2004). It is hard to determine whether IGFl 
would be important for islet development as the result may be due to direct or indirect 
effects of IGFl knockout. In this regard, extra investigations are required. 
On the contrary, IGFl is consistently important for pancreas regeneration. 
During regeneration, IGFl expression in pancreas is increase significantly (Smith et 
al., 1991). Exogenous injection of IGFl improved regeneration and IGFl over 
expression mice showed improved regeneration. Research suggested that IGFl 
mediates regeneration of endocrine pancreas by increase cell replication, recruitment 
of stem cells for differentiation and protect islets against inflammation (Agudo et al, 
2008; Warzecha et al., 2003; Hess et al., 2003). However, exact reasons are not fully 
understood. 
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1.7 Aims and Objectives of Study 
In light of the literature review in the aforementioned introduction, convergent 
evidence has supported for potential roles of vitamin A, vitamin D and liver stroma in 
the development of pancreatic progenitor cells (PPCs) into islet like cell clusters 
(ICCs). In order to test this hypothesis, a series of novel objectives which will be 
adequately addressed by our established methodology in this project as described 
below: 
1) To study the effects of vitamin A and vitamin D alone or in combination on PPC 
proliferation and specification. 
2) To establish the novel co-culture system for liver stromal cells (LSCs) and PPC 
3) To study the effects of LSC on PPC viability and PPC-derived ICC 
differentiation. 
4) To further study some morphogenic factors identified from LSC that are 
responsible for the above effects. 
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2.1 Isolation and culture ofPPCs and LSCs 
2.1.1 Tissue procurement 
Human fetal pancreata and livers employed in this study were approved by our 
Institutional Committees on Human Ethics. Maternal consent was obtained by the 
outpatient clinic of the Prince of Wales Hospital before Surgical Termination of 
Pregnancy. Ethical approval for the use of fetal tissue from the Clinical Research 
Ethnics Committee was obtained (CREC-2005.461). - weeks of early 
gestational ages from human fetal pancreata and livers were collected from surgical 
termination of pregnancy (STOP) by dilation and extraction. Isolation of pancreata 
and livers were under high power dissecting microscope and they were then rinsed 
under sterilized phosphate buffered saline (PBS) (In vitro gen, Carlsbad, CA) as 
previously described (Suen et al., 2008; Leung et al., 2009). 
2.1.2 PPC and LSC culture 
PPCs were isolated as previously described (Suen et al., 2008; Leung et al., 
2009). In brief, pancreas was rinsed in distilled PBS and subjected to digestion by 3 
mg/ml collagenase P (Roche, Mannheim, Germany) in Hanks Balanced salt solutions 
(HBSS) (Gibco Life Technologies, Inc., Grand Island, NY) for 5-8 mins in a vigorous 
shaking 37°C water bath. After digestion, HBSS was added to dilute the Collagenase 
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P solution. The tissues were subjected to centrifugation for 5 mins 1600 rpm. 
Collagenase P solution was removed and HBSS was added to rinse the digested 
tissues. It was then subjected to another centrifugation for 5 mins at 1600 rpm. The 
centrifuged pellet was resuspended in modified RPMI1640 medium (Gibco Life 
Technologies, Inc., Grand Island, NY) supplemented with 10% fetal bovine serum 
(FBS) (Gibco Life Technologies, Inc., Grand Island, NY), 20 mM HEPES (Sigma, St 
Louis, MO), 1 mM sodium pyruvate (Sigma, St Louis, MO), 1% 
penicillin/streptomycin (P/S) (Gibco Life Technologies, Inc., Grand Island, NY) and 
71.5 jiM /5 -mercaptoethanol (Sigma, St Louis, MO) in non-adherent Petri-dish 
(Corning Incorporated, Corning, NY). 
Rounded and non-adherent cell clusters were formed after 24 hrs incubation and 
they were transferred to a new Petri-dish to remove attached fibroblasts and dead cells 
in the pertri-dish. The rounded and non-adherent cells were cultured for another 24 
hrs and then transferred to adherent culture dish (Corning Incorporated, Coming, NY) 
with exogenous addition of 20 ng/ml basic fibroblast growth factor (bFGF) (Sigma, St 
Louis, MO) and epidermal growth factor (EGF) (Invitrogen, Carlsbad, CA). PPC 
outgrowth was induced and migrated out to form a monolayer of cells within 1 week. 
Upon confluence, monolayer of cells was trypsinized using 2.5% TRYPLE (Gibco 
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Life Technologies, Inc., Grand Island, NY) for 6 mins under 37�C and passed until 8 
times at maximum (Suen et al., 2008; Leung et al., 2009). 
Human fetal liver was rinsed under distilled PBS and subjected to digestion by 5 
mg/ml collagenase A (Roche, Mannheim, Germany) in HBSS for 30 mins in a 
vigorous shaking 37°C water bath. After digestion, HBSS was added to dilute the 
Collagense A solution. The tissues were subjected to centrifuge for 5 mins 1600 rpm. 
Collagenase A solution was removed and HBSS was added to rinse the digested 
tissues. It was then subjected to another centrifuged for 5 mins at 1600 rpm. The 
remaining centrifuged pellet was resuspended in modified 1:1 DMEM/F12 medium 
(Gibco Life Technologies, Inc., Grand Island, NY) supplemented with 10% FBS and 
1% P/S in T25 filter-capped flask (Corning Incorporated, Coming, NY). The cells 
attached on the flask and formed a monolayer of cells within 1 week. Upon 
confluence, monolayer of cells was trypsinized using 2.5% TRYPLE for 6 mins under 
37°C and passed until 8 times at maximum (Lee et al., 2011). 
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Figure 2.1 Procedures for PPC isolation and PPC-derived ICC formation. 
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2.1.3 Treatments of vitamin A, vitamin D and IGFl 
PPCs were seeded at a concentration of 3 xlO"^  cells in a 96-well plate (Coming 
Incorporated, Corning, NY) and 1.5 x 10^ cells in a 6-well plate (Coming Incorporated, 
Coming, NY). They were allowed for attachment for at least 4 hours. After 
attachment, they were incubated in serum free medium overnight to arrest cell cycles. 
Vitamin A ( l O ] � - M ) (Sigma, St Louis, MO), vitamin D (lO'^^ — 10"^M) (Sigma, 
St Louis, MO) and IGFl (1, 10, 50, 100 ng/ml) (Sigma, St Louis, MO) were added 
exogenously to PPC and incubated for 2 days or 3 days. 
2.1.4 Culture of Caco-2，HepG2 and DU-145 cell lines 
Positive controls used for verifying primers newly designed, Caco-2, HepG2 and 
Du-145 were cultured as followed. DU-145 cells (a gift from Dr. H. Wise, The 
Chinese University of Hong Kong) were grown in DMEM (Gibco Life Technologies, 
Inc., Grand Island, NY) supplemented with 10% FBS, 100 U/ml of penicillin G 
(Sigma, St Louis, MO) and 100 \ig/m\ streptomycin sulphate (Sigma, St Louis, MO). 
Caco-2 cells were grown in MEME medium (Gibco Life Technologies, Inc., Grand 
Island, NY) supplemented with 2 mM Glutamine (Sigma, St Louis, MO), 1% NEAA 
(Sigma, St Louis, MO) and 10% FBS. HepG2 were grown in DMEM medium (Gibco 
Life Technologies, Inc., Grand Island, NY) supplemented with 1% P/S and 10% FBS. 
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2.2 Induction of PPC-derived ICC Differentiation 
2.2.1 In vitro Directed Differentiation 
PPC-derived ICC differentiation was performed as reported previously (Suen et 
al., 2008; Leung et al., 2009). Briefly, PPCs to week gestation and 3-8 
passages) were trypsinized and suspended in ultra-low attachment plate (Coming 
Incorporated, NY, USA) under 8 days differentiation in high glucose (11 mM) 
DMEM/F12 medium supplemented with IX B27 (Gibco Life Technologies, Inc., 
Grand Island, NY), 0.05% bovine serum albumin (BSA), 10 ng/mL Hepatic Growth 
Factor (HGF) (Invitrogen, Carlsbad, CA), 10 nM Exendin-4 (Sigma, St Louis, MO), 
500 pM Betacellulin (Sigma, St Louis, MO) and 10 mM Nicotinamide (Sigma, St 
Louis, MO). Medium was replaced every 2 days. Resultant ICCs were handpicked by 
micro-pipette under an inverted light microscope (Suen et al., 2008; Leung et al., 
2009). 
2.2.2 In vitro LSC Microenvironment 
In the CO-culture model, LSC were seeded on Transwell (Millipore Filter 
Corporation, Bedford, USA) and co-culture with ICC in ultra-low attachment plate, 
i.e. high glucose (11 mM) DMEM/F12 1:1 medium with basal energy source (IX B27, 
0.05% BSA) supplemented with or without growth factors (differentiation cocktails), 
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i.e. 10 ng/mL HGF, 10 nM Exendin-4, 500 pM Betacellulin and 10 mM Nicotinamide. 
Medium was replaced every 2 days. Resultant ICCs were handpicked by 
micro-pipette under an inverted light microscope. 
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2.3 RNA Expression Detection 
2.3.1 RNA isolation 
Total RNA was isolated from PPCs, ICCs, LSCs, Caco-2, DU-145, HepG2 and 
homogenized human fetal livers, kidneys and other tissues used for positive control. 1 
ml TRIzol (Invitrogen, Carlsbad, CA) was used according to manufacturer's protocols. 
After homogenization, samples were incubated at room temperature for 4 mins to 
allow complete dissociation of nucleotideprotein complexes. Chloroform was used for 
extraction and isopropanol was used to precipitate RNA. 75% Ethanol was used to 
remove organic solvent leaving behind. Finally, the resulted pellet containing RNA 
was dissolved in RNAase free water. 
The absorbance of RNA was determined by UV-spectrophotometer (Hitachi, 
Japan). The value of absorbance at wavelength 260 nm obtained x 40 x dilution factor 
would equal to the concentration. The purity of RNA was determined by comparing 
ratio ofO.D.280 and O.D. 260. 
2.3.2 Reverse Transcription 
First strand cDNA was generated from 2 i^g mRNA in a 20 |il volume using 
superscript III reverse transcriptase (Invitrogen, Carlsbad, CA) with 500 \ig 
oligo(dT)188 (Invitrogen, Carlsbad, CA), 5X RT-buffer (Invitrogen, Carlsbad, CA), 
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40 units/^1 RNAaseOUT (Invitrogen, Carlsbad, CA), 0.1 M DTT (Invitrogen, 
Carlsbad, CA) and 10 mM dNTP (Invitrogen, Carlsbad, CA) according to 
manufacturer's protocol. 
2.3.3 Polymerase Chain Reaction (PGR) 
PGR and real-time PGR primers were designed using online primer 3 version 
0.4.0 according to manufacturer's protocol. Each primer was tested by conventional 
PGR using positive control. Primers used for subsequent experiment were stated in 
Table 2.3 
PGR was performed in 25 reaction volume containing 1 |il cDNA template, 
1.5 mM MgCl2 (Invitrogen, Carlsbad, CA), 0.2 mM dNTP, 0.3 |iM forward primer 
(Invitrogen, Carlsbad, CA), 0.3 |iM backward primer (Invitrogen, Carlsbad, CA), 
PGR buffer (Invitrogen, Carlsbad, CA) and Tag DNA polymerase (Invitrogen, 
Carlsbad, CA) according to manufacturer's protocol. Annealing temperature for each 
primer was summarized in Table 2.1. 
PGR products were then electrophoresized in a 2% agarose gel in IX 
Tris-Acetate-EDTA (TAE) buffer pre-stained with ethidium bromide for 20 mins at 
lOOV. Then resulted band were visualized using UV illuminator (FluroChemSOOO 
Advanced Fluorescence, Chemiluminescence and Visible Light Imaging, Alpha 
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Innotech Corporation, CA, USA). Target band sized for each primer was stated in 
Table 2.3. 
2.3.4 Real-time PGR 
Real-time PGR was performed according to manufacturer's protocol using 
i-Cycler Thermal Cycler (Version 3.1, Bio-Rad Laboratories Incorporation, Munich, 
Germany). Real-time PCR was done in triplicate, in 25 |xl reaction volume containing 
SYBER Green PCR Mastermix (Bio-Rad, Munich, Germany), 0.3 |iM forward primer 
and 0.3 [lM backward primer (Figure 2.3). Melting curve was performed to confirm 
specification of the PCR product. Amplification data was collected using i-Cycler 
Detector and Sequence Detection System Software. 
Fold changes of target genes were calculated using method. The ACj 
value was calculated by subtracting Cj derived from house keeping gene (in our case, 
/3-actin). A A C t was obtained by difference between treatment and control A C J . It 
was then substituted back to 1 她。飞 equation to calculate the folds change. 
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house keeping gsne Forward Primer Backward Primer Temp Size Reference 
h ^ a c t i n TGGCACCACACCTT^TACMTGAG： GCACAGCTTCTCCTTMTGTCACGC / / 2 
hp-actin TGTC 3 AC CTTC C AG ： AGATGT CG3ACTC3TCATACTCC"GCTT / / 2 
r3-actin AGCTATGAGCTGCCTGACG GGATGCC^CAGGMTCCA / / 5 
Expression d rat gene 
rl3F-l AAGCCTaCAAA3TCAGCTC3 GGTCTTGTTTCCTGCACTTC / / G 
rl3F-1R A M ACC ATC GAT TCT GTG ACG GGT TCT TCA GGA AGG ACA. AGG / / 6 
rrjgn3 TGGCGCDTCATCCCTTGGATG CAGTCACCTGCTTCTGCTTCG / / 7 
Ghardcierkd^ion d L3C 
hEp-C/iW GCTCTGAGCGA3TGAGMCC ACGCGTTGTGATCTCCTTCT EO 116 / 
h\|-cadherin CCTCCATGTGCCGGATAG MTGCGM1TCACCA3MGC EO 97 / 
hVimentin AAGCAGiBAGTCCACTGAGTACC GMGOTG^VCGAGCCATTTCC / / 8 
h:D45 AGCACCTACCC—GCTCAGM TTCAGCCTGTTCCTT"GCTT I / 8 
h:D90 A"GMCCTGGCCATCAGCATCG CACGAGGTGTTC'GAGCDAGCA / / 8 
h:D105 G W.CAGTCC A T G T G AC CTTC AG GATGGCA3CTCTGTGGTGTTGACC / / 8 
h:D166 TGAT:TCCe:CACCGTCTTCAG CTCTTTTCATCACTGATCCTTGCA / / 8 
hAFF GCA/iAGCTGAMATSCAGTTGA GGAAAGTTCGGGTCCCAW / / 9 
hAlbumir CCAGGMGACATCCITTGC CCTGAGC:AGAGATTTCC / I 9 
h:K19 /OGTGGATTCC3CTCC3GGCA ATCTTCCTGTCCCTCGAGCA / / 10 
h:K18 TG GTC AC C AC ACAGTCTG CT CCMGGCATCACCAAGATTA / / 10 
Express/on cf RfiR VDR and RXR svstem 
hVDR CTCMACGCJGTG73GACAT ACTGJCCUCMGGCCTCCJ 60 117 / 
QACCAQA TCACCCJCCTCM GTCCGAGAAGQ7CA TGGTGT tO 99 / 
h職 a CTGCTCA TCGCCTCCTTCT ACACMGGTCCGTCAGCAC 60 142 / 
hOYP24 GMfiCCAQGGGMGTGATGA A A QGA CGP, TTTGTTCA GJTCQ 60 135 / 
CC/AGMAG7GCSAGAAGAGC GGGA TC/^G7CGMGGG7C： eO 136 / 
Expression d soluble factors 
hiGF CeAGGCCATGGTGCTATACT TTGTCCTTGACCTTGeATGC £0 134 t 
hVEGFA CCTGCAAAMCACAGACTC3 (3A3AGATCTGG"rCCCGAAA EO 137 / 
hGFI GGAGGCTGGAGATGTATTGC GC:MCCITCCTTCTCTGA EO 150 / 
hGF2 CG1T3AGGA,GTGCTGTTTCC GGGGTATCTGGGGAAGTTGT EO 130 / 
hSCF AC AC CACTGTTTGTG C TG G A GATTCCTGCAGA"CCCTTCA EO 134 / 
hSLP-l CGTTXCTTCAAGACACAGAG GTeMTG'GCCC'GTGMTG E2 125 / 
h^ ro-BTC TGGGMTTC:ACCAGAAGT： CCTTTCCGCTTTGArGTST 59 96 / 
h^ eg4 AGGAGGMGATGGCTTCCAG GGWMCCATCCAiGGAGCA E2 118 t 
h-GF1 GGGCTTTATACGGDTCACA CTTGAGGCCMCW.CCMT EO 126 / 
h-GF2 TGGCTATGAAGGAA3A"GGAA ACTGCCCAGTTCGTTTCAGT EO 150 / 
h:GI7 CAGGCA3ACM3AGACATGG CAGTTGC~GT3ACGGTGnT EO 87 / 
hMGF AGTGGTCGTGCAGTCCAAG GTGGCCA6GATA3AMGCTG EO 108 / 
h3astrin CCAGCCTCTCATCATCGAA TCCATXATCCATAG3CTTC E2 119 / 
h^ThrP GCTCAAGACACCTGGG.flAGA GGAGGTGTCAGACAGGTGGT E2 145 / 
hFNg TTCAGCTCTGCATCGTTTTG TCCGCTACAT^TGMTGACCT EO 112 / 
hLB GGCTGAWAGATGGA~GCT GCTCTGGCTT3TTCCTCACT EO 141 / 
h-GF21 AC CTG G AiG ATC AiG G GA3G AT GCACAGGMsCCTGGATGTCT eS 131 / 
hTGFa CCCTGGCTGTCCTTATCATC CTGTTTCTGAGTGGCAGCAA £9 147 / 
hTGFbl GCAGGG^ TMCACACTGCAA GGCCaTGAGAAjGCAGGM EO 107 / 
hTGFb2 AC AAC AC C CTCTG GCTC AGT CTCCATTGCTGAGACGTCM EO 135 / 
hTGFb3 AGGAGAT6CATGGGGAGAG TTTAG3GCAGACAGCCA3TT EO 134 / 
hTNFa TCAGCC~CTTCTC C"TC:TG (3C:AGAGGGCTGArAG^GA EO 124 / 
hTNFb MCCTGCTGCTCACCTCAr TGCTCAAGG .^GAV\CCATCC EO 102 / 
h3tvlP2 CGCAGCTTCCACCATGMGM C CTGMG :TCTG CTG AG 3TGATA ！ / 11 
h3MP4 AGGAGCTTCCACCACGMGAAC TGGMGC^CCTTTCCCMTCAG .' / 12 
h3MPB GTGMCCTGGTGGAGTACGACAA AG3TCA6AGTCTCTCTGCTGATG : / 12 
h3MP5 TTCrCMGGCGAGTGAGGT AGXTTTGGTACGTGGTCAG ！ / 13 
h3MP7 CAGA.G CATCAAC C C CMGTT AG3ATGACGTTGGAGCT3TC / / 13 
h3MP9 T G T A : M C A 3 G - A C A C G T C : G TGMTGTCCTGGGACACCAG I / 
Cbaracl&iisiiondS PPG 
hGFR1 AGGATGCACCATCTTCMGS AATGGCG3ATCTTCAiCG"AG EO 125 / 
hGFR2 GGCCCTi3TTGC"CTACAA6^  CCATCAGCCACTCTGTTTCA EO 149 / 
[eveiopr^nlai ma 细s of ICO 
h^DXI ACTCCACCTTGGGACC'GTTT TTAAGGTACTCGGCCCAfiCTT / / 2 
h\lGN3 TGTGGGTGCTAAGGGTMGG GGGAGAMiC^GAAGGAACAA ! / 2 
hxlEUROD TCCAAAATCGAGACTCTGCGC GC.WJGCSTCTGAACGAI^ GGA / / 2 
hSL-1 GATCMATGCGCCMG~GCAG CAGCGGAAACACTCGATSTGA / / 2 
hMK>2.2 TCTCCTTGGAGTGGCAGATTC /W\CACGGCGTAiS^GTTCAGC / / 2 
hMlOB 1 GACGGGViCAGAAAAC^CACG ACTCT:TGTCATCCCCAACGA ！ / 2 
hSLUCOK 丨 NASE C—CC 八TGGGGMGTGCTC CACCGAAW.CTGAGGGAAG / / 2 
hNSULIM CAGCCTTGTGMCDAACA:C GGTCTTGGGTGTGTAGAiJ3^A3C / / 2 
Table 2.1 Sequence of the specific PGR primers and their expected product size of different target genes. 
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2.4 Immunocytochemistry 
LSC and PPC monolayers were cultured on coverslips coated with 3% gelatine 
(Sigma, St Louis, MO) in PBS and fixed with 4% paraformaldehyde (Sigma, St Louis, 
MO) in PBS for 60 mins at room temperature. Samples were permeabilized with 
0.01% Triton-X (Sigma, St Louis, MO) in 1% BSA/PBS for 5 mins at room 
temperature, then blocked with 6% normal donkey serum (Invitrogen, Carlsbad, CA) 
in 1% BSA/PBS at room temperature for 1 hour and then incubated with primary 
antibodies (Table 2.2) at 4°C overnight. Samples were then washed with PBS several 
times and incubated with Alexa Fluor 568 donkey anti-rabbit antibodies (1:500) 
(Invitrogen, Carlsbad, CA), FITC-conjugated anti-mouse (1:200) or anti-goat (1:300) 
secondary antibody (Jackson ImmunoResearch, PA, USA) at room temperature for 1 
hr and 4\6'-Diamidino-2-phenylindole (DAPI) (1:1000) (Invitrogen, Carlsbad, CA) 
for 15 mins. Omission of primary antibody was used as negative control. The slips 
were washed thoroughly with PBS several times, mounted in Vectashield and imaged 
using a fluorescence microscope equipped with a DC 200 Digital camera (Leica 
Microsystems, Buffalo Grove, IL). Different images were captured separately with a 
580 nm long-pass emission filter (Alexa 568), FITC band pass 520 一 560 nm barrier 
filter and excitation filter 360 -370 nm (DAPI). Afterwards, images were overlapped 
using image software, Adobe Photoshop CS2 (Adobe Systems, San Jose, CA). 
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Primary antibody Dilution Host Species Brand 
RAR 1:100 Rabbit ^anta Cruz Biotechnology 
VDR 1:100 Rabbit Santa Cruz Biotechnology 
RXR 1:100 Rabbit Cruz Biotechnology 
IGFIR 1:25 Rabbit Cruz Biotechnology 
AFP 1:100 Mouse Santa Cruz Biotechnology 
Albumin 1:100 Goat ^mz Biotechnology 
Dlk 1:500 Rabbit Abeam 
CD29 1:100 Rabbit Abeam 
CD90 1:100 Mouse eBioscience 
Table 2.2 Antibodies used in the immunocytochemistry. 
84 
Chapter 2 General Materials and Methods 
2.5 Western Blotting 
2.5.1 Protein extraction and quantification 
Cell lysates from PPCs were obtained using Cytobuster Protein Extraction 
Reagent (Novagen, Darmstady, Germany) according to manufacturer's protocol. Cells 
were incubated with Cytobuster in room temperature for 15 mins and subjected to 
centrifuge at 16,000 g for 15 mins at 4°C. Protein concentrations were determined 
using Bio-Rad Protein Bradford Kit (Bio-Rad, Munich, Germany) according to 
manufacturer's protocol. 2 \i\ (5X dilution or lOX dilution) samples were added to 
198 \i\ Bradford solution. Resulted absorbance was read at 595 nm with a 
spectrometer. Relative concentration was determined comparing to 0.1 — 0.5 mg/ml 
BSA standard curve. 
2.5.2 Western Blotting 
Western blotting was performed according to manufacturer's protocol with 
minor modifications. Laemmli Buffer (Bio-Rad, Munich, Germany) containing 5% 
p-mercaptoethanol was added to protein samples and denatured at 100°C for 5 mins. 
15 mg protein mixture was added to each lane and electrophoresized in a 12% 
SDS-polyacrylamide gel at lOOV for 2 hrs. It was then electrotransferred to a 
nitrocellulose membrane (Bio-Rad, Munich, Germany) by a Semi-Dry Transfer 
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System at 17V for 1 hr. The membrane was blotted by using 5% skim milk in 0.1% 
Tween20/PBS (PBST) at room temperature for 1.5 hrs. It was then incubated with 
primary antibody (Table 2.3) in 1% BSA/PBST overnight at 4�C, followed by 
peroxidase-labelled sheep anti-rabbit antibody or rabbit anti-mouse antibody (Abeam, 
Cambridge, UK) in 1% BSA/PBST. After throughout washing, bands were visualized 
on autography film using Enhanced Chemiluminescent (ECL) and Western Blot 
Detection Reagents mixtures (Amersham Pharmacia Biotechnology, 
Buckinghamshire, UK). Intensity of the bands was quantified using an image 
analyzer. 
Primary antibody Dilution Host Species Brand 
Santa Cruz Biotechnology 
RAR 1:300 Rabbit 
Santa Cruz Biotechnology 
VDR 1:1200 Rabbit 
Santa Cruz Biotechnology 
RXR 1:500 Rabbit 
Santa Cruz Biotechnology 
IGFIR 1:100 Rabbit 
(3 -actin 1:8000 Mouse Abeam 
Total Smad 1:1000 Mouse Cell Signalling 
Phospho-smadl,5,8 1:1000 Mouse Cell Signalling 
Table 2.3 Antibodies used for Western blotting. 
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2.6 Enzyme-linked Immunosorbent Assay (ELISA) 
2.6.1 Detection of cell viability 
PPC viability was measured using 3 -(4,5 -Dimethylthiazol-2-yl) 
-2,5-diphenyltetrazolium bromide (MTT) ELISA (Sigma, St Louis, MO). Reductions 
of MTT in mitochondria took place only when reductase enzymes were active, and 
therefore conversion was often used as a measurement of viable cells. 
PPCs were seeded in 96-well plate with a concentration of 3 xlO* cells. Cell 
cycle were arrested by serum-free overnight. Exogenous atRA, calcitriol or IGFl 
were added and incubated for 3 days. The measurement was done according to 
manufacturer's protocol. In brief, addition of MTT solution and incubated for 2-4 hrs 
at 37°C under 5% CO2. MTT solution was removed and DMSO (Sigma, St Louis, 
MO) was added to dissolve the purple formazan formed. The absorbance of each well 
was measured at 540 nm using a MicroKinetics plate reader (PerkinElmer, CA, USA). 
2.6.2 Detection of cell proliferation 
PPC proliferation was measured by detecting the DNA replication using 
5-bromo-2'-deoxyuridine (BrdU) ELISA (Amersham Biosciences, UK). BrdU was 
incorporated into newly syntheisized DNA of cells. 
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PPCs were seeded in 96-well plate with a concentration of 3 xlO^ cells. Cell 
cycle was arrested by serum-free overnight. Exogenous atRA and/or calcitriol was 
added and incubated for 3 days. BrdU incorporation assay was performed according 
to the manufacturer's instructions. Briefly, cells were incubated with BrdU solution 
for 4 h at 37°C under 5% CO2. Cells were fixed by for 30 min and subsequently 
treated with blocking reagent for 30 min. After removal of the blocking solution, the 
cells were incubated with peroxidase-labeled monoclonal mouse anti-BrdU for 120 
mins. TMB substrate was added to each well and incubated until color change. It was 
then stopped by the addition of 25 jil 1 M sulphuric acid. The absorbance was 
measured at 450 nm (ref. 490 run) using a MicroKinetics plate reader. 
2.6.3 Measurement of cell death 
Cell death was characterized by membrane blebbing and cytoplasmic 
condensation and resultant Mono- and oligonucleosomes in cytoplasmic fractions 
were detected. 
PPCs were seeded in 96-well plate with a concentration of 3 xlO"^  cells. Cell 
cycle was arrested by serum-free overnight. Exogenous atRA and/or calcitriol were 
added and incubated for 3 days in medium not supplemented with FBS, which can 
induce cell apoptosis by nutrient deprivation. Enzyme-linked immunosorbent cell 
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death assays (Roche, Mannheim, Germany) were performed to assess cell death 
according to the manufacturer's instructions. Briefly, cells were lysed and lysates 
were centrifuged at 200 x g for 10 min. The supematants were collected, added to the 
strip, immuno-reagent was added and shaken at 300 rpm for 2 h. before the solutions 
were removed by suction and rinsed with incubation buffer x3. ABTS solution was 
added and upon color development, ABTS stop solution was added. The absorbance 
was then measured at 450 nm (ref. 490 nm) using a MicroKinetics plate reader. 
2.6.4 Measurement of IGFl levels in condition medium 
LSC was cultured under DMEM/F12 1:1 medium supplemented with IX B27, 
0.05% BSA in high glucose (11 mM) and IGFl assay (Ray Biotech, Inc., Norcross, 
GA) was performed according to the manufacture's protocol. The medium collected 
was immediately chilled in ice and added to wells overnight at 4°C. The following 
procedures were performed under room temperature. Solution was discarded and 
washed with Wash Solution. Biotin antibody provided were added to each well and 
incubated for 1 hr. Solution was discarded and washed with Wash Solution. 
Streptavidin solution was added to each well and incubated for 45 mins. TMB 
One-Step Substrate Reagent was added and incubated for 30 mins. Stop solution was 
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added and absorbance was then measured at 540 nm using a MicroKinetics plate 
reader. 
2.6.5 Measurement of glucose-induced insulin secretion 
To measure glucose-stimulated insulin secretion (GSIS) and 
potassium-stimulated insulin secretion (KSIS), handpicked ICCs with similar size 
were rinsed by PBS and incubated in Krebs-Ringer bicarbonate buffer supplemented 
with 10 mM HEPES and 0.1% BSA for 90 mins. It was then subjected to low 
concentrations of glucose (2 mM) or potassium (2 mM) before resultant solution was 
collected. Afterwards, it was subjected to high concentrations of glucose (25 mM) or 
potassium (25 mM) challenge before resultant solution was collected. 
The collected solution was measured using human ultrasensitive Insulin ELISA 
(Mercodia, Uppsala, Sweden). It was performed according to the manufacture's 
protocol under room temperature. The collected solution and Enzyme-conjugate 
Solution were added to each well and incubated for 1 hr. The solution was discarded 
and washed with Wash Solution. Substrate TMB was added into each well and 
incubated for 30 mins. Stop Solution was added and absorbance was measured at 450 
nm using a MicroKinetics plate reader. 
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To normalize the insulin produced, ICCs were then lysed by Cytobuster Protein 
Extraction Reagent and total protein was quantified by Bradford Assay. 
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2.7 Regeneration model 
2.7.1 Regeneration model of neonatal-STZ rat 
Work on animal tissues was approved by Institutional Committees on Animal 
Ethics. Pregnant Sprague-Dawley rats (time pregnancy 17 days) were obtained and 
caged individually with free access to standard diet and water. They were checked 
regularly from 0900 to 1800 daily for delivery of pups. One-day-old neonates were 
injected intraperitoneal with 100 }ig/g body wt of streptozotocin (STZ) freshly 
dissolved in 0.05 mmol/1 citrate buffer (pH 4.5) (Li et al., 2004). Blood glucose of all 
neonates after STZ treatment was measured by glucometer (Bayer Corp., Tarrytown, 
NY). Only those with blood glucose ranged 11.1 mM - 19.44 mM after the day of 
STZ treatment were chosen for subsequent experiment. To assess whether 
differentiation was involved in pancreas regeneration, NGN3 mRNA expression in 
whole pancreas was investigated. 
2.7.2 Change in IGFl expression in pancreas and liver 
To investigate whether liver-production and local-production IGFl were 
involved in pancreatic regeneration, whole pancreata and livers were homogenized in 
TRIzol. Extracted RNAs were subjected to reverse-transcription and real-time PGR in 
order to analyze the change in expression levels. 
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2.8 Statistical Data Analysis 
Data were expressed as means 士 SEM for all experimental groups. Comparison 
probabilities (P values for chance differences between experimental groups) were 
made using Student's independent two-tailed t-test. Multiple comparisons between 
groups were performed using analyses of variance (ANOVAs) followed by Tukey's 
post hoc tests. For all comparisons, P < 0.05 was considered statistically significant. 
For quantitative real-time RT-PCR, relative expression was normalized to p-actin and 
calculated using the comparative CT method; the fold change was defined as 
Statistical analyses and graphics design were performed using GraphPad Prism 5 
(GraphPad Software, San Diego, CA, USA). 
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Chapter 3 
Vitamin D and vitamin A receptor expression and the proliferative effects 
of ligand activation of these receptors on the development of pancreatic 
progenitor cells derived from human fetal pancreas. 
(The content of this chapter has been published in Stem Cell Reviews and 
Reports. 2011;7:53-63) 
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Chapter 3 Effects of vitamin A and vitamin D on pancreatic progenitor cells 
3.1 Abstract 
The growth and development of pancreatic islet cells are regulated by various 
morphogens. Vitamin A modulates in vitro differentiation of islet cells and vitamin D 
affects beta-cell insulin secretion, while both vitamin ligands act through 
heterodimerization with the retinoid X receptor (RXR). However, their effects in 
modulating pancreatic development have not been determined. In this study, cultured 
human pancreatic progenitor cells (PPCs) isolated from human fetal pancreas were 
stimulated to differentiate into islet-like cell clusters (ICCs). RT-PCR, Western 
blotting and immunocytochemistry were used to examine the expression and 
localization of vitamin D receptor (VDR), retinoic acid receptor (RAR), and RXR in 
PPCs. The effects of added all-trans retinoic acid (atRA, a form of vitamin A), 
calcitriol (activated vitamin D) and of these ligands together on PPC cell viability, 
proliferation and apoptosis were assessed by MTT, BrdU and ELISA assays, 
respectively. Post-treatment neurogenin-3 (NGN3) expression, necessary for islet-cell 
lineage development, was examined by real-time RT-PCR. Results showed that RAR, 
RXR and VDR were expressed in PPCs. RAR and RXR were localized in nuclei, and 
the VDR in nuclei, cytoplasm and plasma membrane. atRA and calcitriol each 
increased PPC viability and proliferation; atRA additionally decreased PPC apoptosis. 
Co-addition of atRA and calcitriol had no additive effects on cell viability but did 
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increase ngn3 responses. In conclusion, RAR, RXR and VDR are expressed in human 
fetal PPCs and PPC proliferation can be promoted by calcitriol, atRA or both together, 
data valuable for elucidating mechanisms underlying islet development and for 
developing clinical islet transplantation. 
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3.2 Introduction 
Type 1 diabetes mellitus (TIDM) is a severe disease with major acute 
complications such as hyperglycemia and ketoacidosis and chronic complications, 
leading to blindness, renal failure and cardiovascular disease (Kitabchi et al., 2009; 
Ovalle et al., 2008; Simo et al., 2009; Marshall et al , 2006) that increasingly affects 
human populations world-wide. It is characterized by absolute deficiency of insulin 
secretion following autoimmune destruction of pancreatic islet beta-cells leading to 
loss of glucose homeostasis (Kitabchi et al., 2009; Marshall et al., 2006). Current 
treatments such as administration of exogenous insulin and dietary regimens focus on 
lowering blood glucose (Simo et al., 2009; Renner et al., 1990; Girish et al., 2006). 
These approaches do not, however, restore glucose homeostasis physiologically nor 
alter the disease state. Transplantation of a complete vascularized pancreas or of 
pancreatic islets provides more promising approaches to long-lasting and effective 
treatment. Despite active organ donation programs, an insufficient supply of 
compatible donor pancreata remains a problem (Lemer et al., 2008). 
Biological research on stem and islet cells has led to the development of 
experimental islet cell replacement using harvested islets and efforts to solve this 
problem using islets grown from stem cells therapy. The signals necessary for 
effective promotion of islet beta-cell development must be identified for stem cells 
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therapy to become an effective treatment, or even a cure, for TIDM and a treatment 
option for type 2 diabetes mellitus (T2DM) (Kodama et al., 2004; Evans-Molina et al., 
2009). Our laboratory has successfully isolated and characterized a population of fetal 
pancreatic progenitor cell (PPC) model from first trimester human fetal pancreas 
using a basic protocol developed for differentiating PPCs into insulin-secreting 
islet-like cell clusters (ICCs) (Suen et al., 2008; Leung et al., 2009). Further 
identification of all the factors necessary for islet beta cell differentiation is required 
before translation of this work into clinical practice can be achieved. 
All-trans retinoic acid (atRA), a vitamin A derivative, is well known for its 
importance in mammalian development (Niederreither et al , 2008; Cheung et al., 
2003; Wohl et al., 1998). It supports pancreas axial patterning and formation during 
early embryonic development (Niederreither et al., 2008; Ostrom et al., 2008; Stafford 
et al., 2003; Alexa et al., 2009; Shi et al., 2005). The RA synthesizing enzyme Radlhl 
is present in the human fetal pancreas during the stage at which the main generation 
of beta-cells takes place (Ostrom et al, 2008). Given that Radlhl is involved in the 
tissue-specific patterning of RA (Niederreither et al., 2008), this finding suggests that 
RA, at appropriate concentrations, may play a role in the development of mature 
pancreatic beta-cells (Ostrom et al., 2008). We therefore set out to examine the 
biological function of different concentrations of RA in our PPC system and whether 
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the retinoic acid receptor (RAR), necessary for RA effectiveness [12], was present 
during PPC differentiation. 
In addition, the active hormonal form of vitamin D, 
1,25-dihydroxycholecalciferol (l,25-(OH)2D3; calcitriol) (Feldman, 2005; Carlberg 
et al., 2007; Kochupillai et al., 2008) promotes insulin secretion and release from 
healthy mature beta-cells (Lee et al., 1994; Norman et al., 1980; Tanaka et al., 1984; 
Nyomba et al., 1984; Bourlon et al., 1999). Calcitriol exerts this effect on glucose 
induced secretion of insulin but has little effect on serum insulin concentrations 
during fasting (Cade et al , 1987). Calcitriol is also involved in the development of 
certain stem cells (Alon et al., 2002), such as keratinocytes (Cianferotti et al., 2007) 
and the vitamin D receptor (VDR), provide effector pathways for genomic and the 
more rapid non-genomic effects of calcitriol through the nuclear and plasma cell 
membrane caveolar VDRs respectively since VDRs are located in both these sites in 
islet beta cells. (Feldman, 2005; Carlberg et al., 2007; Kochupillai et al., 2008) 
Vitamin A and vitamin D are fat soluble vitamins whose active metabolites, 
atRA and calcitriol, can pass through the cell membrane on carrier proteins 
potentiated by factors such as megalin and cubulin to bind to their receptors. The 
nuclear VDR and the RAR are members of the nuclear receptor superfamily which 
modulate transcriptional regulation of many body functions, including reproduction 
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and development as well as many aspects of metabolism (Niederreither et al, 2008; 
Feldman D et al., 2005). atRA and calcitriol act synergistically through RXR:VDR 
heterodimers to effect many of vitamin D's known effects; they also interact to inhibit 
the proliferation of breast (MCF-7) and ovarian cancer (NIH:0VCAR3) (Saunders et 
al., 1995) and promote the differentiation of human promyeloid leukemia cells 
(HL-60) into monocytes (Brown et al., 1994). The RAR and VDR can each 
heterodimerize with the retinoid X receptor (RXR), accounting for further interactions 
of the atRA and calcitriol signaling pathways (Niederreither et al., 2008; Feldman et 
al.’ 2005; Popadic et al., 2008; Wang et al., 2000; De Vos et al., 1997) and also of the 
cytochrome P450 superfamily enzymes CYP26 and CYP24 Niederreither et al., 2008; 
Feldman et aL, 2005; Lou et al., 2005). AtRA also down-regulates cellular levels of 
CYP24 while enhancing the actions of calcitriol (Lou et al., 2005). 
Given these potential interacting pathways, experimental co-treatment with both 
atRA and calcitriol or of whole animals with vitamins A and D, can lead to additive, 
synergistic or even antagonistic effects. In order to develop clinically applicable stem 
cell therapy we aimed to characterize the expression and location of the RAR, RXR 
and VDR, the effects of atRA and calcitriol, individually and in combination on PPC 
proliferation and maturation. 
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3.3 Materials and Methods 
3.3.1 Fetal Tissue Procurement 
The human fetal pancreata used in these experiments were obtained by the 
Department of Obstetrics and Gynecology in the Prince of Wales Hospital at The 
Chinese University of Hong Kong (Suen et aL, 2008; Leung et al., 2009) following 
surgical termination of pregnancy (STOP) by dilation and extraction at 9-15 weeks 
gestation, with informed consent. Ethical approval for the use of fetal tissue was 
obtained from the Clinical Research Ethnics Committee (CREC-2005.461). 
3.3.2 Culture of Pancreatic Progenitor Cells 
Each experiment was performed using preparations from a single isolated fetal 
pancreas for pancreatic progenitor cell preparation, as previously described (Suen et 
aL, 2008; Leung et al., 2009). In brief, the pancreas was immersed in chilled RPMI 
1640 medium and then minced and digested in 3 mg/ml collagenase P (Roche, 
Mannheim, Germany) at 37°C for 5 min. before being resuspended in modified RPMI 
1640 medium supplemented with 10% fetal bovine serum (FBS), 10 mM HEPES 
buffer, 1 mM sodium pyruvate (Invitrogen, Carlsbad, CA, USA), 100 U/ml of 
penicillin G, 100 jag/ml of streptomycin sulphate (Gibco Life Technologies, CA, 
USA), and 71.5 |iM betamercaptoethanol (Sigma Aldrich, St. Louis, MO, USA) in 60 
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mm culture dishes (Corning Incorporated, NY, USA) at 37°C for 48 h. Rounded, 
non-adhesive cell clusters were obtained, transferred to a new culture dish, for 
incubation for 48 h to remove fibroblasts. Themedia were changed with 10 ml 
modified RPMI 1640 medium containing 8 ng/ml basic fibroblast growth factor 
(bFGF) (Sigma) and 10 ng/ml epidermal growth factor (EGF) (Invitrogen) in a T75 
flask to induce cell outgrowth. After 24 h, monolayers of cells migrated out from the 
cell clusters, taking about 3 days to reach 90% confluence, the media being renewed 
daily to support the cell growth. Upon reaching 90% confluence，the cell monolayer 
was harvested with TRYPLE (Gibco Life Technologies) and the cells replated for up 
to 20 passages; passages 3—10 being used for these experiments. DIM45 cells (a gift 
from Dr. H. 
Wise, The Chinese University of Hong Kong) were grown in DMEM supplemented 
with 10% FBS, 100 U/ml of penicillin G and 100 \xg/ml streptomycin sulfate. Caco-2 
cells were grown in MEME medium (Sigma) supplemented with 2 mM Glutamine, 
l%NEAAand 10% FBS. 
3.3.3 RNA Expression Analysis by Reverse Transcription-Polymerase 
Chain Reaction (RT-PCR) 
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Total RNA was extracted from PPCs using Trizol (Invitrogen) according to the 
manufacturer's protocol. As previously described in our laboratory (Suen et al., 2008; 
Leung et al., 2009), first strand cDNA was reverse transcribed using Superscript III 
(Invitrogen) fromS |ig RNA in a reaction volume of 15 Each PGR was performed 
in a 25-\i\ reaction volume with 1 \i\ cDNA. Quantitative real-time PGR analyses of 
different genes were performed using i-Cycler Thermal Cycle (version 3.1) (Bio-Rad 
Laboratory Inc., Munich, Germany) (see Table 1 for specific annealing temperatures). 
The reactions were performed in triplicate in 25 jil volumes with 1 cDNA, SYBR 
Green PGR Master Mix (Bio-Rad Laboratory Inc.), and 0.3 )iM of each primer 
(Invitrogen). Melt-curve data through temperature gradients (+0.5°C every 10 s) were 
analyzed at the end of each RT-PCR experiment to guarantee the specificity of each 
amplified target PGR product. Amplification data were collected using an i-Cycler 
Detector and then analyzed using Sequence Detection System Software (Biorad Inc., 
Hercules, CA). Transcript levels relative to those of p-actin were calculated using the 
2-AACt statistical method (see "Statistical data analysis"). The primer sequences 
employed in this study are shown in Table 3.1. 
3.3.4 Western Blot Analysis 
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Total proteins were isolated from the cultured PPCs using CytoBuster'^^ Protein 
Extraction Reagent (Novagen, Darmstadt, Germany) according to the manufacturer's 
protocol and our laboratory (Suen et al., 2008; Leung et al., 2009). In brief, the 
CytoBuster™Protein Extraction Reagent was added to the supernatant fromthe PPC 
lysate and incubated for 10-15min at roomtemperature before centrifUgation at 
16000g for 15 min at 4°C to remove the cellular debris. Supernatant lysate protein 
content was then quantified using Bio-Rad protein assay reagents (Bio-Rad 
Laboratory Inc.) using aliquots containing 15-30 jig/lane for electrophoresis on 12% 
(wt/vol) polyacrylamide gel and 
electrotransferred to polyvinylidene fluoride transfer membrane. (GE Osmonics 
Labstore,Minnetonka,MN, USA). Nonspecific proteins were blocked by incubation in 
5% (wt/vol) skim milk in phosphate-buffered saline (PBS; Invitrogen) with 0.1% 
Tween-20 in PBS (PBS-T) for 1 h at room temperature. After rinsing twice with 
PBS-T the membranes were incubated overnight at 4°C in PBS-T containing primary 
antibodies (Santa Cruz Biotech., Santa Cruz, CA, USA.) to the proteins of interest: 
rabbit anti-RAR antibody (1:300), anti-RXR antibody (1:500)，anti-VDR antibody 
(1:1200) and mouse anti-actin antibody (1:8000). After the membranes had been 
re-washed twice, they were incubated in PBST with secondary anti-rabbit (1:3700) or 
anti-mouse (1:5000) antibodies at room temperature for 1 h. Positive bands were 
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detected using enhanced chemoluminescense (ECL) and western blotting detection 
reagents (Amersham, Buckinghamshire, UK) followed by membrane exposure to 
X-ray film (Amersham, Buckinghamshire, UK). Protein band intensities were then 
quantified using image analyzer (Molecular Dynamics Image Quant, Sunnyvale, CA, 
USA). 
3.3.5 Immunocytochemistry 
PPC monolayers were cultured on coverslips coated with 3% gelatin in PBS and 
fixed with 4% paraformaldehyde in PBS for 30 min at room temperature. The samples 
were then permeabilized with 0.01% Triton-X in 1% bovine serum albumin 
(BSAyPBS for 5 min at room temperature, before being blocked with 6% normal 
donkey serum in 1% BSA/PBS at room temperature for 1 h before being incubated 
with primary rabbit anti-RAR (1:100), anti-RXR (1:100) or anti-VDR (1:100) 
antibodies (Santa Cruz Biotech.), at 4°C overnight, as described previously (10, 11). 
The samples were then washed with PBS several times and incubated with Alexa 
Fluor 568 donkey anti-rabbit antibodies (1:500) at room temperature for 1 h and 
4 " ,6 ' -diamidino-2-phenylindole (DAPI) (1:1000) nuclear counterstain for 15 min. 
Omission of primary antibodies was used as a negative control. The slips were then 
washed thoroughly with PBS several times, mounted in Vectashield, and imaged 
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using a fluorescence microscope equipped with a DC 200 digital camera. (Leica 
Microsystems, German) Multiple images were captured separately at different laser 
wavelengths before being merged. 
3.3.6 PPC Proliferation Assays 
PPCs were plated at 1.5x1 O* cells per well in 96-well plates with modified RPMI 
medium. The cells were then incubated in serum-free conditions overnight to arrest 
the cell cycle. atRA and calcitriol were then added at concentrations, ranging from 
10—12 to 10—5 M and to 10"^ M, respectively, to cells in modified RPMI medium 
supplemented with 0.5% FBS. Two assays were used to measure cell proliferation 
rates: 5-bromo-2-deoxyuridine (BrdU) uptake and 3-(4,5-dimethylthiazol-2-yl) 
-2-5-diphenyltetrazolium bromide (MTT) assay for mitochondrial activity, which 
have been described previously in our laboratory (Suen et al., 2008). The MTT assay 
(Sigma) was performed according to the manufacturer's protocol. Briefly, after 
removal of the modified RPMI medium, the cells were incubated with MTT solution 
(0.05 mg/ml) for 3 h at 37°C under 5% C02. The formazan was immediately 
dissolved by addition of 100 |il DMSO. The absorbance for each treatment (n=6 per 
treatment) was then measured at 540 nm. The BrdU incorporation assay (Amersham 
Biosciences, UK) was performed according to the manufacturer's instructions. Briefly, 
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after removal of the modified RPMI medium, the cells were incubated with BrdU in 
0.5% FBS modified RPMI medium for 4 h at 37�C under 5% C02. After removal of 
the labeling medium by suction, the cells were fixed by fixative solution provided for 
30 min at room temperature and the fixative was then removed. The cells were treated 
with blocking reagent and incubated for 30 min at room temperature. After removal of 
the blocking solution the cells were incubated with peroxidase-labeled monoclonal 
mouse anti-BrdU for 120 min at room temperature before being washed three times 
with the washing solution. 100 |LI1 of room temperature equilibrated TMB substrate 
was added to each well and the plate was then covered with aluminum foil to keep it 
dark and incubated at room temperature for 10 min. The reaction was then stopped by 
the addition of 25 |il 1 M sulphuric acid. The absorbance of each well was measured 
at 450 nm (ref. 490 nm) using a MicorKinetics plate reader (PerkinElmer, CA, USA). 
Values were averaged for each treatment group (n=3). 
3.3.7 PPC Cell Death Assays 
PPCs were treated with atRA and calcitriol, as described above for the cell 
proliferation assays, except that the medium was not supplemented with FBS. 
Enzyme-linked immunosorbent cell death assays (ELISAs; Roche Diagnostics 
Indianapolis, IN, USA) were performed to assess cell death according to the 
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manufacturer's instructions. Briefly, after PPCs were treated with atRA for 72 h, the 
cells were treated with lysis buffer at room temperature for 30 min. The lysates were 
collected and centrifuged at 200 x g for 10 min. The supematants were collected, 
added to the strip, immuno-reagent was added and shaken at 300 rpm for 2 h. before 
the solutions were removed by suction and rinsed with incubation buffer x3. ABTS 
solution was added and upon color development, ABTS stop solution was added. The 
absorbance of the well contents was then measured at 450 nm (ref. 490 nm) using a 
MicorKinetics plate reader (PerkinElmer). Values were averaged for each treatment 
group (n=3). 
3.3.8 Statistical Data Analysis 
Data are presented as means 士 SEM for all groups. Comparison probabilities (P 
values for chance differences between experimental groups) were made using 
Student's independent two-tailed t-test. Multiple comparisons between groups were 
performed using analyses of variance (ANOVAs) followed by Tukey's post hoc tests. 
For all comparisons, P < .05 was considered statistically significant. For quantitative 
real-time RT-PCR, relative expression was normalized to p-actin and calculated using 
the comparative CT method; the fold change being defined as 2 AACt. Statistical 
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analyses and graphics were carried out using GraphPad Prism 5 (GraphPad Software, 
San Diego, CA, USA). 
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3.4 Results 
3.4.1 Expression and Localization of RAR, VDR and RXR, CYP26 and 
CYP24 in PPCs 
RAR, VDR and RXR mRNA expression was present in 12 & 13 weeks gestation 
PPCs (Figure 3.1 A). Detectable amounts of RAR, RXR and VDR protein were also 
documented in first trimester fetal PPCs and neither receptor protein nor expression 
profiles of these receptors varied with gestational age (between 9 and 15 weeks) of the 
source material (Figure 3.IB, C, D). Subsequent experiments did not, therefore, 
distinguish data from experiments on PPCs by gestational age of the donor fetus. In 
order to further localize the RAR, VDR and RXR in PPCs, immunofluorescence 
labeling was employed (Figure 3.2); results showed that the RAR (Figure 3. 2A & B) 
and the VDR (Figure 3.2C & D) were both present in the plasma membrane and in the 
nucleus as well as being scattered throughout the cytoplasm. However, the RXR was 
located exclusively in the nucleus (Figure 3.2E & F). Specificity of immunoreactivity 
has been validated by controls incubated without primary antibodies in each case 
(Figure 3.2G & H). On the other hand, neither the catabolic enzyme for atRA or for 
calcitriol, i.e. CYP26 and CYP24, respectively, was expressed in our experimental 
PPC system (Figure 3.3). 
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3.4.2 Incubation of PPC with atRA Enhances PPC Viability due to 
Increased Proliferation and Anti-apoptosis 
MTT assays indicated that PPC viability was affected by 72-h treatment with 
atRA in the to 10"^  M range in a dose-dependent manner. At 10—12 M, atRA 
treatment nearly tripled cell viability compared to control incubated cells (Figure 
3.4A). BrdU proliferation assays indicated that treatment with atRA at concentrations 
一 1 ) 一 c 
in the range of 10" to 10" M for 72 h resulted in significantly enhanced cell 
proliferation (by ~200% at M atRA vs. Vehicle controls) (Figure 3.4B). Cell 
death rates for PPCs in serum-free media were almost 6-fold those seen in PPCs 
- —12 
incubated in full serum media. Treatment with 10— M atRA for 72 h decreased cell 
death in serum-free incubated PPCs almost approximately -50% (Figure 3.4C). 
3.4.3 Incubation of PPCs with Calcitriol Enhances Viability due to 
Increased Proliferation 
MTT assays revealed that calcitriol, at to 10—14 M for 72 h, enhanced cell 
growth which was maximal at 10—14 by �50o/o (Figure 3.5A) and significant 
effects were not observed with higher concentrations. BrdU proliferation assays also 
showed that calcitriol treatment, at to 10—14 ^  for 72 h, significantly enhanced 
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cell proliferation (by almost 50%) but that other concentrations had no effect on cell 
proliferation (Figure 3.5B). 
3.4.4 Both atRA and Calcitriol Induce Up-regulation of both the RAR and 
the VDR but not the RXR 
VDR and RAR (Figure 3.6A & B), but not RXR (Figure 3.6C) mRNA levels 
were elevated 13-fold and 3-fold respectively following 48-h exposure to calcitriol 
(10—14 M); in addition, RAR and VDR (but not RXR) mRNA levels were elevated 
3-fold following 48-h exposure to atRA (10—丨�M) (Figure 3.6). 
3.4.5 Combination Treatment with atRA and Calcitriol on Cell Viability 
and NGN3 Expression 
Combined treatment of PPCs with maximally effective concentrations of atRA 
(10—12 M) and of calcitriol (10—14 serum-free media for 72 h did not increase cell 
viability relative to untreated controls and less than either alone (Figure 3.7A). 
Real-time PCR analysis of cDNA reverse transcribed from RNA derived from 
isolated PPCs after combined treatment with both atRA and calcitriol indicated that 
co-treatment greatly increased NGN3 expression by about 6 folds, compared to 
vehicle incubated control cells (Figure 3.7B) though atRA treatment alone decreased 
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NGN3 expression and calcitriol treatment alone did not alter NGN3 expression, 
relative to ngn3 expression in untreated control cells. 
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3.5 Discussion 
The present study is the first characterization of the effects of retinoic acid and 
hormonal vitamin D in our human primary culture derived-pancreatic progenitor cell 
(PPC) system (Suen et al., 2008; Leung et al., 2009). We have demonstrated that 
PPCs express the RAR and VDR in the nucleus, cytoplasm and plasma membrane but 
the RXR only in the nucleus, suggesting that effector systems for atRA and calcitriol 
match those seen in adult tissues, including interaction with the RXR in the nuclei 
(Niederreither et al., 2008; Feldman et aL, 2005; De Vos et al., 1997). There was no 
variation in expression of these receptors with gestational age of PPC donors, 
indicating that vitamins A and D are likely to have consistent effects, such as growth 
and differentiation, in PPC preparations from 9 to 15 weeks gestational age donors. 
Neither of the enzymes catabolic for hormonal vitamin D and atRA, i.e. CYP26 
and CYP24 (Feldman et aL, 2005; Popadic et al, 2008) were detectable in our PPC 
system; thus the usual down-regulatory systems for these vitamins appear to be absent 
in our PPC preparations. Whilst atRA and calcitriol can have antagonistic effects on 
each other (Feldman et al., 2005; Popadic et al., 2008) this seems unlikely to be the 
case in our PPC system since co-treatment with atRA and calcitriol had no such 
effects. Thus, the mechanisms for regulation of the effects of vitamin A and D in our 
PPCs require further investigation. The well known morphogen atRA has dose-effects 
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(Niederreither et al., 2008). Similarly, we found dose dependent variation in its effects 
on PPC cell viability though the effects on proliferation were not dose-dependent, 
suggesting that there were anti-apoptotic effects on PPCs, as confirmed by direct 
measurements. Consistent with the known dose-dependent effects of calcitriol on cell 
proliferation (Alon et aL, 2002), PPC viability was increased by calcitriol but only at 
concentrations of 10_i3—10—14 M, i.e. about the physiological level of fetal serum, 
which is lower than maternal serum level (Salle et al., 2000) and this effect appeared 
to be due to increased cell proliferation. 
Upregulation of both RAR (Chomienne et al , 1991; Wuarin et al” 1994; 
Friedman et al., 1993) and VDR (Albrechtsson et al., 2003; Jensen et al., 2002; Wiese 
et al., 1992; Li et al., 1999) expression with exposure to either atRA or calcitriol, 
individually, suggests binding of each of these ligands to response elements on the 
genes of both receptors. The fact that there was greater RAR and VDR mRNA 
expression following longer incubations with either ligand is compatible with this 
view; atRA can be a signaling partner with calcitriol but this has been thought to 
reflect VDR:RXR heterodimerization (Feldman et aL, 2005; Carlberg et aL, 2007) 
rather than cross stimulation of the genes for these receptors. The finding of the RXR 
in our PPC system as well as the VDR and RAR is consistent with the possibility of 
cross-talk between the actions of atRA and calcitriol being mediated through the 
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interactions of each of these receptors with the RXR (Niederreither et al., 2008; 
Feldman et al., 2005; De Vos et al, 1997). However, we found, surprisingly, that 
combined treatment with atRA and calcitriol did not enhance PPC viability, a 
negative finding that may reflect potentiation of differentiation since expression of 
NGN3, a marker for endocrine cell specialization (Gradwohl et al., 2000) was 
increased over 6-fold by combined treatment as compared to the effect of either 
ligand alone. If confirmed, this would imply that the policy of giving vitamin D 
supplement along in pregnancy instead of cod liver oil would need adjustment. 
Cod-liver oil, act as natural supplement of vitamin A and vitamin D, is well known 
for its beneficial effects on growth in infants and children. (Masterjohii, 2009; Morgan 
et aL, 1937; Metz et aL, 1985; Clerk et al., 1962 ； Clerk et al., 1963) Yet, due to 
vitamin A's teratogenicity, vitamin D supplement along is used instead. From other 
research, specification of endocrine cells occurred within 20-23 weeks gestation. 
(Sarkar et al., 2008) As a result, intake of cod liver oil might prove to have specific 
benefits for endocrine islet cell formation within 20-23 week gestations. 
In conclusion, RAR, VDR and RXR were confirmed to be present in first 
trimester human fetal pancreatic progenitor cells and atRA and calcitriol were each 
shown, individually, to be capable of increasing PPC viability. While further 
investigations are needed to delineate the differentiation properties of PPCs and 
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clarify the roles of vitamin A and vitamin D in islet development, especially of the 
beta cell, the present data suggests that both vitamin A and vitamin D are involved in 
PPC development. These findings may contribute to the development of insulin 
sensitive ICCs which is suitable for subsequent transplantation for the treatment of 
TIDM, and possibly also of T2DM. 
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Figure 3.1 Characterization of RAR, VDR and RXR expression and protein content in 
PPCs. A. RT-PCR analysis of RAR, VDR and RXR gene expression from 12 to 13 
weeks pancreas PPC preparations; controls (-RT) lacked cDNA; human prostate 
cancer cells (DU-145) provided positive controls (De Vos et ai., 1997). B. Western 
blot analysis of RAR, VDR and RXR protein in PPCs derived from 9 to 15 week 
human fetal pancreas. C-E. Relative expression of RAR, VDR and RXR to beta-actin 
of PPCs derived from 9 to 15 weeks of pancreas. Each gene or protein was amplified 
in triplicate from three to five separate PPC samples prepared from different fetal 
pancreata. The protein/actin ratio did not vary with gestational sample age. 
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Figure 3.2 Localization of RAR. VDR and RXR proteins by immunoreactivitv in 
PPCs. PPCs derived from pancreata across a range of gestational ages were 
immunolabeled with antibodies against RAR, A. x400, B. x630; against VDR, C. 
x400, D. x630; against RXR, E. x400, F. x630; negative controls of RAR, VDR and 
RXR immunoreactivity, incubated without any primary antibodies, H. x400, G. x630 
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Figure 3.3 Characterization of enzymes catabolic for atRA and calcitriol (CYP26 and 
CYP24). Expression of these genes was not detectable in our 12-wk pancreas PPC 
preparations. Human prostate cancer cells (DU-145) (Muindi et al , 2007) and human 
colon cancer cells (Caco-2) (Lampen et al., 2001) served as positive controls. 
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Figure 3.4 The effects of atRA on PPC proliferation. A. MTT proliferation assays and 
B. BrdU proliferation assays of PPCs exposed to atRA (10-12 M to 10—5 M for 72 h 
using DMSO as the vehicle control; showed dose-dependent effects, maximal at 
10-12 M atRA. C. Antiapoptotic effect of atRA at 10-12 M (in serum-free conditions 
for induction of cell death). All data were expressed as means 士 SEM of three 
experiments with three independent fetal samples (n=3 for each group; *p<0.05, 
**p<0.01, ***p<0.001 vs. vehicle control and #p<0.05, ##p<0.01, ###p<0.001 vs. 
serum-free vehicle) 
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Figure 3.5 The effects of calcitriol on PPC proliferation. A. MTT and B. BrdU 
proliferation assays of PPCs treated with calcitriol (10—14 M to 10—4 M for 72 h) 
using absolute ethanol as the vehicle control showed increased cell viability at 
concentrations of 10—14—10—13 M. All data are expressed as means 士 SEM of three 
experiments with three independent fetal samples (n=3 for each group. *p<0.05, 
**p<0.01, ***p<0.001 vs. vehicle control) 
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Figure 3.6 Effects of the RAR agonist atRA and the VDR agonist calcitriol on the 
mRNA expression of the RAR, VDR and RXR. A. RAR expression was increased in 
PPC preparations by exposure to AtRA (10-12 M, 48 h) and by exposure to calcitriol 
(10—14 M, 48 h); B. VDR expression was increased in PPC preparations by exposure 
to AtRA (10-12 M, 48 h) and by exposure to calcitriol (10—14 M, 48 h); C. There 
was no effect on RXR expression in PPC preparations of exposure to either AtRA 
(10-12 M, 48 h) or to calcitriol (10-14 M, 48 h). All expression concentrations were 
normalized to beta-actin and relative levels defined as 2 AACT. All data were 
expressed as mean 士 SEM (n=6 per group. *p<0.05, **p<0.01, ***p<0.001 vs. 
vehicle controls) 
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Figure 3.7 The effects of atRA combined with calcitriol on cell proliferation and 
‘maturation’ in PPC preparations. A. Exposure to atRA (10-14 M) / calcitriol (10-12 
M) in combination for 72 h did not enhance cell viability in comoparson with that 
produced by either ligand alone. B. Expression of the endocrine specification marker 
ngn3, measured by real-time PGR, was markedly increased by exposure to these two 
ligands in combination as compared to exposure to either alone. 
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Table 1 Sequence of the specific PCR Primers and their expected product size of different target genes 
Gene Sense primer Antisense primer Annealing temperature Product 
(�C) {b‘pj 
For RT-RCR 
^-actin TGGCACCACACCTTCTACAATGAGC GCACAGCTTCTCCTTAATOTCACGC 60 396 
RARa GACCAG 肌 ACCCTCCTCAA GTCCGAOAAGGTICATGGTGT 60 99 
RXRa CTOCrCATCGCCrCCTTCr ACACAAGCTCCGICAGCAC 60 142 
VDR C1€AAAC6CTGTCTCGACAT ACTOTCCTrCAAGGCCTCCr 60 117 
CYP24 GA,\ACCACi<jGC*AAGTGATOA AACOACCATITGTTCAGTTCG 60 135 
CYP26 CCAGAAAGTGCGAC3AAGA0C GGOATTCAOTCOAAGQGTCr 60 136 
For ml-time PCR 
U^ain TGTCCACCnrrCCAGCAGATGT CGGACTCGTCATACTCCTGCTT 62 51 
RARa GACCAGAFCACCCTCCTCAA GTCC0A0.4AG0TCATGGTGT 60 99 
RXRct CTQCTCATCGCCrCClTCr ACACAAGCTCC»TCAGCAC 60 142 
VDR CTCAAACCJCTGTCTGGACAT ACTOTCCTTCAAGCCCTCCT 60 117 
N0N3 TGTC^SGUGCTAAGGGTAAGO GGGAGAAGCAGAAGGAACAA 60 99 
Table 3.1 Sequence of the specific PCR Primers and their expected product size of 
different target genes 
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Chapter 4 
Human fetal liver stromal cell co-culture enhances the growth and 
differentiation of pancreatic progenitor cells into islet-like cell clusters 
(The content of this chapter has been submitted to Gastroenterology) 
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4.1 Abstract 
BACKGROUND & AIMS: Recent advances in directed differentiation of pancreatic 
stem cells offer potential for the development of replacement therapy for diabetes patients. 
Existing differentiation protocols, however, are complex, time-consuming, and costly; thus 
there is a critical need for alternative protocols. Given the common developmental origins 
of the liver and pancreas, we sought to develop a novel protocol devoid of growth factors 
by using a microenvironment established by liver stromal cells (LSCs) derived from 
human fetal liver. We examined the effects of this LSC microenvironment on the growth 
and differentiation of established pancreatic progenitor cells (PPCs) into islet-like cell 
clusters (ICCs). METHODS: PPCs and LSCs were isolated from and trimester 
human fetal tissues and underwent co-cultures. The growth, differentiation, and 
functionality of PPCs and ICCs were determined by examining cell viability, expression 
levels of critical markers and insulin secretion ability for pancreatic beta-cells. We also 
compared the differential expression profile of growth factors from the LSCs derived from 
ist versus trimester fetal livers. RESULTS: Co-cultures with trimester LSCs 
enhanced PPC growth, ICC differentiation and ICC functionality without the addition of 
exogenous growth factors. A host of morphogenic factors were expressed in LSCs, and 
insulin-like growth factor 1 (IGFl) was identified as being responsible for the above 
effects. CONCLUSIONS: This is the first report showing that LSC microenvironment 
can induce PPCs derived from human fetal pancreas to grow and differentiate into 
ICCs while also enhancing the functionality of ICCs. Further modifications of the 
stroma microenvironment may offer an alternative, efficient and cost-effective 
approach providing islet transplantation. 
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4.2 Introduction 
Transplantation of human pancreatic islets is the ideal curative option for 
replacement of beta-cell mass in diabetic patients (de Kort el al., 2011; Shapiro et al., 
2003; Ryan et al., 2005). Despite the active promotion of organ donation, lack of islet 
donors has adversely affected the availability of this treatment modality. The need for 
alternative sources of islets has prompted a rapid rise in stem cell therapy and islet 
regeneration research (Yechoor et al., 2010; Kordowich et al., 2010; Juhl et al., 2010). 
Stem cells, characterized by their capacity for pluripotency and potential to 
differentiate into islet cells, thus, could be used to help to replace absent, damaged, or 
malfunctioning islets. Hence, stem cells offer the potential of being an unlimited 
source of human islets for diabetes research and transplantation; in view of this, 
considerable efforts have been invested in investigating islet engineering (de Kort el 
al., 2011; Shapiro et al., 2003; Ryan et al, 2005; Yechoor et al., 2010; Kordowich et 
al., 2010; Juhl et al., 2010; Guo et al., 2009). 
Combined treatment with activin A and retinoic acid has been demonstrated to 
efficiently induce the generation of insulin-producing cells from mouse embryonic 
stem cells (Shi et al., 2005). However, this simple protocol was not effective when 
applied to human embryonic stem cells (Jiang et al , 2007), raising concerns about the 
ability to translate research conducted with mouse stem cells into human stem cells 
given the inherent inter-species differences (Shi et al., 2005; Jiang et al., 2007; 
Joglekar et al., 2009; Suen et al., 2006; Suen et al., 2008). Our group has established 
a system for the isolation and culture of pancreatic progenitor cells (PPCs) derived 
from human fetal pancreas tissue. These PPCs have been shown to have a high 
capacity for proliferation and differentiation when cultured with appropriate 
differentiation cocktail, and the effects of several morphogens, e.g. sPDZD2, vitamin 
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A and vitamin D related to human pancreatic development have been studied in this 
system (Suen et al., 2008; Ma et al., 2011; Ng et al., 2011; Leung et al., 2009). 
Recently, different approaches have been utilized for islet engineering, such as 
genetic modifications, directed differentiation and in vivo stem cell injection (Yechoor 
et al, 2010; Kordowich et al., 2010; Juhl et al., 2010; Guo et al., 2009). Within these 
approaches, directed differentiation is the most popular means of islet engineering 
(Yechoor et al., 2010). D' Amour and colleagues have reported a complicated step-
wise protocol (D'Amour et al., 2006) for differentiating human embryonic stem cells 
into islets that mimics in vivo development and produces an insulin content similar to 
that of human adult islets. Though this result is exciting, the protocol is variable 
among different stem cells, notably different cell lines of embryonic stem cells. 
Furthermore, substantial difficulties, such as the high costs of the large doses of 
growth factors needed, remain for directed differentiation. Therefore, with the idea of 
mimicking the developmental environment, we aim to develop more economical and 
convenient methods to achieve differentiation using a microenvironment, or stem cell 
‘niche’，for islet cell development. 
Mesenchymal/stromal cells consist of a heterogenous population of cells that 
provide structural and physiological support for somatic cells (Alphonso et al., 2009; 
Krebsbach et al., 1999). Recent research has shown that they support differentiation 
(Lee et al., 2011; Soto-Gutierrez et al., 2008) survival, and functional improvement 
(Sordi et al , 2010; Luo et al., 2007). It would be of interest, therefore, to assess the 
differentiation potential induced by a human fetal stroma generated microenvironment. 
Since to date there are no well established protocols available for isolating pancreatic 
stroma and organ development is a complicated and interactive process involving 
many different organs (Ranjan et al., 2009; Guney et al., 2009), in this study, human 
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fetal liver stroma was introduced into cellular microenvironment because methods for 
its isolation and culture (Lee et al., 2011) are well-established and liver stroma cells 
(LSCs) are developmentally closely related to pancreatic cells (Ji et al., 2009; Imai et 
al., 2009; Meivar-Levy et al., 2003; Deutsch et al., 2001; Odom et al., 2004; Si-Tayeb 
et al., 2010; Zaret et al , 2008; Morrison et al., 2004; Imai et al.，2008). 
During embryogenesis, neighboring tissues are under the influence of similar 
combinations of transcription factors, differing by just one or a few factors (Odom et 
al., 2004; Si~Tayeb et al , 2010). Developmentally, emergence of the ventral pancreas 
has been shown to be related to the emergence of the liver; their specifications are at 
the same time and in the same general domain of cells (Deutsch et al., 2001; Odom et 
al., 2004; Zaret et al., 2008). Fibroblast growth factor (FGF) signaling from the 
cardiac mesoderm diverts endodermal cells to express genes for liver instead of those 
for pancreas, implying that a lack of FGF signaling from the cardiac mesoderm would 
lead to the development of pancreatic tissues (Deutsch et al., 2001; Zaret et al., 2008). 
Such findings further encourage us in pursuing the possibility that stromal cells which 
support liver development could also support pancreatic development. Moreover, in 
lower organisms (e.g. Nile Tilapia), there is a single hepatopancreas rather than a 
separate pancreas and liver, further indicating that the development of these two 
organs is likely to be associated (Morrison et al” 2004). Interestingly, adult liver also 
shows a regulation of pancreatic cell mass by neuronal pathway (Imai et al, 2008). 
Additionally, we have shown that vitamin A and D, whose serum levels are regulated 
by the liver, enhance islet specification (Ng et al., 2011). 
In light of the aforementioned findings, we hypothesize that the liver plays a 
positive role in islet development via regulation of growth factors and cytokines 
secretion and we now report experiments designed to provide better insight into LSC 
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actions on PPC growth and differentiation. These data are essential for understanding 
liver-pancreas interactions in development as well as for revealing the potential of 
stem cell microenvironment for the promotion of stem cell proliferation and 
differentiation. 
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4.3 Materials and Methods 
4.3.1 Use of human and animal tissues 
The work on human and rat tissues was approved by our Institutional 
Committees on Human Ethics and Animal Ethics, respectively, The Chinese 
University of Hong Kong. Maternal consent for use of fetal tissues was obtained by 
the outpatient clinic of the Prince of Wales Hospital before surgical termination of 
pregnancy. Ethical approval for the use of human fetal tissue from the Clinical 
Research Ethnics Committee (CREC-2005.461) was obtained. 
4.3.2 Cell preparation, characterization, and differentiation 
Human PPCs and LSCs were obtained as described in the Supplementary 
Materials and Methods section. LSC characterization was performed using reverse 
transcriptase-polymerase chain reaction (RT-PCR) and immunocytochemistry. The 
procedure of human islet-like cell cluster (ICC) differentiation is described in the 
Supplementary Materials and Methods. 
4.3.3 Examination of PPC growth and ICC differentiation and functions with LSC 
co-culture 
To establish the co-culture model, human LSCs were first separated into (from 
9 up to 12 weeks) and (from 13 up to 16 weeks) trimester groups according to 
ultrasound measurements of fetal growth parameters, as previously reported (Suen et 
al, 2008; Ma et al., 2011; Ng et al., 2011; Leung et al., 2009). To determine the 
optimal irradiation for LSCs to stop proliferation, LSC aliquots were seeded on 
transwells under different irradiation levels (2000, 4000, 6000, 8000, and 10000 rad). 
After 8 days, cell counts were carried out to determine any changes in cell numbers 
and 8000 rad were selected for further study. To optimize the cell number effect of 
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LSCs on PPC cell viability and number, we co-cultured 9-16weeks LSCs (2, 4, 6, 8, 
or 10 X 104 cells) on transwells with PPCs (1.5 x 10^  cells) in 6-well plates. After 3 
days, PPCs were subjected to MTT metabolism assays and cell counts. To determine 
the effect of and trimester LSCs on PPC cell viability and number, LSCs (8 x 
104 cells) were co-cultured in transwells with PPCs (1.5 x 10^  cells) in 6-well plates. 
After 3 days in co-culture, PPC number and viability were determined by cell counts 
and MTT metabolism assays. MTT and cell count procedures are described in detail 
in the Supplementary Materials and Methods. 
To assess the effects of LSCs on ICC differentiation, LSCs were co-cultured in 
transwells with PPC-derived ICCs, with or without a differentiation 'cocktail'. Total 
RNA of the resultant ICCs were collected and subjected to real time PCR for the 
following genes: PDXl, NGN3, ISL-1, NKX2.2, NKX6.1, NEUROD, 
GLUCOKINASE, INSULIN, MHC-1, and MHC-II. In addition, the resultant ICCs 
were subjected to an enzyme-linked immunosorbent assay (ELISA) to determine their 
insulin secretory capacities. The detailed procedures used for real-time PCR and 
insulin ELISA are provided in the Supplementary Materials and Methods, and the 
primers sequences are listed in Table 4.1. 
4.3.4 Identification of growth factors and investigation of their effects 
Total RNA samples from and trimester LSCs or homogenized human 
fetal livers were collected and subjected to RT-PCR and real-time PCR. LSC 
conditioned media samples were collected for insulin-like growth factor I (IGFl) 
ELISA. The detailed procedures employed for IGFl ELISA were reported in the 
Supplementary Materials and Methods and the primer sequences are listed in Table 1. 
IGFl receptor (IGFIR) expression and localization in PPCs were determined 
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by RT-PCR, Western blotting, and immunocytochemistry. To determine the effects of 
IGFl and IGF2 on PPC cell viability, PPCs (3 x lo^ cells) were seeded in 96-well 
plates and exposed to a range of IGFl or IGF2 concentrations (1, 10, 50, and 100 
ng/ml). After 3 days, PPC viability was measured by MTT metabolism assay. 
Likewise, IGFl or IGF2 (1, 10, 50, or 100 ng/ml) was added to the differentiation 
cocktail for the culture. Total RNA samples of the resultant ICCs were collected and 
subjected to real-time PCR for the PDXl, NGN3, NKX2.2, NKX6.1, ISL-1, 
NEUROD, GLUCOKINASE and INSULIN genes. The detailed procedures employed 
for real-time PCRs are described in the Supplementary Materials and Methods section 
and the primers sequences were listed in Table 4.1. 
To determine the contribution of the IGFIR, MAB391 neutralizing antibodies 
were supplemented in PPC growth and ICC differentiation experiments. PPC viability 
experiments were performed to determine the dose response profile for MAB391 
(0.001 - 10 |Lig/ml) (described in detail in the Supplementary Materials and Methods). 
4.3.5 Statistical analysis 
Data are presented as means 士 SEM for all groups. For all comparisons, p-
values less than 0.05 were considered statistically significant. Statistical analyses and 
development of graphics were performed using GraphPad Prism 5 (GraphPad 
Software, San Diego, CA). 
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4.4 Results 
4.4.1 Isolation, culture, and characterization of LSCs 
9 to 16-gestational week human fetal liver tissues were digested with 
collagenase A into single cells and cultured in modified DMEM/F12 1:1 medium with 
10% FBS and 1% penicillin/streptomycin (P/S). Populations of LSCs with different 
morphologies, such as stellate-shaped cells and cuboidal-shaped cells, etc. appeared to 
adhere on the plastic culture flask after overnight incubation and free floating cells 
were discarded. Cells grew slowly during the first week of incubation, culminating in 
the development of a monolayer of cells. After a single passage, a monolayer of single 
stellate-shaped cells was obtained (Figure 4.1 A). These cells were expanded to more 
than 20 passages over a period of 4 to 5 months (data not shown). 
As shown in Figure 4.IB, RT-PCR analysis of stromal cells at passages 3-8 
showed that the cells expressed detectable amounts of mRNA for hepatic precursor 
markers (CK18, CK19, EpCAM, N-CAD and CD45) and stromal cell markers (CD90, 
CD105, CD 166 and VIMENTIN). The presence of liver stromal cells' markers, say 
Dlk, CD29, and CD90 proteins were localized by immunocytochemistry, which was 
found almost in every single cell (Figure 4.1C). In contrast, alpha-fetoprotein (AFP) 
and albumin, markers for hepatocytes and hepatoblasts, were detected neither at the 
mRNA nor at the protein levels (Figure 4.IB & 4.1C). Only cells that fulfilled the 
above conditions were used for subsequent experiments while other cells were 
discarded. 
4.4.2 Establishment of the LSC co-culture system 
To prevent blockage of transwells by overwhelming growth of LSCs, optimal 
irradiation (8000 rad) for LSC was determined; there was no significant change in cell 
136 
Chapter 4 Effects of human fetal liver stroma niche on PPC growth and ICC differentiation 
number after irradiation for 8 days (data not shown). PPC viability and cell count data 
indicated that the optimal LSC number per culture for preventing depletion of 
medium nutrients was � 8 x lO^ cells (Figure 4.2A, 4.2B). Moreover, it was found that, 
upon co-culture with LSCs (8 x 10^ cells), PPC viability increased 1.5-fold (P < .001 
vs. no CO-culture control) as measured by MTT metabolism (Figure 4.2A) and PPC 
counts increased 4.5-fold (P < .001 vs. no co-culture control) (Figure 4.2B). On the 
other hand, LSCs were separated into trimester (9 -12 weeks) and trimester (13 
-16 weeks) groups, according to the gestational age of the source fetus and co-culture 
of PPCs enriched with LSCs derived from trimester versus trimester fetal livers 
did not differ from each other in terms of MTT metabolism or cell number (Figure 
4.2C, 4.2D). 
4.4.3 LSC co-culture enhances PPC-derived ICC differentiation 
• 12 15 
ICC co-culture with LSCs plus the addition of a differentiation cocktail “ 
showed enhanced mRNA expression of PDXl (8-fold, P < .05), NGN3 (7-fold, P 
< .001), NKX2.2 (6-fold, P < .001), NKX6.1 (4-fold, P < .05) (Figure 4.2E), 
GLUCOKINASE (5-fold, P < .001) and INSULIN (5-fold, P < .001) (Figure 4.2F). 
The induction effects of and trimester derived LSCs were similar (data not 
shown). Subsequent experiments were designed to distinguish from the effects of a 
differentiation cocktail versus the effects of and trimester LSC co-culture alone. 
Compared to non-LSC control (with a differentiation cocktail only), ICC co-culture 
enriched with trimester LSCs, there is no significant change in transcription 
markers and functional genes, except for PDXl (3-fold, P < .05) (Figure 4.3A, 4.3B). 
While ICC co-culture enriched with trimester LSCs showed a greater upregulation 
of PDXl (4-fold, P < .001), NGN3 (11-fold, P < .001), ISL-1 (6.5-fold, P < .01)， 
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NKX2.2 (14.5-fold, P < .05), NKX6.1 (9-fold, P < .001), NEUROD (4-fold, P < .01) 
(Figure 3A), GLUCOKINASE (7.5-fold, P < .001), and INSULIN (15-fold, P < .05) 
(Figure 3B) comparing to control. 
ICCs co-cultured with trimester LSCs showed increased basal secretion of 
insulin (2-fold, P < .001 vs. no LSC co-culture), but no significant glucose-stimulated 
insulin secretion (GSIS) (Figure 4.3C). However, Potassium stimulated-insulin 
secretion (KSIS) experiments designed to evaluate the functionality of differentiated 
ICCs showed that ICCs incubated in LSC co-culture had increased KSIS (1.5-fold, P 
< .001 vs. no LSC co-culture control) (Figure 4.3D). Although the LSC for co-culture 
was derived from a different fetus, no significant alterations in the expression of 
MHC-I nor MHC-II were observed in the resultant PPCs (Figure 4.3E). On the other 
hand, a 2-fold (P < .05) increase in MHC-I and MHC-II expression was observed 
when ICCs were co-cultured with trimester LSCs and there is no significant 
alterations in the expression of MHC-I or MHC-II were observed in the resultant ICCs 
that co-culture with trimester LSCs (Figure 4.3F). 
4.4.4 Differential expression of mRNA for cytokines and growth factors between 
ist and 2nd trimester LSCs 
PCR showed that LSCs from both and trimester fetal tissues expressed 
SCF, NGF, VEGFA, FGFl, FGF2, FGF7, IGFl, IGF2, TGFb, HGF, IL-6, BMP2, 
BMP4, and BMP6 mRNAs (Figure 4.4A), but not Reg4, GASTRIN, PTHrP, 
BETACELLULIN, GLP-1, TNFa, TNFp, IFNy, FGF21, BMP5, BMP7, or BMP9 
mRNAs (data not shown). Several molecules (IGFl, IGF2, HGF, NGF, SCF, BMP2, 
BMP4 and BMP6) appeared to show differential expression between and 
trimester LSCs by RT-PCR (data not shown). Therefore, real-time PCR was 
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performed, showing that IGFl (35-fold, P < .001), IGF2 (10-fold, P < .05), BMP4 (5-
fold，P < .05) and BMP6 (5-fold, P < .05) mRNA expression was much greater in T^ 
trimester LSCs than in trimester LSCs (Figure 4.4B). Within them, IGFl showed 
the most significant difference in expression so human fetal liver tissues were used to 
verify the difference. Human fetal liver tissues from trimester also had higher 
IGFl mRNA expression than trimester liver (10-fold, P < .001) (Figure 4.4C). In 
addition, IGFl ELISA demonstrated the presence of IGFl protein in both and 
trimester LSC-conditioned medium and conditioned medium from trimester LSCs 
had greater amounts of IGFl protein than conditioned medium from trimester 
LSCs (1.5-fold, P < .01) (Figure 4.4D). 
4.4.5 Characterization of IGFl receptors in PPCs and the effects of exogenous 
IGFl on PPC growth and ICC differentiation 
Expression of IGFlR, IGF2R, IGFl and IGF2 mRNAs was confirmed in fetal 
PPCs (9 -16 gestational weeks). Consistently, expression of the IGFIR protein, target 
functional receptors for IGFl and IGF2, was confirmed and located in the cell 
cytoplasm and at the cell membrane of PPCs (Figure 4.5A). As shown in Figure 4.5B, 
2nd trimester LSCs were found to have 100-fold (P < .001) higher levels of mRNA 
expression of IGFl than and trimester PPCs. 
Exogenous 50 ng/ml IGFl produced an augmentation of growth effect (1.5-
fold, P < .001) on ist trimester PPC but not trimester PPC (Figure 4.5C), thus, we 
have chosen trimester PPC for subsequent IGFl growth analysis. In the case of 
IGF2, both trimesters PPC also shows no significant change in cell viability (Figure 
4.5C). In addition, we have evaluated whether dose effect existed in both IGFl and 
IGF2 on ist trimester PPC cell viability. For IGFl, 50 ng/ml exerts the maximal effect 
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(1.5-fold, P < .001) (Figure 4.5D) while there is no dose dependent effect for IGF2 
(Figure 4.5E). 
Exogenous 1 ng/ml IGFl produced an augmentation effect on PDXl 
expression on trimester ICC (>7-fold, P < .05 vs. no IGFl control) but not 
trimester ICC (Figure 4.6A), thus, we have chosen trimester for subsequent IGFl 
differentiation analysis. In the case of IGF2, both trimesters ICC also shows no 
significant change in PDXl expression (Figure 4.6A). Following 1 ng/ml IGFl 
treatment, ICCs showed a significant upregulation in mRNA expression of such 
developmental genes as PDXl (8-fold, P < .01)，NGN3 (16-fold, P < .001), ISL-1 
(6.5-fold, P < .05), NKX2.2 (4-fold, P < .01)，NKX6.1 (11-fold, P < .01), NEUROD 
(15-fold, P < .05) (Figure 4.6B) as well as functional genes GLUCOKINASE (>40-
fold, P < .01) and INSULIN (10-fold, P < .01) (Figure 4.6C). In addition, we have 
evaluated whether dose effect existed in both IGFl and IGF2 on PDXl expression of 
2nd trimester ICC. For IGFl, 50 ng/ml exerts the maximal effect (20-fold, P < .001) 
while there is no dose dependent effect for IGF2 (Figure 4.6D and 4.6E). 
4.4.6 Neutralizing antibodies against IGFIR inhibit ICC differentiation 
Given that only IGFl but not IGF2 appears to have measurable effects on PPC 
growth and ICC differentiation, blockade of IGFIR using MAB391 neutralizing 
antibodies should selectively reveal the effects of IGFl on PPC growth and ICC 
differentiation. We observed that the growth effect triggered by 50 ng/ml IGFl on 
PPCs reported above was inhibited in the presence of .01 \ig/m\ MAB391 (Figure 
4.7A). The growth effects on PPCs triggered by LSC co-culture, however, were not 
inhibited by MAB391 (data not shown). Meanwhile, the enhanced expression of 
PDXl mRNA in ICCs induced by IGFl was reduced by 50% (P < .001) in the 
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presence of exogenously addition of 1 jig/ml MAB391 (Figure 4.7B). Exogenous 
addition of 1 |ig/ml MAB391 reduced PDXl mRNA expression to 33% of control 
levels in ICCs co-cultured with trimester LSCs (P < .001 vs. no MAB391) (Figure 
4.7D)，but not in ICCs co-cultured with trimester LSCs (Figure 4.7C). 
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4.5 Discussion 
This work is the first study to demonstrate that a co-culture system with 
primary LSCs isolated from human fetal liver can enhance PPC growth and ICC 
differentiation. There were several important aspects of our results that should be 
noteworthy. Firstly, we observed better differentiation using co-cultures with 
trimester fetal liver derived LSCs than with co-cultures containing trimester fetal 
liver derived LSCs. This LSC gestational-age effect should not be surprising given 
that glucagon and insulin are expressed in human endocrine cells during the 
trimester, but not during the trimester (Sarkar et al., 2008). The extreme rarity of 
abortions beyond 16 gestational weeks has so far precluded the possibility of 
conducting investigations employing cells from more mature fetal tissues. In addition, 
methodologically, it is important to observe that these enhancing effects were obtained 
in the absence of exogenous addition of growth factors. Moreover, the use of human 
cells, rather than mouse cells, avoids translational challenges related to inherent 
differences between human and mouse tissues (Joglekar et al., 2009). 
The human fetal liver stroma derived LSCs supporting PPC growth and ICC 
differentiation in the present study consisted of a cell population defined by cells 
adherent to culture plates and positive for the stromal cell marker vimentin 
(Krebsbach et al., 1999), the fetal liver cell markers Dlk, EpCAM, N-CAD, CK18, 
CK19 and CD45 (Zhang et al., 2008; Tanimizii et al, 2004; Jensen et al., 2004) and 
the primitive cell markers CD29, CD90, CD105, and CD 199 (Krebsbach et al., 1999), 
while being negative for AFP and albumin (hepatoblast and hepatocyte markers, 
respectively) (Zhang et al., 2008; Tanimizu et al., 2004; Jensen et al., 2004). The cell 
isolation and culture methods employed in these experiments were investigated 
extensively by other groups and the resultant LSC populations were found to be 
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capable of hematopoiesis (Lee et al., 2011; Ledran et al., 2008). Similar to 
hematopoiesis, we found that our LSC co-culture consistently improved ICC 
differentiation in the presence of differentiation cocktail, as evidenced by increased 
mRNA expression of developmental genes (PDXl, NGN3, NKX2.2, and NKX6.1) 
and functional genes (GLUCOKINASE and INSULIN). 
The present observations show that human fetal liver derived LSC co-culture 
enhances PPC cell number and viability as well as enhancing the expression of PPC-
derived ICC developmental and functional genes. These indicate that LSC co-culture 
increases PPC proliferation and induces ICC differentiation. In particular, 
trimester LSC, devoid of growth factors, were demonstrated to be capable of inducing 
greater upregulation of developmental and functional genes in ICC than 
differentiation cocktail previously described (Suen et aL, 2008; Ma et al., 2011; Ng et 
al., 2011; Leung et al., 2009). Moreover, differential expression of growth factors was 
found between and trimester LSC in our system. 
The discrepancy between and trimester LSC may be due to the difference in 
cell population as they were isolated from different gestational week livers with 
variable degree of maturity (Campagnoli et al., 2000; Terrace et al., 2009). As a result, 
further clarification of their identity would be useful for further investigations. 
Confirmation of ICCs with insulin-secreting ability is critical for translating 
scientific research into a clinical replacement therapy protocol. Although our co-
culture ICCs were able to secrete insulin in response to potassium, they had a limited 
or negligible glucose responsive capability, similar to cells differentiated under other 
directed differentiation protocols (Segev et al., 2004; Brolen et al., 2005). These 
results suggest that fetal LSCs alone, at least with the current protocol, cannot induce 
the formation of fully mature and functional ICCs. This may be due to the absence of 
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critical factors derived from a fully functional liver (e.g. vitamin A, D (Ng et al., 2011) 
in stellate cells and neuronal signals (Imai et al., 2008)), other supporters (e.g. 
epithelial cells of blood vessel (Ranjan et al., 2009; Lammert et al., 2001)), and others 
unknown reasons. With our preliminary efforts in seeking for additional supporter 
cells, it is plausible to propose that a mixed source of cells, i.e. LSC and bone marrow 
stromal cells (BMSC) co-culture, could enhance greater up-regulation of PDXl, 
NGN3, and GLUCOKINASE in ICCs than a single cell type (SuppL Figure 1 A). 
Immuno-property changes are an important consideration in the development of 
stem cell therapy. The slightly elevated MHC-I and MHC-II mRNA expression 
observed in ICCs after LSC co-culture may be due to further ICC maturation. As 
PPCs showed no drastic change in MHC-I and MHC-II mRNA expression, cells co-
culture obtained from different fetus appeared not to affect the immunogenicity. In 
combination with our previous study on reduced immunogenicity in trimester PPC 
(Ma et aL, 2011), an investigation into using and trimester PPC with LSC co-
culture, coupled with extra immuno-marker expression, would assist in reducing 
immuno-rej ection for future transplantation. 
RT-PCR experiments were used to screen for potential expression of 
developmentally critical candidate molecules. Of the many factors previously 
described as related to islet development or functions, (i.e., SCF, NGF, VEGFA, FGFl, 
FGF2, FGF7, IGFl, IGF2, TGFb, HGF, IL-6, BMP2, BMP4, BMP6) (Ranjan et aL, 
2009; Lammert et al., 2001; Li et aL, 2006; Kanaka-Gantenbein et al., 1995; Movassat 
et al., 2003; Ameri et al., 2010), we found that the expression of four molecules, i.e. 
IGFl, IGF2, BMP4, and BMP6, differs significantly between and 2"�trimester 
LSCs. Thus, the altered expression of these four factors could explain, at least in part, 
the LSC gestational age-related difference in enhancement of ICC differentiation. In 
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this regards, our subsequent experiments identified a positive role for IGFl and 
negative roles ofIGF2 and BMP4 in ICC differentiation (Suppl. Figure 4.IB & 4.1C). 
The present results provide additional interesting data on the effects of IGFl, 
which has previously been reported to be necessary for pancreatic regeneration but to 
inhibit pancreatic development (Yii et aL, 2003; Lu et al., 2004; Swenne et aL, 1987; 
Rabinovitch et al , 1982; Wang et al., 1995; Smith et aL, 1991; Warzecha et al, 2003; 
Kulkarni et aL, 2005). Contrary to reports of developmental inhibition in studies of 
liver IGFl-deficient (LID) (Yu et aL, 2003) and pancreas IGFl-deficient (PID) mice 
(Lu et aL, 2004), our data together with earlier findings from in vitro culture studies 
on rat fetal islets (Swenne et aL, 1987; Rabinovitch et al , 1982), suggest that IGFl 
enhances PPC growth and ICC differentiation. Notably, we showed here that IGFl 
enhanced growth of trimester PPCs and enhanced differentiation of trimester 
PPC-derived ICCs through IGFIR, but not vice versa. Hence, it appears that IGFl 
exerts different effects on stem cells from different stages of gestation; such stage-
specific effects may explain those apparently contradictory observations in 
regeneration and development of IGFl (Yu et al., 2003; Lu et aL, 2004; Swenne et al’， 
1987; Rabinovitch et al., 1982; Wang et al., 1995; Smith et aL, 1991; Warzecha et al., 
2003; Kulkarni et al., 2005). Different stem cells were identified in mature pancreas 
for regeneration (e.g. ductal stem cell (Wang et aL, 1995)) and during fetal 
development (e.g. mesenchymal stem cell in pancreas (Sarkar et al., 2008)). 
Since results obtained under culture conditions may not necessarily reflect the in 
vivo state, a rat neonatal streptozotocin regeneration model (Li et aL, 2004) was then 
designed to address this issue (Suppl. Figure 4.2A and 4.2B). Our preliminary data 
showed that IGFl expression in neonatal rat pancreas appears to temporarily increase 
(Suppl. Figure 4.2C), which was consistent with those in regenerating pancreas as 
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reported previously (Smith et al , 1991); these observations might be, at least partly, 
attributed to, stimulatory production of interleukin-10 that could be protective against 
inflammation (Warzecha et al., 2003). Interestingly, a temporary decrease in IGFl 
expression was detected in neonatal rat livers (SuppL Figure 4.2D) which may be 
related to regulation of homeostasis. However, IGFl expression in liver did not 
exhibit an appreciable change in the adult regeneration model (Smith et al, 1991). 
Therefore, the decrease we observed in neonatal rats could reflect the 'mimicking' 
action of fetal IGFl levels. Indeed, we found that ICCs exposed to higher levels of 
IGFl (100 ng/ml) have lower expression of PDXl than ICCs exposed to 50 ng/ml 
IGFl. Likewise, clinical studies have shown that human fetuses have lower 
circulating IGFl levels (30-50%) than adults (Mark et al., 2008; Bennett et al., 1983). 
Nevertheless, extensive investigations are required for further confirmation of our 
speculation. 
In conclusion, the present study has shown that human fetal LSC co-culture 
enhances PPC growth and ICC differentiation apparently through, at least in part, 
secretion of IGFl. Further investigations of the ability of stromal microenvironments 
in the induction of ICC differentiation are warranted, particularly with respect to 
determining how combining stromal cells from multiple sources may optimize in vitro 
induction of ICC differentiation. It is because optimal stromal-microenvironment has 
the potential for development into an efficient and cost-effective alternative, for 
obtaining transplantable ICCs, to the direct differentiation islet engineering and other 
stem cell therapies. 
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4.6 Supplementary Materials and Methods 
4.6.1 Cell preparation and culture 
Human fetal pancreata and livers used in these experiments were provided by 
the Department of Obstetrics and Gynecology at the Prince of Wales Hospital of the 
Chinese University of Hong Kong. The fetal organs were collected from fetuses 
obtained from surgical termination of pregnancy (STOP) by dilation and extraction at 
9 - 1 6 weeks of gestation (CREC-2005.461). 
PPC isolation and culture were performed as previously described (Suen et al., 
2008; Ma et al., 2011; Ng et al., 2011; Leung et al., 2009). Briefly, the pancreata were 
minced and digested in 3 mg/ml collagenase P (Roche, Mannheim, Germany) at 37 °C 
for 6 min. The digested cell mixtures were re-suspended in modified RPMI medium 
supplemented with 10% fetal bovine serum (Gibco Life Technologies, Inc., Grand 
Island, NY), 10 mM HEPES buffer, 1 mM sodium pyruvate, 71.5 [iM Beta-
mercaptoethanol (Sigma, St Louis, MO) solution with 100 U/ml of penicillin G and 
100 ^g/ml of streptomycin (Gibco Life Technologies, Inc., Grand Island, NY) in non-
adherent 60-mm dishes (Coming Incorporated, Coming, NY) at 37 Round and 
non-adherent cell clusters formed within 48 h of incubation and 20 ng/ml basic 
fibroblast growth factor (Sigma, St Louis, MO) and epidermal growth factor 
(Invitrogen, Carlsbad, CA) were used to induce PPC outgrowth. Cells from passages 3 
-10 were used for the experiments. 
All experiments were performed using LSCs prepared from one isolated 
human fetal liver. Briefly, the isolated liver was immersed in chilled DMEM/F12 1:1 
medium, and then minced and digested in 5 mg/ml collagenase A (Roche, Mannheim, 
Germany) at 37 for 60 min. The digested cell mixture was re-suspended in 
modified DMEM/F12 1:1 medium supplemented with 10% fetal bovine serum, 100 U 
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of penicillin G, and 100 [ig/m\ of streptomycin sulfate (Gibco Life Technologies, Inc., 
Grand Island, NY) in T75 culture flasks (Coming Incorporated, Coming, NY) at 37 
for 24 h. Non-adhesive cells were discarded and a monolayer of cells adhered to 
the culture flask. Upon reaching 80% confluence ( � 3 day), the monolayer of cells was 
harvested with TRYPLE (Gibco Life Technologies, Inc., Grand Island, NY) and 
replated for up to 20 passages. Cells from passages 3 - 1 0 were used for the 
experiments. 
Caco-2 cells were grown in EMEM medium (Sigma, St Louis, MO) 
supplemented with 2 mM Glutamine, 1% NEAA, 1% P/S, and 10% FBS, while 
hepG2 cells were grown in DMEM medium (Sigma, St Louis, MO) supplemented 
with 1% P/S and 10% FBS. The Caco-2 and hepG2 cells served as positive controls in 
the RT-PCR experiments. 
4.6.2 In vitro ICC differentiation 
PPC derived ICC differentiation was performed as previously reported (Suen 
et al., 2008; Ma et al., 2011; Ng et al., 2011; Leung et al., 2009). Briefly, PPCs (9 to 
15-week gestation) were trypsinized and suspended in ultra-low attachment plates 
(Corning Incorporated, Coming, NY) for 8-day differentiation in high glucose (11 
mM) DMEM/F12 medium supplemented with Ix B27, 0.05% bovine serum albumin 
(BSA)，10 ng/mL hepatic growth factor (HGF), 10 nM exendin-4, 500 pM 
betacellulin, and 10 mM nicrotinamide. LSCs were seeded on Transwells (Millipore 
Filter Corporation, Bedford, Mass.,) and co-cultured with ICC in ultra-low attachment 
plates (Corning Incorporated, Corning, NY) in high glucose (11 mM) DMEM/F12 1:1 
medium with a basal energy source (Ix B27, 0.05% BSA), with or without growth 
factors (differentiation cocktail), namely 10 ng/mL HGF, 10 nM exendin-4, 500 pM 
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betacellulin, and 10 mM nicrotinamide (Sigma, St Louis, MO). The formed ICCs 
were handpicked under an inverted microscope. 
4.6.3 RNA expression analysis 
Total RNA was extracted from PPCs, ICCs, and LSCs using Trizol (Invitrogen, 
Carlsbad, CA) according to the manufacturer's protocol. First strand cDNAs were 
reverse transcribed using Superscript III (Invitrogen, Carlsbad, CA) from 3 |ig of 
RNA in 20-|il reaction volumes. PGR was performed in 25-|il reactions with 1 \i\ of 
cDNA per reaction. Quantitative real-time PGR analyses of different genes were 
performed using an i-Cycler Thermal Cycle, version 3.1 (Bio-Rad Laboratory 
Incorporated, Munich, Germany). The reactions were performed in triplicate in 25-}xl 
volumes with 1 |il cDNA, SYBR Green PGR Master Mix (Bio-Rad Laboratory 
Incorporated, Munich, Germany), and 0.3 jiM of each primer (Invitrogen, Carlsbad, 
CA). Melt-curve data across temperature gradients (+0.5 °C every 10 s) were analyzed 
at the end of each RT-PCR experiment to guarantee the specificity of each amplified 
target PGR product. Amplification data were collected using an i-Cycler Detector and 
then analyzed using Sequence Detection System software. Transcript levels relative to 
those of P-actin were calculated using the comparative CT method, with fold change 
defined as 八ct Sequences of the primers employed in this study are listed in Table 1. 
4.6.4 Immunocytochemistry 
LSC and PPC monolayers were cultured on coverslips coated with 3% gelatin 
in PBS, and fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 
60 min at room temperature. Samples were permeabilized with 0.01% Triton-X in 1% 
BSA/PBS for 5 min at room temperature, blocked with 6% normal donkey serum in 
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1% BSA/PBS at room temperature for 1 h, and then incubated with rabbit anti-IGFlR 
(1:25 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-DLK (1:500 
dilution) (Abeam, Cambridge, UK), and rabbit anti-CD29 (1:100 dilution) (Abeam, 
Cambridge, UK) or mouse anti-CD90 (eBioscience, San Diego, CA), and mouse anti-
AFP (Santa Cruz Biotechnology, Santa Cruz, CA) or goat anti-albumin (Santa Cruz 
Biotechnology, CA) primary antibodies at 4°C overnight. After several PBS washes, 
the samples were incubated with Alexa Fluor 568 donkey anti-rabbit antibodies (1:500) 
(Invitrogen, Carlsbad, CA), FITC-conjugated anti-mouse (1:200) or anti-goat (1:300) 
secondary antibody (Jackson ImmunoResearch, PA, USA) at room temperature for 1 
h, and then incubated with 4',6'-diamidino-2-phenylindole (DAPI) (1:1000) 
(Invitrogen, Carlsbad, CA) for 15 min. Primary antibodies were omitted in negative 
controls. The slips were washed thoroughly with PBS several times, mounted in 
Vectashield, and imaged using a fluorescence microscope equipped with a DC 200 
digital camera (Leica Microsystems, Buffalo Grove, IL). Different images were 
captured separately at different laser wavelengths and superimposed fro examination. 
4.6.5 PPC viability and cell count assays 
PPCs were plated at 1.5 x 10^  cells per well in 6-well plates or 3 x lo"^  cells 
per well in 96-well plates with modified RPMI medium. Before LSC co-culture or 
treatment with human recombinant IGF1/IGF2 (Sigma, St. Louis, MO), PPCs were 
incubated in a serum free condition overnight to arrest the cell cycle. They were then 
co-cultured with LSCs or subjected to IGF1/IGF2 treatments (1, 10, 50, or 100 ng/ml) 
or MAB391 (0.001—10 ng/ml) (R&D Systems, Inc., Minneapolis, MN) plus IGFl (50 
ng/ml) for 3 d in modified RPMI medium with heat-inactivated FBS. 
The MTT assay (Sigma, St. Louis, MO) was performed in accordance with the 
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manufacturer's protocol. Briefly, after removal of the modified RPMI medium, the 
cells were incubated with MTT solution (0.05 mg/ml) for 2.5 - 4 h at 37°C under 5% 
CO2. The formazan that formed was immediately dissolved by addition of DMSO 
which was quantitated by measuring absorbance at 540 nm. For the cell counting 
assay, PPCs were visualized by Trypan Blue (Sigma, St. Louis, MO) and counted 
under a light microscope. 
4.6.6 IGFl and insulin ELISA 
LSCs were cultured under DMEM/F12 1:1 medium supplemented with IX 
B27 and 0.05% BSA, in the presence of high (11 mM) glucose. IGFl assays (Ray 
Biotech, Inc., Norcross, GA) were performed according to the manufacturer's 
protocol using medium that had been collected immediately, chilled in ice and added 
to wells that were kept 4 overnight. The remaining procedures were performed at 
room temperature. Excess solution was discarded and the cells were washed with 
assay kit's Wash Solution. Biotin antibodies were added to each well and allowed to 
incubate for 1 h. Again, the solution was discarded and the cells were washed with the 
assay kit's Wash Solution. Streptavidin solution was added to each well and allowed 
to incubate for 45 min. TMB One-Step Substrate Reagent was added and allowed to 
react for 30 min. Stop solution was added and absorbance was measured immediately 
at 540 run. 
ICCs that formed were rinsed in PBS and incubated in Krebs-Ringer buffer 
supplemented with 10 mM HEPES and 0.1% BSA for 90 min. The ICCs were then 
serially subjected to low and glucose/potassium conditions and the solutions were 
collected after each exposure. The collected solutions were analyzed using an 
ultrasensitive human insulin ELISA (Mercodia, Uppsala, Sweden) according to the 
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manufacturer's protocol at room temperature. The collected solution and enzyme-
conjugate solution were added to wells and incubated for 1 h. After discarding the 
excess solutions, and washing the ICCs with Wash Solution, substrate TMB was 
added to each well and allowed to develop for 30 min. Stop Solution was added and 
absorbance was measured immediately at 450 nm. ICCs were then lysed by 
Cytobuster Protein Extraction Reagent (Novagen, Darmstady, Germany) and total 
protein was quantified using a Bradford Assay (Bio-Rad Laboratory Incorporated, 
Munich, Germany). 
4.6.7 Western blotting analysis 
Total protein was extracted from PPC lysates using Cytobuster Protein 
Extraction Reagent (Novagen, Darmstady, Germany). Protein content was quantified 
using a Bradford Assay (Bio-Rad Laboratory Incorporated, Munich, Germany). 
Western blotting was carried out as previously described^ Briefly, total protein (10 
|ig/lane) was subjected to electrophoresis on a 12% (wt/vol) SDS-polyacrylamide gels 
and electrotransferred to nitrocellulose membranes (Bio-Rad Laboratory Incorporated, 
Munich, Germany). The membranes were blotted using 10% skim milk in 0.1% 
Tween-20 in PBS (Invitrogen, Carlsbad, CA) for 1 h at room temperature. The 
membranes were then incubated with rabbit anti-IGFlRb (c-20) (1:100 dilution) 
(Santa Cruz Biotechnology, Santa Cruz, CA) or mouse anti-beta-actin (1:8000 
dilution) (Abeam, Cambridge, UK), overnight at 4 followed by a peroxidase-
labeled anti-rabbit IgG antibody (1:2600 dilution) or anti-mouse IgG antibody (1:2500 
dilution) (Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at room temperature. 
Positive bands were revealed using Enhanced Chemiluminescense (ECL) detection 
reagents and autoradiography film (Amersham Pharmacia Biotechnology, 
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Buckinghamshire, UK). 
4.6.8 Neonatal streptozotocin regeneration model 
Pregnant Sprague-Dawley rats (time in pregnancy, TP-17) were obtained and 
caged individually with free access to standard diet and water. They were checked 
regularly from 09:00 to 18:00 daily for delivery of pups. One-day-old neonates were 
injected intraperitoneally with 100|ig/kg body wt of streptozotocin (STZ) (Sigma, St. 
Louis, MO) freshly dissolved in 0.05mmol/l citrate buffer (pH 4.5). Blood glucose of 
all neonates after STZ treatment was measured by glucometer (Bayer Corp., 
Tarrytown, NY). Only those with blood glucose ranged l l . lmM - 19.44mM after the 
day of STZ treatment were used for subsequent experiments. RNA of pancreata and 
livers of neonates were collected and stored at for realtime PCR analysis. Every 
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Figure 4.1 Characterization of LSCs isolated from human fetal liver.. 
All PPC (N 二 3) and LSC (N = 3) ranged from 9 - 1 5 weeks were used for all the experiment. (A) 
Fibroblast-like shaped LSCs on plastic culture dishes. (B) Expression of selected liver precursors (CK18, 
CK19, Ep-CAM, N-CAD and CD45) and stromal cell markers (CD90, CD105, CD 166 and VIMENTIN) was 
detected by RT-PCR while hepatoblast and hepatocyte markers (AFP and ALBUMIN) were not expressed. (C) 
Expression of DLK, CD29, CD90, AFP and albumin was examined by immunocytochemistry, where DLK, 
CD29 and CD90 were positively expressed and located in the cell cytoplasm and cell membrane while AFP 
and albumin were negatively expressed. Magnification of objective lens at lOx’ 40x, and 63x. 
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Figure 4.2 LSC co-culture enhances PPC growth and promotes ICC differentiation in the presence of 
differentiation cocktail. 
All PPC (N : 3) and LSC (N : 3) ranged from 9—16 weeks were used for the experiment unless specified as 
ist and 2nd trimester LSC (N = 3 from each group). In general, (A) MTT metabolism and (B) cell number 
increase while co-culture with LSC and MTT metabolism (1.5-fold) and cell number (4.5-fold) peaked at 
LSC co-culture with 8 x 104 cells. (C) MTT metabolism and (D) cell number were not significantly changed 
in PPCs when co-cultures with 1st and 2nd trimester LSCs. ICCs incubated in LSC co-cultures with a 
differentiation cocktail were found to have higher mRNA expression levels of (E) several developmental 
markers (PDXl, NGN3, NKX2.2 and NKX6.1) and (F) functional genes (GLUCOKINASE and INSULIN) 
than ICCs induced by differentiation cocktail alone. All data are expressed as means 士 SEM for three 
experiments in each group. *p < .05, **p < .01 and ***p < .001 vs. Control. 
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Figure 4.3 Characterization of ICCs grown in LSC co-culture. 
All PPC (N=3) ranged from 9—16 weeks were used for the experiment while LSC were divided into and 
2nd trimester (N 二 3 from each group). (A) Expression of developmental genes (PDXl, NGN3, ISL-1, 
NKX2.2, NKX6.1 and NEUROD) and (B) functional genes (GLUCOKINASE and INSULIN) in ICCs 
co-cultured with 1st trimester LSCs in the absence of differentiation cocktails only a slight up-regulation from 
that of ICCs induced by differentiation cocktails (Control) while co-cultured with 2nd trimester LSCs showed 
a significant up-regulation. Compared to Control, ICC with LSC co-cultures were found to have (C) higher 
basal insulin secretion level and (D) better response to KSIS. The mRNA expression of MHC-I and MHC-II 
in both (E) PPCs and (F) ICCs incubated in LSC co-cultures were not significantly altered relative to 
non-co-culture Control. All data are expressed as means 士 SEM for three experiments in each group. *p < .05, 
**p < .01 and ***p < .001 vs. Control. 
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Figure 4.4 Expression of selected cytokines and growth factors in LSCs derived from 1st and 2nd trimester 
livers. 
LSC used in this part were divided into and trimester (N = 3 from each group), (A) mRNA expression 
profile of selected cytokines and growth factors (SCF, NGF, VEGFA, FGFl, FGF2, FGF7, IGFl, IGF2, TGFb, 
HGF, IL-6, BMP2, BMP4 and BMP6) in LSCs by RT-PCR. (B) Differential expression of selected cytokines 
and growth factors (IGFl, IGF2, HGF, NGF, SCF, BMP2, BMP4 and BMP6) between 1st and 2nd trimester 
LSCs. (C) Greater IGFl mRNA expression in 2nd trimester versus 1st trimester human fetal livers. (D) The 
IGFl protein content in 2nd trimester LSC conditioned medium was greater than that in 1st trimester LSC 
conditioned medium. All data were expressed as means 士 SEM; N = 3 per group. *p < .05, **p < .01 and 
***p < .001 vs. 1st trimester LSCs. 
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Figure 4.5 IGFIR characterization in PPC and IGFl but not IGF2 enhances PPC growth. 
PPC and LSC used in this part were divided into 1st and 2nd trimester (N = 3 from each group). (A) 
Expression of IGFIR, IGF2R, IGFl, and IGF2 mRNA, IGFIR proteins, and their localization in PPCs. (B) 
Differential expression of IGFl in PPC and LSC derived from 1st and 2nd trimester fetal tissues. (C) Growth 
effect of PPC was only observed in 1st trimester PPC but not 2nd trimester PPC. (D) Dose dependent effect of 
IGFl and (E) no effect of IGF2 on PPC viability as indexed by MTT metabolism. All data are expressed as 
means 士 SEM; N = 3 per group. *p < .05，**p < .01 and ***p < .001 vs. Control. 
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Figure 4.6 IGFl but not IGF2 enhances PPC derived ICC differentiation. 
PPC used in this part were divided into 1st and 2nd trimester (N = 3 from each group). (A) Enhanced PDXl 
expression was only observed in 2nd trimester ICC but not 1st trimester ICC. (B) Dose dependent effects of 
IGFl and (C) no effect of IGF2 on PDXl expression in ICC was observed. ICCs that were differentiated 
under the influence of exogenous IGFl (1 ng/ml) had higher expression levels of several (D) developmental 
markers (PDXl, NGN3, ISL-1, NKX2.2, NKX6.1 and NEUROD) and (E) functional genes 
(GLUCOKINASE and INSULIN) than ICCs that were differentiated in the absence of exogenous IGFl 
(Control). All data are expressed as means 士 SEM; N = 3 per group. *p < .05, **p < .01 and ***p < .001 vs. 
Control. 
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Figure 4.7 The IGFIR neutralizing antibody MAB391 inhibits PPC growth and ICC differentiation. 
PPC used in (A) was derived from trimester while in (B) was derived from 2"廿 trimester. In (C) and (D), 
PPC used were ranged from 9 -15 weeks. (A) The growth effect of IGFl (50 ng/ml) on PPCs was inhibited in 
the presence of MAB391 (.01 — 10 fig/ml). (B) The enhanced PDXl expression in ICCs produced by IGFl (1 
ng/ml) was inhibited in the presence of MAB391 (1 ^ig/ml). Addition of MAB391 (1 |Lig/ml) (C) had no effect 
on PDXl mRNA expression in ICCs with 1st trimester LSC co-cultures but (D) reduced PDXl mRNA 
expression in ICCs with 2nd trimester LSC co-cultures. All data are expressed as means 士 SEM for three 
experiments in each group. *p < .05, **p < .01 and ***p < .001 vs. IGFl treatment group while #p < .05,冊p 
< .01 and ###p < .001 vs. Control. 
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Supplementary Figure 4.1 Effects of BM co-culture microenvironment and BMP4 on ICC differentiation. 
PPC. LSC and BM (N=3) were derived from 9 — 20 gestational weeks. (A) A combined LSC plus bone 
marrow stromal cell (BMSC) co-culture upregulated developmental markers and functional genes (PDXl, 
NGN3 and GLUCOKINASE) more than co-culture with either alone. (B) Exogenous addition of BMP4 (5 
ng/ml and 40 ng/ml) triggers phosphorylation of Smadl,5,8 in PPCs. (C) Exogenous addition of BMP4 (10 
ng/ml) had no significant effects on PDXl expression in ICCs. Each value represents the mean 士 SEM of 
three separate experiments. *p < .05, **p < .01 and < .001, vs. Control group. 
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Supplementary Figure 4.2 Expression profile of IGFl in pancreas and liver across 6 days of neonatal 
regeneration 
(A) One-day-old rat pups received injections of STZ (100 |Lig/kg) and their change of plasma glucose 
concentration was measured and peaked at day 2 after STZ treatment. (B) Ngn3 mRNA expression was 
assessed daily across 6 day of regeneration and peaked at d04 after STZ injection. IGFl mRNA expression 
profile in (C) liver and (D) pancreas across the 6-day regeneration period. Each value represents the mean 士 
SEM of three separate experiments. *p < .05, **p < .01 and ***p < .001, vs. dayO or Control group. 
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House keeping gene Fonvard Primer Backward Primer Temp Size Reference 
hp-act in TGGCACCACACCTTCTACMTGAGC GCACAiGCTTCTCClTMTGTCACGC / / 15 
hp-act in TGTCCACCTTCCAGCAGATGT CGGACTCGTCATACTCCTGC^ / / 15 
rp-act in AGCTATGAGCTGCCTGACG GGATGCCACAGGAHCCA / / 61 
Expression d rat gene 
rlGF-1 AAGCCTACAAAGTCAGCTCG GGTCTTGTTTCCTGCACTTC / / 62 
rlGF-1R A M ACC ATC GAT TCT GTG ACG GGT TCT TCA GGA AGG ACA AGG / / 62 
rNgn3 TGGCGCCTCATCCCTT6GATG CAGTCACCTGCTTCTGCTTCG / / 63 
Characterization d LSC 
h E p - C _ GCTCTGAGCGAGTGAGMCC ACGCGTTGTGATCTCCTTCT 60 116 / 
hN-cadherin CCTCCATGTGCCGGATAG AATGCGMTTCACCAGMGC 50 97 / 
hVimentin AAGCAGGAGTCCACTGAGTACC GAAGGTGACGAGCCAnTCC / / 64 
hCD45 AGC^CCTACCCTGCTCAGM TTCAGCCT6TTCCTTTGCTT / / 65 
hCD90 ATGMCCTGGCCATCAGCATCG CACGAGGTGTTCTGAGCCAGCA / / 65 
hCD105 GAAACAGTCCAnGTGACCTTCAG GATGGCAGCTCTGTGGTGTTGACC / / 65 
hCD166 TGATCTCCGCCACCGTCTTCAG CTCTTTTCATCACTGATCCTTGCA / / 65 
hAFP G C A W C T G A A M T G C A G T T 6 A GGAMGTTCGGGTCCC/WA / / 66 
hAlbumin CCAGGMGACATCCTTTGC CCTGAGCCAGAGATTTCC / / 67 
hCK19 AGGTGGAnCCGCTCCGGGCA ATCTTCCTGTCCCTCGAGCA / / 67 
hCK18 TGGTCACCACACAGTCTGCT CCAAGGCATCACCAAGATTA / / 67 
Expression d soluble factors 
hHGF C G AGG C C ATGGTG CTATACT n C T C C ^ G A C C ^ G G A T G C 60 134 / 
hVEGFA CCTGCAAMACACAGACTCG GAGAGATCTGGTTCCCGAM 60 137 / 
hlGF1 GGAGGCTGGAGATGTATTGC GCCMCCTTTCCTTCTCTGA 60 150 / 
hlGF2 CGTTGAGGAGTGCTGnrCC GGGGTATCTGGGGAAGTTGT 60 130 / 
hSCF ACACCACTGTTTGTGCTGGA GATTCCTGCAGATCCCnCA BO 134 / 
hGLP-1 CG^CCCTTCAAGACACAGAG GTGMTGTGCCCTGTGAATG 62 125 I 
hPro-BTC TGGGMTTCCACCAGA/CTC CCnTCCGCTTTGATTGTGT 59 96 / 
hReg4 AGGAGGMGATGGCnCCAG GGTAAMCCATCCAGGAGCA 62 118 / 
hFGFI GGGCTTTTATACGGCTCACA CTTGAGGCCMCAAACCMT 60 126 / 
hFGF2 TGGCTATGAAiGGA/VSATGGM ACTGCCCAGnCGTTTCAGT 60 150 I 
hFGF7 CAGGCAG^CMCAGACATGG CAGTTGCTGTGACGCTGTTT 60 87 / 
hNGF AGTGGTCGTGCAGTCCAAG GTGGCCAGGATAGAMGCTG 60 108 / 
hGastrin CCAGCCTCTCATCATCGAA TC CATC CATC CATAGG CTTC 62 119 / 
hPTHrP GCTCMGACACCTGGGA^ A GGASGTGTCAGACAGGTGGT 62 145 / 
hlFNg TOAGCTCTGCATCGTTTTG TCCGCTACATCTGMTGACCT 60 112 / 
hlL6 GGCTGAAAAAGATGGATGCT G CTCTG GCTTGTTCCTC ACT 60 141 / 
hFGF21 ACCTGGAGATCAGGGAGGAT GCACAGGMCCTGGATGTCT 59 131 / 
hTGFa CCCTGGCTGTCCTTATCATC CTGTTTCTGAGTGGCAGCAA 59 147 / 
hTGFb! GCAGGGATMCACACTGCM GGCCATGAGAAGCA3GM 60 107 / 
hTGFb2 ACMCACCCTCTGGCTCAGT CTCCATTGCTGAGACGTCM 60 135 / 
hTGFb3 AGGAGATGCATGGGGAGAG TTTAGGGC^GACASCCAGTT 60 134 / 
hTNFa TCAGCCTCTTCTCCTTCCTG GCCAGAGGGCTGATTAGAGA 60 124 / 
hTNFb MCCTGCTGCTCACCTCAn TGCTCMGGAGAAACCATCC 60 102 / 
hBMP2 CGCAGCnCCACCATGMGAA CCTGMGCTCTGCTGAGGTGATA / / 68 
hBMP4 AGGAGCTTCCACCACGMGAAC T G G M G C C C C m C C C M T C A G / / 69 
hBMPB GTGMCCTGGTGGA3TACGACM AGGTCAGA3TCTCTGTGCTGATG / / 69 
hBMP5 m n C M G G C G A G T G A G G T AGGCITTGGTACGTGGTCAG / / 70 
hBMP7 CAG^GCATCMCCCCMGTT AGG^TGACGTTGGAGCTGTC / / 70 
hBMPg TGTACAACAGGTACACGTCCG TGMTGTCCTGGGACACCAG / / 69 
Characterization of PPC 
hIGFRl AGGATGCACCATCnCMGG MTGGCGGATCnCACGTAG 60 125 / 
hlGFR2 GGCCCTGHGCTCTACMGA CCATCAGCCACTCTGTTTCA 60 149 I 
Developmental markers of ICC 
hPDXI ACTCCACCTTGGGACCTGTTT TTMGGTACTCGGCCCAGCTT / / 15 
hNGN3 TGTGGGTGCTAAGGGTMGG G G G A G M G C A G M G G M C M / / 15 
hNEUROD TCCAAAATCGA3ACTCTGCGC G C / i M 3 C G T C T G M C G M G G A / / 15 
hlSL-1 GATCAAATGCGCCAAGTGCAG C A G C G G A A A C A C T C G A T G T G A / / 15 
hNKX2 2 TCTCCTTGGAGTGGCA.GATTC AMCACGGCGTAGAGTTCAGC / / 15 
hNKXB.1 GACGGGAASAGMAACACACG ACTCTCTGTCATCCCCAACGA / / 15 
hGLUCOKINASE CTCCATGGGGMGTGCTC CACCGAAAMCTGAJ3GGAAG / / 15 
hINSULIN CAGCCTTTGTGMCCMCACC G G T C H G G G T G T G T A G M G W C / / 15 
Table 4.1 Sequence of the specific PCR primers and their expected product size of different target genes. 
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5.1 General Discussion 
Diabetes, characterized by insufficient insulin for glycemic control due to the 
absence or malfunctioning j3 -cells (Alsaleh et al., 2010; Vantyghem et al., 2011; 
Richter et al., 2011) can be treated by replacement therapy such as insulin injection, 
pancreas transplantation and islet transplantation (Vantyghem et al., 2011). However, 
due to unphysiological nature and difficulty in glycemic control, insulin injection is 
not a very suitable replacement therapy. Comparatively, transplantation of pancreas or 
islets provides a physiological and reliable glycemic control as well as minimizing 
chronic complications arsing from diabetes (Vantyghem et al., 2011; Richter et al., 
2011). Yet, owing to the lack of pancreas or islets donations, transplantation is 
hampered and alternative substitution is required. Intensive research has been focused 
on newly developed stem cell therapy (Hori et al., 2009) and many laboratories have 
paid considerable time and effort in islet engineering; yet, there are still a lot of 
difficulties encountered (Leung et al., 2009; D'Amour et al., 2006; Segev et al., 2004; 
Brolen et al., 2005); they include, for example, unresponsiveness to glucose, 
inefficient and complicate stepwise induction process, as well as involvement of 
costly growth factors (Leung et al, 2009; D'Amour et al., 2006; Segev et al., 2004). 
These issues have adversely affected the clinical applications of islet engineering for 
transplantation. 
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Existence of the differences in islet architecture and differential flexibility for 
differentiation of ESC derived from different species make research difficult to 
directly translate to human. Avoidance of translational challenge (Joglekar et al., 
2009; Cabrera et al , 2006), it is plausible to use stem cells that derived from human. 
In view of the less flexibility of adult stem cells and tumoriogenecity of ESCs, we 
have used human fetal pancreas derived PPC and fetal liver derived LSC, which strike 
a balance between flexibility and tumoriogenecity, to address our hypothesis in this 
study. 
In view of the lacking of pancreatic developmental clues in relations to vitamin A, 
vitamin D and liver stroma, we have firstly investigated the potential roles of vitamin 
A and vitamin D and their interactions in regulating islet cell development. Secondly, 
we have investigated effects of the presence of LSC on ICC differentiation. To our 
surprised, LSC microenvironment can be made used as a novel induction technique 
devoid of exogenous addition of growth factors for islet engineering with higher 
efficiency, convenience and economy. The data we obtained may contribute to future 
direction and formulation of islet engineering. 
5.1.1 Proliferative effects and enhanced expression of NGN3 by vitamin A 
and vitamin D 
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The expression of RAR, RXR and VDR in the nucleus, cytoplasm and plasma 
membrane has indicated that their respective ligands, atRA and calcitriol, may exert 
certain effects in PPC. With no variations in expression of these receptors between 
different gestational age of PPC donors, vitamins A and D are likely to have 
consistent actions in PPC preparations from 9 to 15 weeks gestational age donors. 
Interestingly, down regulatory system, CYP26 and CYP24, catabolic enzymes of 
vitamin A and vitamin D, respectively, were not detected in PPCs. It has been 
reported that vitamin A and vitamin D act in an antagonistic manner (Rohde et al., 
2005), however, this was not true in our case. This may be explained by the existence 
of another regulatory system or their metabolic enzymes are only expressed in the 
presence of their respective ligands (Feldman et al., 2005; Ozpolat et al., 2005) that 
required further investigations. 
In consistent with the known dose-dependent effects of morphogen, atRA (Toed 
et al., 1996), PPCs also exerted differential growth effects across different 
concentration of atRA M), peaking at The increase in viability 
was partially contributed to cell proliferative and anti-apoptotic effect. Different from 
atRA, calcitriol only exerted growth effect on PPC at concentrations of lO'^^-lO'^'^M, 
i.e. about the physiological level of fetal serum (Tsang et al., 1981) and its effect was 
via cell proliferation. 
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As there are no effective commercial blockers or antagonists available for RAR 
and VDR, it is difficult to determine their functional roles with their ligands. However, 
up-regulation of RAR and VDR expression in response to atRA and calcitriol, 
respectively, suggests that atRA and calcitriol exert their effects probably via binding 
to response elements by respective receptors (Feldman et al., 2005; Tsang et al” 1981). 
Alternatively, atRA and calcitriol could up-regulate both RAR and VDR and, possibly, 
this might provide an insight into the signaling cooperation of atRA and calcitriol. 
Unexpectedly, no enhance viability was observed in PPC after co-addition of 
atRA and calcitriol; this may be due to the antagonistic effects of atRA and calcitriol 
(Rohde et al., 2005). Yet, as they could cross-activated the expression of RAR and 
VDR, antagonistic effect should not be applied in our case. On the other hand, it is 
well believed that proliferation and differentiation cannot exist together and they are 
antagonistic. In view of this fact, we have analyzed the expression of some 
developmental markers and, in this case, NGN3, a critical marker for specification of 
endocrine lineage during islet development (Rukstalis et al., 2009) was selected. After 
co-treatment of atRA and calcitriol, NGN3 expression in PPCs increased to more than 
6-fold. This implied that they are not antagonistic, instead, in the presence of 
complementary molecules, they can switch on mechanism of the specification of 
endocrine lineage. 
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Cod-liver oil, a natural supplement of vitamin A and vitamin D, is recommended 
in infants and children for a long time for its beneficial effects on growth (Masterjohn 
et al., 2009). However, due to recent findings on vitamin A's teratogenicity (Werler et 
al., 1996), vitamin D supplement along should be used instead. However, based on 
our result, policy of giving vitamin D supplementation along during pregnancy would 
need an adjustment. As specification of endocrine cells occurs within 20 — 23 weeks 
of gestation (Sarkar et al., 2008), intake of cod liver oil at this stage might be 
supportive for endocrine islets cell formation. 
5.1.2 Induction of PPC derived ICC by LSCs 
It is the first time that we have established a human fetal liver derived LSC 
microenvironment which is able to direct human fetal pancreas derived PPCs into 
insulin-secreting ICC within an 8-day protocol. This newly developed method is 
based on our previous study in directing specification of endocrine lineage of PPCs, 
via enhanced expression of NGN3, by combination treatment of vitamin A and 
vitamin D (Ng et al., 2011) and in additional to they are regulated by adult and fetal 
livers by transport and storage function (Senoo et al., 2010; Lehmann et al, 2010; 
Kubota et al., 2007; Gascon-Barre et al., 2001). In light of this background, it prompts 
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US to our investigation into the effects of LSC microenvironment on the PPC 
proliferation and differentiation into ICCs. 
In this study, we have employed a human fetal liver stroma, or stem cell niche, 
which is a supportive unit for growth and development. Although there is no concrete 
ways for characterization at the moment, isolation and culture methods are well 
studied and the resultant cell population is consistently found supportive for 
hematopoiesis (Chagraoui et al., 2003). In the presence of differentiation cocktails, 
LSC consistently improved ICC differentiation evidenced by the increase expression 
of developmental (PDXl，NGN3, NKX2.2 and NKX6.1) and functional marker genes 
(GLUCOKINASE and INSULIN). 
First of all, we have to optimize various conditions so as to establish the 
co-culture model. In order to prevent blockage of transwell and depletion of resources 
in medium by cell overgrowth, optimal cell number (8 x lO* cells) of LSC were 
exposed to 8000 rad to stop its proliferation. To avoid negative effect of co-culture, 
PPC cell viability under co-culture was also determined. Surprisingly, co-culture of 
LSC could enhance their viability. Afterwards, LSCs were separated into (9 - 12 
wk) and trimester (13 — 16 wk) as derived from different gestational weeks of 
human fetus as previously reported (Suen et al., 2008). There was no differential 
growth in PPCs between and trimester LSC co-culture. 
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With the success for the establishment of our co-culture model, LSCs were used to 
induce PPC-derived ICC differentiation. In the presence of growth factors, ICCs 
formed expressed developmental genes (PDXl, NGN3, ISL-1, NEUROD, NKX2.2, 
NKX6.1) and functional genes (GLUCOKINASE and INSULIN). In the absence of 
growth factors, LSC co-culture could still induce ICC differentiation. When compared 
to differentiation cocktail induction, trimester LSC could enhance significantly the 
expression of developmental and functional genes expression. To confirm the 
resultant ICCs functions, glucose-stimulated insulin secretion (GSIS) and 
potassium-stimulated insulin secretion (KSIS) were examined. In consistent with the 
gene expression profile, trimester co-culture LSC had higher basal insulin 
secretion levels. Despite the unresponsiveness to glucose, there was a significant 
change in KSIS. This means that trimester LSC could improve functions of ICC. 
In order to determine identities of growth factors or cytokines involved in 
enhancing differentiation, the expression of some growth factors was further analyzed 
in LSCs. In this regard, SCF, HGF, NGF, VEGF A, FGFl, FGF2, FGF7, IGFl, IGF2, 
TGFb, IL-6, BMP2, BMP4 and BMP6 genes were expressed and some of them were 
reported necessary for islet development (Ranjaii et al., 2009; Lamniert et al., 2001; 
Li et a l , 2006: K an a k a - G ant e iibe in et a!” 1995; Movassat et a l , 2003: Ameri et al.. 
2010). 
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5.1.3 Potential effects of liver stroma derived IGFl on PPC derived ICC 
differentiation 
Making use of the differential effects of and trimester LSC in ICC induction, 
differential mRNA expression of IGFl, IGF2, BMP4 and BMP6 between and 
trimester LSC was found. They were then exogenous added into the differentiation 
cocktails to investigate their effects alone. We have identified positive roles of IGFl 
and negative roles of IGF2 and BMP4 by examining the change in expression of 
PDXl. IGFl enhanced PDXl expression in ICC while others show no observable 
change. 
9 - 1 5 week derived PPCs showed a positive mRNA expression of IGFl, IGF2, 
IGFIR and IGF2R. The IGFIR protein that binds to both IGFl and IGF2 was 
localized at the cell cytoplasm and cell membrane of the PPCs. Application of 
exogenous IGFl (1 — 100 ng/ml) to the PPCs showed an increase in cell viability at a 
concentration of 50 ng/ml while PPC-derived ICCs had an increased expression of 
PDXl, peaked at 50 ng/ml. When PPCs were separated into and trimester, the 
growth response of IGFl was observed only in trimester PPC while differentiation 
response was observe only in trimester PPC derived ICC but not vice versa. 
As IGFl, but not IGF2, enhances PPC growth and ICC differentiation, blockage 
of IGFIR would reveal IGFl effects only (Hiden et al., 2009). To address this issue, 
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we used MAB391 neutralizing antibodies for IGFIR to block the effect via IGFIR. 
Growth effect triggered by 50ng/ml IGFl on PPCs was inhibited at .0lug/ml 
MAB391. However, growth effect triggered by LSC co-culture was not inhibited. 
These observations may be due to presence of other growth factors which can also 
trigger proliferation effects. 
Besides, the enhanced expression of PDXl by IGFl was reduced in ICC by 
MAB391. With exogenous addition of MAB391, there was no significant change in 
PDXl expression in ICCs under trimester LSC co-culture while PDXl mRNA 
expression was reduced to 33% (P < .001) in ICCs under trimester LSC co-culture. 
These data indicates that the better induction by trimester LSC was, at least, partly 
attributable to IGFL 
From previous studies of Liver IGFl Deficient (LID) (Yu et al., 2003) and 
Pancreas IGFl Deficient (PID) (Lu et al., 2004) mice, IGFl was necessary for 
pancreatic regeneration while inhibiting pancreatic development. In our in vitro 
culture results, IGFl enhanced growth in trimester PPC and enhanced 
differentiation in trimester PPC-derived ICCs through IGFIR but not vice versa. 
From this, we hypothesize that IGFl exerts different effects on different stages of 
stem cells which explain the contractive results for regeneration and differentiation as 
the stem cells during regeneration and development are at different origin and stages. 
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Since results obtained under culture condition may not necessarily reflect in vivo 
condition, a rat neonatal STZ regeneration model has been used. Similarly to other 
pancreas regeneration model, IGFl mRNA expression in pancreas has increased 
significantly for anti-inflammatory response (Smith et al., 1991). However, IGFl 
mRNA expression in the liver has been decreased 2 to 3-fold after STZ injection. 
Change in IGFl expression in liver and pancreas during pancreatic regeneration are in 
parallel with each other. This may be due to homeostasis regulation by liver in 
response to rise in IGFl level; however, since in adult pancreatic regeneration model, 
IGFl expression in the liver does not change, homeostasis regulation fails to explain 
the situation (Smith et al., 1991). Alternatively, the decrease of IGFl in liver in 
neonates regeneration model may due to mimicking of IGFl level in fetal 
development. From our result, we found that ICC exposed to higher level of IGFl 
(100 ng/ml) may decrease PDXl expression comparing to 50 ng/ml IGFl and clinical 
studies showed that fetus has lower IGFl circular level than adult (Mark et al., 2008; 
Bennett et al., 1983). Further investigation is required for confirmation of the 
hypothesis. 
5.1.4 Significance of islet engineering in the management of diabetes 
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Replacement of deficient, damaged or malfunctioning islets by transplantation is 
undoubtedly the most effective and promising approach in treating and curing 
diabetes. Considerable clinical cases have reported that patients with successful 
transplantation under immunosuppression can lead to an insulin-independent life for a 
long period of time (Merani et aL, 2006). In this respect, successful islet 
transplantation depends on several critical factors; they include, but are not limited to, 
sufficient number of islets, islet durability and islet functionality after islet transplant 
(Ryan et al., 2002). Therefore, it is in desperate need to search for renewable and 
unlimited source as well functional islets in response to glucose challenge for clinical 
islet transplantation in patients with diabetes. 
In this study, we have attempted to examine three such critical factors as vitamin 
A, vitamin D and liver microenvironment that are essential to get involved in the 
involution of PPC growth, ICC differentiation and ICC functionality. Taken all data 
together from this study, we propose that vitamin A, vitamin D, IGFl and several 
other inductive molecules derived from LSCs should be considered to introduce into a 
differentiation cocktail for direct differentiation of PPCs into ICCs as well as inducing 
functionally insulin-producing islet cell for clinical transplantation. On the other hand, 
further modifications of the microenvironment induction approach could be achieved 
by the application of other supporter cells, notably the bone marrow stromal cells. 
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Such a stem cell niche for islet cell development may offer an alternative, efficient 
and cost-effective approach in providing islet transplantation for the management of 
diabetic patients. 
5.1.5 Conclusions 
In the present study, RAR, VDR and RXR are found to exist in PPCs and their 
respective ligands, vitamin A and vitamin D are involved in PPC proliferation while 
combination treatment can up-regulate NGN3 expression in PPC. On the other hand, 
LSCs derived from human fetal liver can induce ICC differentiation with or without 
the presence of differentiation cocktails. These observations are due, at least partly, to 
the growth factors produced by LSCs and IGFl is identified as being one of the 
inductive molecules and responsible for these effects. 
In summary, vitamin A, vitamin D and LSC play a critical role for the 
development of human fetal derived PPCs into ICCs, thus providing a potential for 
clinical islet transplantation in patients with type 1 diabetes and some severe forms of 
type 2 diabetes. 
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5.2 Future Studies 
As mentioned, vitamin A and vitamin D can enhance PPC proliferation and 
NGN3 expression. However, the underlying mechanism(s) whereby they are involved 
with particular reference to their interactions during islet cell development remains to 
be fully elucidated. In addition, it is worthwhile further investigating their effects in 
PPC-derived ICC differentiation so as to confirm their roles in islet development. 
Based on the idea of LSC enhanced ICC differentiation through secretion of 
secret factors, it is advisable to screen these factors in 3 levels, i.e. proteins, small 
molecules and miRNA. Total protein content could be screen by the use of 2D gel 
electrophoresis and Mass Spectrometry while small molecules can be screened by 
Mass Spectrometry after filtering. Besides, miRNA and change in gene expression 
should be screened using microarray. Through studying of these 3 levels, all required 
components and their in-depth knowledge of interactions could be found. 
Apart from the studies of LSC, it is also interesting to study if other potential cell 
sources from different organs, which are closely related to the pancreatic development, 
involves in the maturation of ICC. Based on other researches on the isolation 
techniques of different cells, we can co-culture them with PPC to examine whether 
they are involved. Afterwards, isolating specific cell types using Flow Cytometry and 
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converting them into cell line could make the experiment easily repeatable and thus, 
clinical applications would be viable. 
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